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ABSTRACT
Cell adhesion is an intricate process, involving proteins o f the extracellular matrix, 
cell surface receptors for these proteins and a complex interplay o f physical, 
biochemical and cytoskeletal events. This may affect the cell itself, the substrate to 
which the cell will attach or the environment in which cells grow. Although 
morphological studies o f cell adhesion have been made in exquisite detail, such results 
are only qualitatively useful in predicting cell-substratum compatibility. Usually a 
quantitative cell adhesion is measured by subjecting the attached cells to the 
hydrodynamic forces for detachment from the surface Unfortunately a very few  
quantitative methods o f cell adhesion measurement have been proposed but they all 
suffer from the need for complex equipment Moreover, the reproducibility o f these 
methods remained a dream due to uncontrolled, limited (in their ranges) and 
indefinable forces produced by the devices used in these methods. In the present work 
these dreams became reality when a simple and reproducible cell adhesion measuring 
device "Microflow chamber" has been developed which produces a wide range o f  
hydrodynamic forces for cell detachment.
A convergent channel is a unique feature of the "Microflow chamber" which 
distinguishes this device from previously developed methods. That is in the 
Microflow chamber the physical conditions o f the detachment assay are completely 
defined. It is pleasing about this device that it is able to take account o f the adhesive 
potentials o f the cell, substratum and the environment o f the attached cells. The 
reproducibility of this device was extraordinary as it was amenable to make difference 
among the adhesion strength o f different cell lines, on different substrates and in 
different environments. That is after taking from liquid nitrogen within 72 hours every 
cell line tested has its specific and constant adhesion strength (in terms o f critical 
shear) value. The majority o f the cell lines tested in this work show their specific and 
constant shear value even after 6 months o f taking from liquid nitrogen.
The substrates on which cells grow also exert some effect on their adhesion 
strength. In particular fibronectin coated substrata were found to possess a catalytic
Vactivity for enhancing the adhesion strength of L929 cells. As cell adhesion is an 
active phenomenon the adhesion strength was also found dependent on the 
endogenous production o f adhesion proteins without which cells remained confined 
into the first phase and never entered into the second phase o f  cell adhesion (two 
phases are proposed in the present study). In fact it is due to the Microflow chamber 
that in the present work a considerable understanding o f the cell adhesion 
strengthening phenomenon has been reached which can be considered a start o f  the 
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1CHAPTER 1 INTRODUCTION 
1. CELL ADHESION
In reference to cell in cell biology "adhesion" has been a portmanteau word 
applied to the interaction o f cells with each other and with surfaces. A variety o f these 
definitions include early and late cell binding events and the specific and non specific 
adhesions. Cell adhesion phenomena can be seen in a wide range o f taxa, from 
prokaryotes to eukaryotes and from unicellular organisms to metazoans. The study o f 
the differential binding and embryonic development o f cells in multicellular 
organisms began in 1907 when Wilson(1907) showed that mechanically dissociated 
and mixed cells of two different species of marine sponges sorted themselves out to 
produce two types o f organisms, each consisting o f the cells o f  only one species. A 
similar approach was later applied by Holtfreter (1948) who showed that dissociated 
embryonic cells derived from different tissues could sort themselves out from regions 
and structures resembling parent tissues. These experiments showed that there is a 
selective adherence among cells o f various types.
This paradigm was extensively employed by Moscona et al (1962) to show 
similar phenomena from chicken and mice. Various attempts were subsequently made 
to develop more direct assays o f cell- cell adhesion to isolate molecular fractions that 
might be responsible for different selectivity or specificity (Frazier and Glaser, 1979; 
Hausman and Moscona, 1976). More recently, these issues have been widely 
addressed and it is only within the last decade that details o f the molecular basis o f  
cell adhesion are beginning to emerge (Edelman 1985a, Edelman, 1985b; Edelman, 
1988, Nagafuchi & Takeichi, 1988, Nelson & Hammerton, 1989).
According to publications to date cell adhesion can be considered as an 
intricate process, involving proteins o f the extracellular matrix, cell surface receptors 
for these proteins and a complex interplay o f physical, biochemical and cytoskeletal 
events (Buck & Horwitz 1987; Vasilev, 1985; Morrow et al, 1989). Two approaches 
to studying the problem o f cell adhesion have been developed:
2(1) The adhesion oof cells to each other
(2) The adhesion oof cells to extracellular substrates 
These will now be discussed below.
1.1. CELL-CELL ADHESION.
In cell to cell adhesion, at the first encounter between one cell and another 
there is an initial binding event. This initial binding is brought about by a non 
covalent molecular interaction between component(s) o f the extracellular matrix and 
receptors on the cell surface.
Many cell surface molecules have been implicated in cell adhesion, 
presumably such molecules are involved in initial binding. These have been referred 
to as cell adhesion molecules(CAMs)(Edelman et al, 1987, Friedlander et al, 1989). 
CAMs were first identified by means o f immunological based assays in which 
specific antibodies, capable o f blocking cell adhesion, were used to purify cell surface 
molecules as putative CAMs. A number o f these molecules have been detected. 
Among them the most studied are neural cell adhesion molecule(N-CAM), neuron 
glial cell adhesion molecule(Ng-CAM) and liver cell adhesion molecule(L-CAM). All 
the molecules that have been characterized are shown to be large glycoproteins.
1.1.1. N-CAMs
NCAMs consist of one or more structurally related polypeptide chains (figure
1.1). These appear in various forms with regard to glycosylation i.e highly sialylated 
and less sialylated forms of N-CAMs exit. The highly sialylated form, which 
dominates during the embryonic period contains polysialic acid. The less sialylated 
form dominates in adult animals and has no polysialic acid. Moreover the binding rate 
o f the less sialylated form is much higher than that o f the highly sialylated form. It is 
suggested that the N-CAM on one cell binds to an N-CAM on adjacent cell 
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FIGURE 1.1.
STRUCTURAL FEATURES OF SOME OF THE PROMINENT CELL-CELL 
ADHESION MOLECULES. DETAILS MAY BE SEEN IN THE TEXT.
41.1.2. L-CAM
L-CAM was originally isolated from embryonic chick liver but has been found 
in all types o f  epithelia. It consists of one polypeptide chain that is amino 
glycosylated on the N-terminal end. The C-terminal portion o f the polypeptide chain 
is associated with the membrane (figure 1.1). It is not known if  the binding reaction is 
homophilic or heterophilic i.e. if  the molecule binds to itself on the other cell or to a 
ligand o f different identity (Thiery et al, 1984; Cunningham et al, 1984; Hatta et al, 
1985; Obrink, 1986).
1.1.3. Ng-CAM
Ng-CAM is a secondary CAM, consists o f a large glycoprotein (200Kd) that 
appears to be posttranslationally cleaved into two components o f 135Kd and 80Kd 
(figure 1.1). It has been implicated in neuron-neuron and neuron-glial cell binding. It 
has an unidentified ligand to which it binds on opposed cell, therefore the binding 
must be heterophilic (Brachenbury et al, 1981; Grumet et al, 1984; Kruse et al, 1985). 
Many other adhesion related molecules have been found. These include, cadherin, 
cell-CAM and ELAM.
1.1.4. CADHERIN
The cadherins are a family o f homologus cell surface glycoproteins which 
mediate Ca^+ dependent cell-cell adhesion. This family includes: E-cadherin, N- 
cadherin, P-cadherin. They are found on epithelial cells, nerve cells and on the cells 
of the placenta respectively (Shirayoshi et al, 1983; Yoshida et al, 1984; Hatta et al, 
1987; Takeichi, 1988; Nose et al, 1988).
1-1.5. CELL-CAM
Cell- CAM is involved in cell-cell adhesion and compaction of early embryos. 
It is present in early embryo and several epithelia(Damsky et al, 1983; Hixson et al, 
1985; Vestweberet al, 1985)
51.1.6. ELAM  (<endothelial leukocyte adhesion molecule)
.ELAM is a member o f integral membrane adhesion proteins which share a 
common extracellular domain orgnisation consisting o f an NE^-terminal lectin like 
segment. It serves; as an inducible receptor for Neutrophil binding to endothelial cells 
via sialic acid groups (Walz et al, 1990).
Apart from these molecules an important event that can strengthen an adhesion is the 
formation of specialised cell junctions. Cell junctions can be classified into three 
functional groups:
1. Tight junctions seal cells together in an epithelial cell sheath in a way that inhibits 
even small molecules from leaking from one side to the other (Simons & Fuller, 
1985; Madra, 1988).
2. Anchoring junctions consist o f adherens and desmosomes. Adherin junctions are 
button like points o f intracellular contact that rivet cells together in a variety o f  
tissues, most of which are epithelials. They also connect actin filaments to the 
extracellular matrix. Desmosomes are connection sites for intermediate filaments 
(Garrod, 1986).
2- Gap junctions play an important role in cell coupling in embryogenesis. For 
instance the cells within each group remain coupled via gap junctions with each other 
and so tend to behave as a cooperative assembly (Pitts & Finbow, 1986; Loewenstein, 
1987)
Thus cells in tissues are linked to each other and to the extracellular matrix via these 
molecules.
The present work is primarily concerned with the second approach o f cell adhesion 
study i.e. cell to substrate adhesion.
1.2. CELL-SUBSTRATE ADHESION
This is the subject o f the present study. It is conveniently divided into 
following identifiable stages:




Each o f these steps , perhaps with the exception o f number 1, may require, like cell­
cell adhesion, an array o f factors from cell bound proteins to proteins in the solution 
to metal ions. Cellular metabolism also plays a central role in 2,3 and 4.
1.2.1. PROTEIN ADSORPTION ON THE SURFACE
The first reaction that occurs when a virgin surface (plastic/metal/glass) is 
immersed in a solution containing proteins is that the latter irreversibly bind and 
denature onto the surface. (Soderquist & Walton, 1980; Castillo et al, 1984; William 
et al, 1986; Absolom et al, 1987). The protein adsorption studies date back at least to 
1925 and thereon almost all published research work has invoked a Langmuir type 
adsorption process (Hitchock, 1925; Kemp & Rideal. 1934; Absolom et al, 1987) 
Thus the act of pouring medium containing serum into a culture bottle causes a rapid 
deposition of a protein layer on the flask. This layer may only be fractions o f a 
micrometer in thickness (Castillo et al, 1986; Anderson et al, 1990).
Nearly all mammalian cell adhesion to synthetic substratum is aided by 
adsorbed proteins and is actively receptor mediated (Evans, 1985; Vogler, 1989; 
Cozens-Roberts et al, 1990). After protein adsorption, if there are receptors for some 
of these adsorbed protein(s) on the cell surface and if the conformation o f the 
adsorbed proteins is not so extensively altered by adsorption as to destroy the high 
ligand-receptor affinity, then cell adhesion can result (Schakenraad et al, 1987).
As stated earlier, adsorption o f proteins to the surface is largely irreversible 
and much more rapid than contact o f the cell to the surface so that cells interact with 
an interface of previously adsorbed proteins rather than the original form of 
substrate(Baier & Dutton 1969; Horbett & Weathersby, 1981; McAuslan et al, 1988; 
Lee et al, 1991). Recently Schakenraad et al(1989) suggested that protein adsorption
7is completed wittfiin minutes and must precede attachment and spreading which 
generally require several hours.
Under static conditions , transport of proteins toward a substratum is controlled either 
by sedimentation, diffusion or convection. The properties o f the substrate surface e.g. 
hydrophilicity/hydlrophobicity and surface charge are assumed to regulate the amount 
and surface structure(conformation) o f adsorbed proteins. (Uyen et al 1990; Fabrizius- 
Homan & Cooper* 1991).
Wachem et al(1985) showed that a moderate wetability o f  a surface is a 
precondition for maximal cell adhesion in the presence o f serum in the culture 
medium. Wetabiliity was defined by the measurement of contact angle o f the material. 
For example cellophane was found to be the most hydrophilic polymer with a contact
o
angle o f 16 and flouroethylenepropylene polymer was the most hydrophobic
o
polymer with a co>ntact angle o f 102 . Tissues culture plastic with a contact angle of
o
35 was considered a moderately wettable polymer. Moderately wettable surfaces 
showed a good cell adhesion whereas both more hydrophilic and more hydrophobic 
polymers showed poor cell adhesion.(Wachem et al, 1987).
The mechanism by which the surfaces control the amount and conformation o f the 
proteins is still unknown.
Apart from wetability, surface charge is reported to play a part in controlling 
the protein adsorption on the surfaces (Maroudas, 1975; Sugimoto, 1981). For 
instance, protein adsorption onto the negatively charged poly HEMA 
(hydroxyethylmethacrilate) is supposed to be slight and reversible and no cell 
adhesion was found to occur onto this surface(Wachem et al, 1987; Gerson & Scheert, 
1988; Schakenraad & Busscher, 1989). However, maximal adhesion o f fibroblasts 
upon positively charged poly-HEMA was observed by Hattori et al(1985).
Despite these reports a considerable confusion exits in the literature 
concerning protein adsorption and cell adhesion. For example fibronectin (a cell 
adhesion protein) adsorption has been the subject of contrary reports. Klebe et al 
(1981) demonstrated that the substrates capable of binding fibronectin shared one
8common surface property; namely, they were all hydrophobic and they all bound 
protein non specifically. On the other hand those substrates that did not bind 
fibronectin were all hydrophilic in nature.
In findings contrary to the above, Grinnel & Feld (1981) suggested that the 
fibronectin adsorbed on a hydrophilic substrate has a different orientation than the 
fibronectin on a more hydrophobic substrate. This author also suggested that 
fibronectin adsorbed on the hydrophilic substrate was biologically more active. Thus 
one must compromise on that, the moderate wetability, the better the cell adhesion 
(Lydon et al (1985). The surfaces which are not moderately wettable (defined earlier) 
and do not have high surface charge must be treated chemically or physically i.e. 
treatment with oxidising agents or electrical glow discharge to render them suitable 
for cell adhesion.
Martin and Rubin(1974) treated polystyrene with sulphuric acid and exposed 
it to u.v. light. This resulted in a suitable surface for the adhesion o f fibroblast cells. 
In fact this treatment was thought to lead to the sulphonation o f the polystyrene with a 
consequent increase in the number of charged groups per unit area which in turn 
supported cell adhesion. Later Curtis et al (1983) discarded the assumption that 
sulphate groups accounted for enhanced cell adhesion to polystyrene in favour o f the 
idea that sulphuric acid treatment caused hydroxylation o f aromatic groups on the 
surfaces. These hydroxyl groups, emerged on the surface, were suggested to be 
involved in cell adhesion. Three years later, Curtis et al, 1986; and Smentana et al,
1990) suggested that an increase in the adhesion densities o f hydrooxyl groups was 
entirely responsible for cell adhesion whereas fibronectin(a prototype adhesion 
protein) is only an activator o f cell adhesion.
Lydon et al (1985) responded to the claims of Curtis et al (1983) and put a 
question mark on the hydroxyl groups in cell adhesion Lydon et al raised the point 
that if the hydroxyl groups are responsible for cell adhesion why does poly- HEMA 
with its higher density o f hydroxyl group, not support cell adhesion and poly methyl 
methacrylate (MMA) which has no hydroxyl group supports cell adhesion. This issue
9is still a matter of debate among cell biologists. According to Revel and Wolken 
(1973) cellular protein synthesis as well as protein(s) released from dying cells during 
incubation in a protein free media could form an extracellular matrix (ECM) even in 
the absence of (exogeneously added protein(s). It can be concluded that proteins are 
present in almost every situation where the substrate comes into contact with the cells. 
Modifications o f  commercial cell attachment substrates by electrical glow discharge, 
simply changes the pattern o f protein adsorption (Blais et al, 1974). In no described 
case does the cell actually touch the surface and attach except through these 
intermediate adsorbed protein(s). With regard to the latter, a most significant 
development o f the last decade has been the identification o f a number o f  
glycoproteins and collagens which were capable o f adsorption on the surface and 
promotion of the cell adhesion. The first major glycoprotein o f this type to be 
identified was fibronectin (Vehri & Mosher, 1978; Yamada et al, 1976,Yamada, 
1983; Yamada & Olden, 1978) while later laminin and vitronectin have joined the list 
(Wewer, et al, 1987; Chi & Hui, 1989). More recently some new proteins such as 
thrombospondin (Santoro & Frazier, 1987), entactin (Chakravrti et al ,1990) and 
epilegrin (Carter et al, 1991) have also been discovered.
The most obvious properties o f these molecules is to promote cell adhesion For the 
present discussion only fibronectin, vitronectin, laminin and the collagens will be 
described briefly.
1.2.1.1. FIBRONECTIN
Among all the adhesion proteins, fibronectin is structurally and functionally 
well understood. It is a large glycoprotein (440Kd) present in blood plasma and in 
tissues. Both plasma and cellular fibronectins are similar in structure and function; 
however, they are distinguished by certain physical properties such as solubility and 
mobility on SDS polyacrylamide gels. Under reducing conditions, plasma fibronectin 
migrates as a closely spaced doublet whereas cellular fibronectin migrates as a single 
band (Dufour et al, 1986). Three types of posttranslational modifications could in part
Fibrin Gelatin
Heparin Collagen







SCHEMATIC REPRESENTATION OF THE DOMAIN STRUCTURE OF FIBRONECTIN.
THE KEY SHOWS DOMAIN ARRANGEMENTS IN THE FIBRONECTIN MOLECULE. 
THE DIFFERENT CELL BINDING SITES ARE ALSO SHOWN. THE DETAILS MAY BE




explain these differences; the variation in glycosylation, the degree o f  
phosphorylation, and the presence or absence o f sulphates. However the experiments 
aimed at eluciidating the causes o f differences in electrophoresis mobility have 
indicated that tlhese post translational modifications can not solely be responsible for 
the differences between the plasma fibronectin and cellular fibronectin. For example 
it was suggested that differences between plasma fibronectin and cellular fibronectin 
reside in the size o f the fragments, particularly the heparin binding domain (figure
1.2) (Paul & Hynes, 1984; Sekiguchi et al, 1985).
The protein contains two identical subunits, each o f 240-250Kd, each linked 
together near their carboxyl terminal by two disulfides (figure 1.2) (Ehrismann et al, 
1982; Ruoslahti et al 1986; Zardi et al, 1987). Fibronectin possesses many binding 
domains, each o f which binds specifically to macromolecules such as heparin, 
proteoglycan, collagen, fibrinogen, actin and DNA. (Skorstengaard et al, 1986; 
Akiyama & Yamada. 1987; W olf & Lai, 1990) (figure 1.2). In addition, fibronectin 
binds to the cell membrane via a cell binding site. It has been shown that at least three 
distinct types of internal amino acid sequence homology known as type (i), type (ii) 
and type (iii) exit along the molecule(Hynes, 1985; Gutman & Komblit, 1987; 
Narasimhan & Lai, 1989).
The structure o f the fibronectin molecule varies depending on the cellular 
source of the protein. These variations are due to alternative splicing o f the 
fibronectin mRNA. Three regions o f alternative splicing have been identified so far , 
two o f them consist of splicing in or out of one type (iii) homology segment (iiiA or 
iiiB) whereas the third one has been termed connecting segment (iiics) (Zardi et al, 
1987). Alternative splicing may effect the functions o f fibronectin. Indeed the 
principal region of the human plasma fibronectin molecule mediating the adhesion o f 
melanoma cells is the alternatively spliced type (iii) connecting segment (iiics) 
(Ruoslahti, 1988, and Oyama et al, 1989).
Formerly, the site in fibronectin that promotes cell attachment was found to be 
in the middle portion o f the molecule, that is in one o f what is now known to be the
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type (iii) homology segment. This attachment site consists o f a sequence o f a 4  amino 
acids i.e.- arg-gly-asp-ser(RGDS) (fig. 1.2). The role o f the RGD sequence as the 
recognition site was demonstrated by making progressively smaller fragments o f  
fibronectin and by assaying for the cell attachment promoting activity It was found 
that RGDS containing peptides, in a soluble form could block adhesion o f cells to 
fibronectin coated substratum, while coupled RGDS peptide to solid surfaces could 
promote cell adhesion to these surfaces (Pierschbacher and Ruoslahti 1984). The 
specificity of the RGDS sequence is extensively precise, substitution or deletion o f a 
single amino acid abolishes the activity of this peptide (Hautanen et al,1989). For 
example, it was indicated that the serine residue o f the tetrapeptide sequence (RGDS) 
can be cystine without any considerable loss o f the activity o f peptide but activity 
could be lost when Arg or Asp residues were selectively deleted or replaced by 
another amino acid. Even substitution o f Asp acid with Aspargine (A spN H ^ greatly 
diminished the activity o f tetrapeptide (Peirschbacher and Ruoslahti, 1984).
Humphries et al (1987) examined a series o f overlapping synthetic peptides 
spanning the entire iiics region for their effects on F10 murine melanoma cell 
adhesion to the parent fibronectin molecule. Two non adjacent CS peptides CS1 and 
CS5 were found to inhibit melanoma cell adhesion to fibronectin. The CS1 peptide 
(Humphries et al, 1986) and CS5 peptides are located at the amino terminal ends o f  
the alternatively spliced type (iii) connecting segment, respectively. Both contain the 
active sequence -arg-glu-asp-val- (REDV) (fig. 1.2). Recently Komoriya et al (1991) 
identified the minimal active (adhesive) amino acid sequence within the CS1 peptide. 
The deduced active amino acid sequence derived from carboxyl terminal o f CS1 was 
-leu-asp-val- (LDV) (fig. 1.2).
Early experiments, correlating the extent of cell adhesion and cell spreading 
with adsorption of fibronectin to the culture substratum from growth medium 
containing serum suggested that fibronectin accounted for most o f the cell adhesion 
activity in serum(Grinnell & Feld, 1982). In contrast to these studies a number of 
lines of evidence now suggest that under most common tissue culture conditions,
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vitronectin is a more effective molecule than fibronectin for cell attachment and 
spreading.(Knox 1984). Structural and functional characteristics o f vitronectin are 
given as below.
1.2.1.2. VITRO NECTIN
For the first time Holmes (1967) showed that a serum fraction, isolated by 
making use o f its affinity for glass beads, promoted the attachment and spreading o f  
cultured cells. Barens & Sato (1980) subsequently showed that this serum fraction 
could be used as serum spreading factor to provide for cell attachment in serum free 
culture medium. The active component in this fraction was found to have an 
approximate M.wt>70,000. and that it was not fibronectin, or a fragment thereof. 
Latter this factor was identified as vitronectin (Hayman et al, 1983,1985). Vitronectin 
promotes the attachment and spreading o f a wide variety o f both fibroblasts and 
epithelial cells. Vitronectin, like fibronectin, is a multifunctional protein with number 
o f active sites (fig 1.3). These sites includes, a cell attachment site, a 
glycosaminoglycan binding site and a heparin binding site (Suzuki et al, 1985 and 
Izumi et al, 1988).
Human vitronectin is a monomeric glycoprotein o f 75Kd. The amino acid 
sequence o f this protein was deduced from cDNA and contains 459 residues (Jenne & 
Stanely, 1985). Heparin was stated to bind with an area o f basic amino acids near the 
carboxyl terminal o f vitronectin (Hayman et al, 1983). The cell binding site is located 
near the amino terminus. The minimum cell attachment site in this glycoprotein is 
similar to the cell attachment site in fibronectin i.e. RGDS (Ptyela et al, 1985a). 
Although both fibronectin and vitronectin support cell adhesion, Underwood and 
Bennet (1989) suggested that it is vitronectin that is the effective molecule for cell 
adhesion.
Two reasons for this findings were given, firstly, batches o f foetal calf serum 
prepared for tissue culture are frequently clotted at 4°c which leads to depletion o f 
fibronectin. It was reported a range o f 5-50 fold excess o f vitronectin compared with
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fibronectin amomgst different lots of tissue culture grade foetal calf serum (Hayman et 
al, 1985). Secondly, the dependency of cells upon serum vitronectin, rather than 
fibronectin, in atttachment, was shown to be due to less adsorption on the substratum 
in the presence o f  vitronectin.
The vitronectin was also able to coat the substratum efficiently in the presence 
o f fibronectin and other proteins.(Underwood and Bennet, 1989). Stimulation of 
spreading by vitronectin has been postulated in a dose dependent manner. At a 
concentration o f 18jig/ml more than 95% of BHK cells become completely spread on 
the substratum while at 10jig/ml only 15% of the cells were capable o f spreading 
(Whately & Knox, 1980). In addition to fibronectin and vitronectin there is another 
type of glycoprotein which constitutes a major part o f the ECM. This 
protein "laminin” appears to be most effective as an attachment protein for epithelial 
cells, however, it is also reported to support the attachment o f some fibroblast cells 
(Codongo et al 1987).
1.2.1.3. LAMININ
Laminin, the major glycoprotein specific to basement membrane has multiple 
biological roles where it functions in cell adhesion, cell growth, morphology o f the 
cells, differentiation and in matrix assembly (Kleinman et al, 1985 and Martin & 
Timple, 1987).
Laminin is a large(850Kd) cruciform shaped complex with three short and one 
long arm assembled from three different sub units i.e. A, B1 and B2 (fig. 1.4) (Engell 
et al, 1981, and Timple & Dziadek, 1986). The mechanism by which a cell adheres to 
laminin has not been completely elucidated. Two distinct proteolytic fragments of 
laminin PI (pepsenic digestion product) and E8 (elastase digestion product) have been 
characterized for their activity in promoting the cell adhesion (Aumailley et al, 1987 
and Goodman et al, 1987). These fragments respectively correspond to the central 
region and the end o f the long arm. The domain in PI responsible for attachment is
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expected to be the -tyr-isoleu-gly-ser-arg- sequence, which belongs to the B1 chain o f  
the laminin. This sequence is absent in fibronectin and other proteins which have 
specific sequence RGDS (Graf et al, 1987a and Iwamoto et al, 1987).
Two different peptide sequences o f E8 fragments have been characterized for 
their capacities to  promote cell attachment: one is situated near the carboxyl terminal 
end o f the B2 chain (Sasaki & Yamada, 1987 and Liesi et al, 1989) and the other at 
the carboxyl terminal o f the A chain (Sasaki et al, 1988 and Tashiro et al, 1989). 
Another site on the A chain contains the sequence -arg-gly-asp-(RGD) and is 
expected to be biologically active (Humphries et al, 1986 and Ruoslahti & 
Pierschbacher, 1987). Grant et al, (1989) suggested that peptide YIGSR acts in 
concert with RGD sequence o f laminin A chain. The RGD peptide may mediate its 
cellular effects by binding with integrin receptors (membrane integrated proteins, a 
superfamily of receptors). However, cell attachment to laminin mediated by receptors 
of the integrin family is not systematically inhibited by the -arg-gly-asp-(RGD) 
peptide (Gehlsen et al, 1988).
Laminin at 5|ig/ml promotes the attachment o f various epithelial cells to plastic or to 
type (iv) collagen coated substrates (Graf et al, 1987a). Both fibronectin and laminin 
appear to be able to bind to collagen, the latter is a member o f the family of 
extracellular matrix proteins, which have the ability to mediate the attachment and 
spreading o f many cell types.
A conclusion on protein adsorption can be made, that is, if  a culture vessel is placed 
in a growth medium containing serum, proteins adsorb non specifically to the surface 
and mediate cell adhesion. If the cells are seeded on a substrate in the absence of 
adsorbed proteins, then the proteins on the cell surface may directly adsorb to the 
surface and the cell will, providing the conditions are favourable, secrete its own 
proteins (e.g. fibronectin, vitronectin, laminin and collagen) toward the surface in the 
form o f an extracellular matrix. If the substrate does not support protein adsorption, or 
even if it does, but there are no receptors on the cell surface, the substrate will not 
support cell adhesion. After protein adsorption the next cellular event in the sequence
17
involved in cell adhesion is the attachment of the cell to the surface. This is discussed 
below:-
1.2.2. CELL ATTACHMENT
As a first step towards attachment the cell makes contact with the protein 
coated substratum. If the cell is small, as in the case o f bacteria, charges will take the 
cell to the surface. With larger mammalian cells gravitational forces assume the 
control role in cell-substrate contact (figure 1.5) (Grinnell, 1978). Following contact 
of the cells with the substrate, attachment bonds between cell and previously adsorbed 
proteins on the substratum are formed (figure 1.5) ( Lydon & Foulger, 1988 and 
Klein-Soyer et al, 1989). One of the major challenges o f  cell biology and 
biochemistry is the elucidation o f the macromolecular structures involved in 
attachment bonds and then to understand their functions and regulation.
As stated earlier, it is only within the last decade that many extracellular adhesion 
proteins such as fibronectin, laminin and vitronectin have been identified and fairly 
characterized. However, understanding of the binding between these extracellular 
matrix and cells was in a rather confused state for some time. However recent detailed 
analysis o f the cell binding site on fibronectin led to a precise understanding o f the 
mechanism of cell-extracellular matrix interactions. In a splendid series o f studies 
Pierschbacher et al, 1982) used proteolytic techniques to produce successively smaller 
fragments of the fibronectin molecule, which retained cell adhesion promoting 
activity. Later they synthesized a series o f peptides which overlapped the cell binding 
site and deduced that the critical feature o f this site was a tripeptide with the sequence 
arg-gly-asp- (RGD) (Pierschbacher & Ruoslahti 1984).
Identification of RGD sequence was the reward o f extensive efforts to define 
the structural basis for the adhesive properties o f fibronectin. Moreover, the success in 
delineating the function of RGD sequence encouraged further work to similar sites 
within other matrix molecules (Horwitz et al, 1985; Ruoslahti & Pierschbacher, 1986; 
Graf et al, 1987b). The assignment o f the cell binding activity o f the fibronectin
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molecule to a tripeptide sequence(RGD) provided a strong hint that interaction 
between fibronectin and the cell membrane was indeed very specific and it likely 
involved a membrane receptor protein. This has since been confirmed by several lines 
of evidence (Liotta et al, 1985; Pytela et al, 1985b; Kitten et al, 1986). The cellular 
recognition system that comprises the receptors are collectively called integrin 
receptors and are briefly discussed below
1.2 .2 .1. INTEGRINS
The information that a cell receives from the extracellular matrix has a marked 
influence on its behaviour with regard to the cell adhesion. The cell surface proteins 
that interact with the components of the extracellular matrix are the integrin receptors. 
This name was coined because they play a bridging role between cytoskeleton and the 
extracellular matrix (figure 1.6).
Early work on adhesion receptors was done by generating antibodies to cell 
surface proteins that could block cell-substrate adhesion (Damsky et al, 1981; N eff et 
al, 1982). The results suggested that a group o f proteins with molecular weights in the 
range o f 100-150 KDa were responsible for the attachment o f cells to substrates. 
However, the complexity o f the proteins recognised by the antibodies and the ability 
of the antibodies to inhibit adhesion to multiple matrix proteins were confusing. Now  
its known that the complexity o f the proteins immunoprecipitated by the adhesion 
inhibiting antibodies was due to the sharing o f subunits among the adhesion receptors. 
Some years ago affinity chromatography o f cell and tissue extracts on immobilized 
fibronectin cell attachment fragments or RGD peptide was applied to the isolation o f  
adhesion receptors. The fibronectin fragment affinity matrix yielded, upon elution 
with the RGD peptide, a fibronectin receptor that consists o f two polypeptides, an a  
and a p subunit (Pytela et al, 1985b). Affinity chromatography on vitronectin gave a 
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than the fibronectin receptor (Pytela et al, 1985b). Both receptors could be isolated 
from the same osteosarcoma cells and fibroblasts. The related structures and 
specificities o f  the fibronectin and vitronectin receptors made scientists realize at that 
time that they were dealing with a recognition system, not just receptors to individual 
matrix protein. When the affinity chromatography isolation procedures were applied 
to other cell types, additional receptors were obtained. (Pytela et al, 1986). 
Subsequently these receptors were characterized and it was found that all integrins are 
heterodimers of non-covalently linked sub units (Hemler, 1990 and Ruoslahti, 1991).
Both subunits are integral membrane glycoproteins. Both a  and p subunits o f  
integrins have a segment with the characteristics o f a transmembrane domain near the 
COOH terminus, suggesting that each subunit spans the membrane and that the short 
portion of the polypeptide extending from the COOH terminal end o f the 
transmembrane domains is cytoplasmic. The a  sub unit contains areas thought to bind 
calcium and the p subunit contains 4 cystine rich repeats (Marlin & Springer, 1987; 
Dransfield & Hogg, 1989; Kirchhofer et al, 1991). The extracellular domains contain 
the adhesion protein binding region. The cytoplasmic domains o f both subunits are 
relatively small and contain regions capable of binding to cytoskeletal elements (e.g. 
talin, vinculine) that link the integrins to the actin cytoskeleton (Akiyama et al, 
1990b). More than eleven distinct a  subunits have been described. They are divided 
into three main sub-classes based on the p subunits, with which a  chains associate. 
The p i sub family includes receptors for fibronectin, laminin and various collagen. 
The p2 sub family consists o f leucocyte specific receptors, while the p3 sub family 
consists of platelet glycoproteins and vitronectin receptors (Kelly et al, 1987; Vogel et 
al, 1990; Ruoslahti, 1991).
These groupings should be considered provisional as new information 
concerning a /p  subunits and substratum specificity is appearing at a rapid pace. The 
amino acid sequences o f several integrins have been determined for cDNA. One o f  
the chicken integrin complex was the first subunit sequenced (Tamkun et al, 1986). 
Later both subunits of the human fibronectin receptor were sequenced (Argraves et al,
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1987). Now the sequence of many integrins is known. There is no sequence 
similarity between the a  and (3 subunits o f any one of the individual integrins but each 
a  subunit is similar to the other a  subunits and each p subunit to the other p subunits. 
The extent of this similarity is 40-50% at the amino acid level. The receptor binding 
requires divalent cations such as Ca^+, Mg^+, or Mn^+ and perhaps cations can 
modify the affinity and specificity o f the receptors. Integrins are a multigene family 
and consists o f many members. In this work only fibronectin receptors, vitronectin 
receptors and laminin receptors will be described.
1.2.2.1.1. FIBRONECTIN RECEPTORS (FNR)
Members o f  this family o f integrins contain one of six (or more) unique but 
related a  subunits associated with the common p subunit in a non-covalent dimer 
(Hemler et al, 1989). The larger component termed the a  subunit usually ranges in 
size from 140-165Kd and the smaller p subunit is 120-130Kd in size (Argraves et al, 
1987; Hemler et al, 1987; Takada et al, 1987a). The avian FNR is called a 3 p l and 
mammalian fibroblast FNR is designated as oc5pi (Takada et al, 1987b). Current 
evidence suggests the avian fibronectin receptor is a multifunctional receptor or a 
mixture o f related receptors. Monoclonal antibodies that bind to the receptor inhibit 
cellular interactions with fibronectin, laminin vitronectin and collagen (Buck & 
Horwitz, 1987). Thus at present, it is probably prudent to refer to this complex rather 
than simply the fibronectin receptor.
The avian integrin receptor complex also binds to the cytoskeletal protein talin 
but not to a-actinin or vinculine.(Horwitz et al 1986). The binding site for talin on the 
receptor complex is on the intracellular portion, distinct from that for fibronectin. The 
mammalian fibronectin receptor (a 5 p l)  consists of a 145-155 KDa a  and 125 KDa P 
subunit. Both subunits have been cloned and sequenced. The function o f the high 
affinity a5 p i FNR has recently been probed using monoclonal antibodies. Although 
capable of mediating initial attachment of normal fibroblasts, the receptor is not 
essential for subsequent cell spreading on a fibronectin substratum (Akiyama et al,
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1989). This function might be performed by vitronectin receptors or a recently 
discovered fibronectin receptor a4bl which recognise -leu-asp-val- (LDV) sequence. 
(Komoriya et al, 1991).
Akiyama et al (1989) also discovered that the formation o f specialized cell 
contacts with the substratum and actin microfilaments orgnisation seem to be partially 
dependent on this receptor function. The localization pattern o f fibronectin receptors 
in the plasma membrane o f cultured cells is consistent with receptor involvement in 
cell adhesion. On stationary cells, the receptor is organised into immobile aggregates 
that appear to be associated with the ends o f extracellular fibronectin fibrils 
(Ruoslahti & Pierschbacher, 1987). Receptor function is maintained after treating 
cells with proteinases in the presence of Ca^+, whereas receptor function is lost after 
treating cells in the absence o f Ca^+. Clearly, the fibronectin receptor is at least 
stabilized or protected by Ca^+ (Akiyama and Yamada (1985). The (31 sub family 
have another group o f receptors which recognise laminin as described below.
1.2.2.1.2. LA M IN IN  RECEPTORS (LM R)
Cells can interact with laminin through a multiple receptor system. Probably a 
mixture of pi integrin receptors can interact with laminin, although with lower 
affinity than the fibronectin receptor (Horwitz et al, 1985 and Cohen et al, 1987). The 
a 3 p l fibronectin receptor and a 6 p l human platelet receptors also bind with RGD 
sequence within the laminin molecule (Aumailley et al, 1987, and Goodman et al,
1987). Other laminin receptors isolated from rat Rugli cells and neuronal cells 
(Gehlsen et al, 1988) are also p i integrins, probably the homologs o f a 3 p l or a 6 p l.  
There is another laminin receptor o f molecular weight 69KDa (yet to be named). The 
anti-69KDa antibodies inhibit cell attachment on laminin, while having no effect on 
fibronectin (Wewer et al, 1987). Synthetic peptide containing the sequence Tyr-Ile- 
Gly-Ser-Arg (YIGSR) can elute the 69 KDa receptor from laminin affinity columns 
(Grafet al, 1987b).
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A major laminin binding protein of 56 KDa characteristic o f muscle cells has been 
isolated and cloned from chick and rat skeletal muscle. This extracellular, membrane 
protein interacts with the major heparin binding domain in the laminin a l  chain 
(Clegg et al, 1988). There are many other LMRs yet to be named depending on 
whether or not the present integrin classification remain intact in the future 
(Sonenberg et al, (1988).
I.2.2.I.3. VITRONECTIN RECEPTORS (VNR)
The vitronectin receptors belong to the p3 sub family and they recognise RGD 
sequence (Pytela et al, 1986). Surprisingly, the VNR binds to vitronectin but not to 
fibronectin (Pytela et al, 1987). In fact VNR binds to the RGD sequence with higher 
affinity than the FNR (Pytela et al, 1987). It consists o f a 125Kd a  chain and 115d p3 
chain. The localization o f the VNR on cultured cells suggests that it plays a role in 
cell adhesion (Cheresh et al, 1987).Moreover the VNR is involved in spreading o f the 
cells, as their association with the cytoskeleton was observed at the late stage o f the 
cell adhesion (Singer et al, 1988). A novel vitronectin receptor (avp3) has been 
identified recently on carcinoma and other epithelial cells, which consists o f the same 
a-subunit associated with a new p-subunit distinct from any known integrin (Hemler 
et al, 1989).
In conclusion, almost all integrins recognise the RGD sequence but with a 
different specificity for each individual protein. At the present time it is not clear how 
the receptors can show such specificity for individual protein(s). Two possible 
explanations for this can be given.
1  It could be that while the RGD sequence is critical for the receptor-ligand 
interaction, other sites in the ligand protein are needed to stabilize the interaction and 
it is these latter sites that decide the specificity
2 The other possibility is that the RGD sequence itself assumes different 
conformations in different proteins and it is these unique conformations that are 
selectively recognised. Experiments in vitro with short peptide containing RGD may
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not be giving a clear picture, because short peptides are obviously more flexible than 
the same sequence in a protein. Thus the model peptides are capable o f assuming very 
many different conformations, which may recognise more than one receptor.
Nevertheless, once an interaction between extracellular protein and the 
integrin receptor has occurred the cell attachment to the surface has been initiated. 
Further attachment sites develop through a state of attachment called spreading. The 
process of spreading and strengthening o f cell adhesion requires metabolic energy 
(section 1.3.1). Spreading also involves biochemical and cytoskeletal events which 
are indicated as below.
1.2.3. SPREADING
Cell spreading begins well after initial attachment and continues during and 
after the first hour o f initial attachment (Pethica et al, 1984 and Vogler & Bussian,
1987). The cell spreading is quite different from the initial previous steps which led to 
a stabilized adhesion. In order to spread (specific morphology) cells require a suitable 
stimulus and this is usually supplied by the serum present in the growth medium or 
the cell itself produces fibronectin and vitronectin like proteins (Knox & Griffith,
1980).
Horwitz et al, (1986) and Tamkun et al,(1986) suggested that spreading is 
mediated by an interplay between the cytoskeleton, integrins and extracellular matrix 
proteins. Indeed it has been known for some time that these complexes are closely 
localized in cell to surface contact area (Yamada, 1983 and Geiger, 1983).
For example fibronectin was found in the vicinity o f focal contact sites where 
microfilament bundles terminate and where the plasma membrane is close to the 
substratum. Other proteins which are enriched in the close cell-substrate contact area 
(focal contact) are cytoskeletal proteins. These include: vinculine talin and a-actinin
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FIGURE 1.7
SCHEMATIC REPRESENTATION OF SOME OF THE COMPONENTS
LOCALIZED AT SITES OF CLOSE CELL TO SUBSTRATE ADHESION
PM = Plasma membrane 
FN = Fibronectin 
R = Receptor 
T = Talin 
V = Vinculin 
a.A= a-actinin
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(figure 1.7) (Burridge; & Feramisco, 1980; Burridge & Mangeat, 1984; Bretscher & 
Weber, 1983.). Why the focal contacts form during the spreading is not clear. 
However, arrangements of proteins mentioned above, in a sequence on these sites 
indicates that spreading is an active process. This occurs via the extracellular protein- 
receptor-cytotoskeletal interactions in the focal contact area (figure 1.7).
The cellular mechanism controlling spreading by means o f  specific structures 
and their interactions with the cytoskeleton are still very poorly understood. So far the 
only evidence available is that the fibronectin receptor may directly interact with talin 
and vinculine of the cytoskeletal proteins (Horwitz et al, 1986).
Chen et al,(1986), Dejana et al,(1988) and Mullar et al,(1989) presented evidence that 
a specific ligand is required for clustering of individual receptors such as fibronectin 
from extracellular matrix and talin from the cytoplasmic side. They further explored 
the initial 30 minutes o f cell adhesion where most o f the cells remain round and 
adhere only at their periphery. At this stage fibronectin receptors are scattered all 
around the cell surface and just a few receptor clusters were localized in 
correspondence to vinculin. From thirty to sixty minutes cells flatten considerably. 
Receptors are scattered within the plane o f ventral membrane and still do not 
correspond to microfilament bundles. After one hour o f seeding the cells , the 
correspondence between receptor clusters and vinculin was considerably improved 
but was still far from completion. Two hours after seeding, cells acquired full flatness. 
At this time complete correspondence o f receptors with vinculin was seen.
Muller et al, (1989) suggested that talin aggregation with fibronectin receptor may be 
the first events induced by fibronectin substratum, while a-actinin and actin become 
localized at the attachment site during the most advanced stages o f spreading. Despite 
these interesting observations, there is little direct biochemical evidence showing that 
the molecules mentioned above are the only elements involved in spreading. There 
may be some other molecules and metabolic events participating in this complex 
process, which is yet to be determined. Cellular spreading is always preceded by the
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process of strengthening or consolidation of cellular adhesion and it is also possibly 
triggered by metabolic events (section) as indicated below.
1.2.4. STRENGTHENING OF CELL ADHESION AND GROWTH OF 
CELLS
At this stage cells adhere tightly to the underlying substrate through discrete 
regions of plasma membrane, referred to as adhesion plaques (Woods & Couchman,
1988). The assembly and disassembly o f adhesion plaques can be explained as below.
1.2.4.1. ADHESION PLAQUES
Many cells, including fibroblasts and epithelial cells form adhesion plaques 
when plated onto appropriate substrata. Adhesion plaques are generally absent in 
migrating cells, while they are abundant in stationary anchorage dependent cells 
(Kolega et al, 1982). The formation o f  the focal adhesion is preceded by a structural 
precursor consisting o f a bundle o f actin filaments oriented radially within the leading 
edge of the cell (Gieger et al, 1984 and Rinnerthaller et al, 1988). The precursor can 
be divided into two portions: a proximal part that becomes stationary and forms the 
plaque on the cytoplasmic face o f the focal adhesion membrane and a distal part, 
which continues to advance with the leading edge (Depasquale & Izzard, 1987).
The components taking part in the formation o f adhesion plaques come from 




The extracellular face contributes, fibronectin, laminin and vitronectin (Laterra et al, 
1983 and Woods et al, 1986). Actin, vinculin, talin are structural proteins o f the 
cytoplasmic face which participate in adhesion plaques (Kupfer et al, 1986; Volberg 
et al, 1986 and Marchisio et al, 1987). Integrin receptors are an obvious choice for the 
linkage between the cytoskeleton and the extracellular matrix (Kelly et al, 1987 and
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Singer et al, 1988). For example the transmembrane linkage o f talin to the 
extracellular matrix via the fibronectin receptors provides one mechanism by which 
cytoplasmic components can become coupled to the extracellular matrix (Horwitz et 
al, 1986).
Adhesion plaques are dynamic structures, thus in cultured cells they assemble, 
disassemble and then reassemble at specific times during the cell growth. (Gieger et 
al, 1984b; Small & Rinnerthaler, 1985 and Bum et al, 1988). It is not clear how this 
complex assembly/disassembly mechanism is regulated. However this mechanism is 
attributed to limited proteolysis and phosphorylation o f the extracellular matrix and 
cytoskeletal protein(s) ( Anteler et al, 1985; Kamps et al, 1986 and Herman et al, 
1986).
Giving the example o f proteolysis, talin was found to be a preferred substrate 
for a calcium dependent protease in vitro (Burridge, 1986). Plasmin was found to 
degrade extracellular matrix e.g. fibronectin. Thus the link(s) between fibronectin, the 
integrin and talin can be abolished (Chen et al, 1985 and Fairbaim et al, 1985). Once 
this linkage is eliminated, the adhesion plaque would be disassembled.
Evidence suggesting that the phosphorylation may be another important factor 
in the disruption o f focal adhesion in the cells has been obtained by using chemical 
activators o f specific kinases and by transforming cells with Rous sarcoma virus. For 
example tumour promoting phorbol esters (TPA) induce a rapid loss o f  stress fibres 
and displacement of vinculine from adhesion plaques ( Kellie et al 1985, Meigs and 
Wang, 1986, Lamb et al, 1988).
Recently, biochemical studies have shown that Rous sarcoma virus(RSV)- 
kinase is found tightly associated with plasma membrane o f RSV transformed cells. 
The above mentioned kinase was able to phosphorylate a member o f  the integrin 
family i.e. the fibronectin receptor. It was further noticed that the phosphorylation o f  
these fibronectin receptors also uncouples the linkage o f talin with the extracellular 
matrix, thereby disassembling the adhesion plaques. Adhesion plaques are thought to 
be structures essential for growth o f  cells.
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These observations (referred to above) suggest that the extracellular matrix 
macromoleculies, presumably sending some informations to the cell interior by acting 
through their membrane receptors, can modulate the growth o f  the cells. A brief 
insight into thiis aspect of adhesion is given below.
1.2.4.2. PROTEIN-RECEPTOR INTERACTION; 'THE REGULATOR OF 
CELL GROWTH”
The mechanism by which the control o f cell growth might be accomplished is 
still sketchy. However, recently considerable progress has been made toward the 
understanding o f this rather sophisticated mechanism. It was known for some time 
that the composition o f the extracellular matrix-cell surface complex had important 
regulatory and structural consequences for the cells. For example , the interaction o f a 
cell with either of two purified matrix molecules e.g. collagen and fibronectin, can 
have profoundly different adhesion, biosynthetic pattern and capacity for that cell to 
migrate and proliferate. ( Yamada, 1983).
A striking change in morphology was observed when fully differentiated 
epithelial cells were cultured on purified collagen. The cells underwent a fundamental 
alteration in morphology from epithelial to mesenchymal cells.(Greenberg & Hay, 
1982). Yamada et al (1976) treated oncogenically transformed cells, originally, 
deficient in fibronectin, with purified exogenous cellular fibronectin. They found that 
the transformed cells were restored to a normal cell shape, normal adhesiveness and 
actin microfilament orgnisation. Furthermore, extracellular matrix molecules can also 
regulate the amount and type o f the other extracellular molecules (Klienman et al,
1981). For example the fibronectin could considerably stimulate the synthesis o f  
collagen by hepatocytes (Foidrt et al, 1980, and Klienman, 1981).
Recently, one hypothesis put forward for the control of cell growth is that 
extracellular proteins through their binding with the cytoskeleton via their receptors, 
send direct signals to the interior o f the cells and control its growth. (Unemori and 
Werb, 1986). It is difficult to visualise how the binding o f an extracellular molecule to
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a transmembrane receptor can produce changes in cell behaviour. A solution to this 
puzzle is just beginning to emerge. For example, Menko and Boettiger, (1987) 
suggested that binding o f extracellular molecule(s) to integrin (s) may directly 
activate a second messenger system(s) and initiate a signal that is then transduced to 
the nucleus to influence gene expression and cell growth.
The various stages in cell adhesion have been described. It is now appropriate to 
discuss some of tlhe factors which effect the cell adhesion. These factors include:
1- Energy and protein synthesis (active or passive adhesion)
2- Inducers of cell adhesion:
(i) divalemt cations
(ii) others
1.3.IS CELL ADHESION AN ACTIVE OR PASSIVE PROCESS ?
The facts which are given in above sections and other lines o f evidence 
(including present work) suggest that cell adhesion is a metabolically active process. 
Unfortunately, there is no consensus on this issue, rather conflicting reports have been 
published now for more than two decades. A brief review o f this long debated issue 
will be stated as below.
1.3.1. M ETABOLIC EN ERG Y
Carter (1967) suggested that spreading o f mouse fibroblasts on cellulose 
acetate sheet was passive. The passive spreading means that spreading is not the result 
of the forces or components which originated from inside the cell, rather it is due to 
forces acting between the surface o f the cell and the surface o f the substrate.
Wolpert et al (1969) rejected the idea o f passive spreading by saying that if  
cell spreading was caused by passive process, it ought not be significantly affected by 
lower temperature, which did however reduce active cell attachment. To prove that 
adhesion is an active process Michaelis and Dalgrano (1971) were able to inhibit the 
attachment of pig kidney cells to glass by using metabolic inhibitors. However they
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were convinced that energy is required for the molecular conformational changes in 
the cell periphery but not for the de novo synthesis o f new proteins (this protein issue 
will be addressed shortly).
Klebe (1975) went one step further. He blocked ATP synthesis with metabolic 
inhibitors and v/as able to show inhibition o f cell attachment. Metabolically inhibited 
but viable cells regained their ability to attach to the substratum, when glucose was 
added to the medium, while metabolically dead fibroblast cells did not attach to the 
substrate. In contrary findings to these observations Nath & Srere (1977) 
demonstrated that the inhibition o f ATP synthesis was not important in cell adhesion. 
Recently, Maruyama et al (1989) investigated the role o f cellular metabolism in the 
lymphocyte adsorption on poly hydroxy methyl methacrilate (poly HEMA) and 
polyamine co- polymers. They deliberately varied the metabolic process either by 
lowering temperature (4°c) or by treatment with colchicine that disrupts the structure 
of cytoskeleton.
In response to low temperature and colchicine, the cell attachment and spreading were 
considerably inhibited on poly HEMA while these processes remained non responsive 
on polyamine co- polymer surfaces. In fact they left the debate about the involvement 
of energy in cell adhesion open to several interpretations.
1.3.2. REQ UIREM ENT FOR PRO TEIN SY N T H E SIS
If the cell adhesion is an active process along with an energy need, the protein 
requirements for cell adhesion should be a necessity. Against this notion, the role o f  
protein synthesis in cell adhesion has been always controversial. For example as 
stated earlier, Michaelis and Delgrano (1971) proposed that energy is one requirement 
of cell adhesion while protein synthesis is not relevant to cell adhesion. Indeed, to 
date several contradictory reports have been published. The most important o f these 
will be considered in the following paragraphs.
W eiss and Chang (1973) published a completely conflicting report. They noted that 
when ascites tumor cells were deprived o f protein synthesis with cycloheximide (up
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to lpg/ml) this resulted in an increased rate of cell adhesion. Although no other report 
in favour o f their idea has come by in the literature yet, the relevance o f protein 
synthesis in cell adhesion has become a controversial issue. Pena & Houghes (1978) 
demonstrated that baby hamster kidney cells (BHK) seeded on fibronectin coated 
surfaces acquired spreading, which was independent o f cell protein or nucleic acid 
synthesis. From these observations, the role o f protein synthesis in cell adhesion 
cannot be ruled out because an important member o f the extracellular matrix is 
fibronectin, this itself suggests the possible role o f protein(s) in cell adhesion.
Grinnell & Feld (1980) found that if  fibronectin secretion is inhibited, cell 
spreading is inhibited unless the surfaces are coated with fibronectin. The ability o f  
human fibroblasts to attach to native and denatured collagen in the presence or 
absence o f fibronectin was studied (Farsi et al 1985). It was found that the attachment 
was independent o f serum or exogenous fibronectin. However, the attachment in the 
absence o f serum or fibronectin (fibronectin was blocked with antibody) was found to 
be dependent on cellular protein synthesis. Albelda et al (1989) seeded endothelial 
cells on a fibrinogen coated substratum and exposed them to cycloheximide 
(25|ig/ml) . This cycloheximide treatment was able to eliminate most o f  the 
fibronectin fibrilar along with fibronectin receptor orgnisation. These results indicated 
the importance of fibronectin and endogenous protein synthesis.
Recently, Flickinger & Culp (1990) noted that on a collagen substratum 
prolonged cycloheximide treatment failed to reorgnise the actin into stress fibres. 
While on fibronectin coated substratum cycloheximide treatment had no effect on 
stress fibre formation. These studies clearly suggest a role for fibronectin and other 
endogenous proteins for successful cell adhesion. A contrary report by Neumier et al 
(1985) found that hepatocytes were well adhered on plastic in the presence o f  serum 
or fibronectin and subsequent spreading could not be prevented when protein 
synthesis was inhibited with cycloheximide (28|ig/ml).
As stated earlier (section 1.2.1) a major controversy took place when Curtis et al 
(1983, 1984, 1986, 1987) ruled out the role o f fibronectin as a mediator o f  cell
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adhesion. Rather they suggested that fibronectin is an activator o f cell adhesion. 
Curtis gave credit to hydroxyl groups on polymer surfaces as mediators o f cell 
adhesion. Lydon et al (1985) criticized this idea on the basis o f the facts that adhesion 
is inhibited on the hydroxyl rich polymer poly HEMA. Smentana et al(1990) 
discarded Lydon et a l's  arguments in favour o f  Curtis and suggested that hydroxyl 
groups in hydrogel like poly HEMA induce adhering and spreading o f the cells.
It may be a misleading debate over whether or not cell adhesion is passive or an 
active phenomenon. It seems more likely that where cell adhesion was considered 
passive, spreading in serum free medium may depend upon the active secretion o f  
adhesion proteins to the extracellular matrix. Moreover, a number o f  observations 
(Price, 1970; Wolpert et al, 1969) including our own experience in our laboratory 
suggest that for a variety of cell types there is no passive spreading as cells remained 
rounded in serum free medium.
In evaluating the role o f protein synthesis in cell adhesion it is very important 
to determine whether the cell adhesion occurs in the absence o f endogenous protein 
synthesis. However simply stopping protein synthesis may not be sufficient, since 
cells can retain adhesion proteins as a large internal pool. The secretion o f proteins 
from this pool may mediate adhesion. Perhaps together, inhibition o f protein synthesis 
plus secretion in the presence o f antibody to specific adhesion protein or peptide 
inhibitors would be an important tool to evaluate the role o f protein synthesis in cell 
adhesion
At this point it is important to take a brief look at the inhibitors o f  both protein 
synthesis and secretion. The details o f protein synthesis and secretion are available in 
almost every biochemistry and cell biology text book. Therefore, at present, the mode 
of action of only very common protein synthesis inhibitors will be briefly discussed. 
For example Actinomycin D binds to DNA and blocks the movement o f RNA  
polymerase and in this way prevents RNA synthesis which results in protein synthesis 
inhibition. Another inhibitor that blocks protein synthesis at the transcriptional level is 
alpha- amantin which blocks synthesis o f mRNA by binding to RNA polymerase.
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Some agents inhibit protein synthesis at the elongation step e.g. Puromycin causes 
premature release o f nascent polypeptide by its addition to growing chain end. 
Cvcloheximide and emetine are well known and effective protein synthesis inhibitors. 
Emetine (structure 1.1) is prepared from the ground roots o f Uragoga Ipecacuhana 
and is the principal alkoloid o f this plant. It stabilizes the 80 s eukaryotic ribosomes, 
so that they can no longer move along mRNA and so irreversibly inhibits protein 
synthesis (Olienic, 1977). Cycloheximide (structure 1.2) is obtained from cultures o f  
streptomyces griseus. It blocks the translocation reaction on ribosomes, thus 
inhibiting chain initiation as well as chain elongation. The latter by acting on the 60 s 
sub unit of the eukaryotic ribosomes (Obrig et al, 1971).
Intracellular secretory pathways can be impaired by microtubule disrupting drugs 
such as cholchicine, vinblastin and uncouplars o f oxidative phosophorylation (Kruse 
& Bernstein, 1975; Harwood et al, 1976; Dehan and Prockop, 1972).
The secretion of some adhesion proteins can be impaired in response to monovalent 
ionophores. For example monensin (structure 1.3) a monovalent ionophore can inhibit 
secretion of fibronectin and collagen from cultured human fibroblasts (Mollenhauer et 
al, 1990).
Monensin is a well characterized metabolite o f Streptomyces cinnamonnensis that 
binds to ions with specificity o f  Ag> Na> K> Rb> Cs> Li> Ca . The binding 
specificity o f monensin to sodium ion is ten times more than to potassium ions. As 
indicated in the structure 1.3 the alkyl groups are spread over the outer surface 
rendering the complex lipid soluble thus allowing the monensin to enter the cell 
membrane. It causes the exchange o f protons with sodium and thus impairs the 
secretory pathway. (Mollenhauer et al, 1990). Apart from the inhibition, there are 
some inducers known to exert a wide range o f biological effects on tissue culture, the 









1.3.3. INDUCERS OF CELL ADHESION 
These inducers include:
1- Divalent cations
2- Others (see latter)
1.3.3.1. DIVALENT CATIONS
Many lines o f evidence suggest a role o f divalent cation in cell adhesion. Both 
Mg^+ and Ca^+ appear to be active at physiological concentrations in many o f the 
systems tested (Grinnell, 1976; Takeichi & Okada, 1972; Maroudas, 1975) observed 
that Mn^+ was able to promote the attachment and spreading o f BHK cells in serum 
free medium. Grinnell & Lamke (1984) suggested a specific binding site for cations 
on the cell surface. Later Edwards et al (1987) proposed that divalent cation binding 
site is an extracellular site. These authors undertook a classical study and found that 
adhesion and spreading o f BHK21 cells in the presence o f serum or vitronectin 
require divalent cations in the order o f Mn^+>Co^+>Mg^+>Ca^+. Surprisingly on 
purified fibronectin no added divalent cation was required, since the requirement was 
largely met by adventitious Ca^+. On the basis o f such a difference in divalent cation 
requirements between different protein binding surfaces, they pointed a site for 
divalent cation on the extracellular surface.
Simultaneously. Argraves et al (1987) deduced an amino acid sequence o f a 
subunit ecto domain from the cDNA o f the fibronectin receptor and found that the a- 
sub unit ectodomain has five sequence elements homologos to Ca^+binding sites 
similar or homologos to several proteins like calmodulin (Szeberg et al, 1981). Later 
Suzuki et al(1987) and smith & Cheresh (1988) demonstrated Ca^+ binding site on a- 
sub unit o f vitronectin receptor. They also discovered multiple short sequence 
elements that are homologos to the Ca^+ binding elements o f other proteins, again 
like calmodulin. Now it has been discovered that almost every integrin receptors has a 
divalent cation binding site (Akiyama et al, 1990a). Becham and Jacobson (1990)
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presented evidence that Mg^+ promotes complete Hela cell spreading on RGDS 
coated peptides. Biochemical evidence was presented that the interaction o f  collagen 
receptors with RGDS containing peptide is enhanced in the presence o f Mg^+.
After Kirchofer et al's (1990) findings, scientists began to suspect the divalent 
binding site on p-sub units or the role o f (3-sub units in creating divalent cation site in 
a-sub units. Kirchofoer et al (1990) demonstrated the effect o f Ca^+on two different 
integrins i.e. one p i and and other p3. Both o f these have different responses to Ca^+. 
The former was insensitive to calcium but responsive to magnesium while the latter 
was sensitive to calcium . Loftus et al (1990) gave a precise picture o f Ca^+ binding 
to integrins. It has been proposed that the aspartic acid in the RGD is involved in 
coordinating a divalent ion between the protein and divalent binding site within the a  
and/or p subunits o f the integrins. Clearly more studies are needed to establish the 
role o f other divalent ions such as Mn^+ and Co^+.
1.3.3.2. OTHER INDUCERS
These inducers are diverse in their nature with different effects on normal and 
tumor cells in culture. The most important effect being the modulation o f cell 
adhesion. For example epidermal growth factor induced synthesis o f fibronectin via 
inducing the mRNA corresponding to fibronectin. Deposition o f fibronectin on the 
substratum was also induced in response to epidermal growth factor (Seebacher et al
1988). Similarly vitamin D3 treated cells were reported to be clearly more adherent 
than control cells. This effect was attributed to induction o f fibronectin synthesis 
(Franceschi, et al, 1987).
Glass et al (1988) have demonstrated that Arg-vasopression and prostaglandin 
E2 were effective agents in the induction o f mesenglial cell adhesion. When the 
fibronectin receptor was used as a model, phorbol ester treatment caused a rapid and 
profound enhancement o f integrin mediated CHO (Chinese hamster ovaiy cells) cell 
adhesion (Danilov & Juliano, 1989). Since it has been found that fibronectin is either
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totally absent or present in very small amounts in transformed and tumor cells, these 
inducers are beginning to make their place in chemotherapy o f cancer.
The last and most important point to be made in the present work concerns 
how cell adhesion is determined. Cell adhesion has been observed qualitatively for 
many years. Unfortunately very few quantitative methods o f cell adhesion 
measurement have been proposed. However, their limitations and accuracy never 
allowed them to become universally accepted cell adhesion measurement methods. 
Their complexity and non reproducibility is reviewed in the following section.
1.4. MEASUREMENT OF CELL ADHESION
In general, adhesion o f a cell attached to the substratum is defined according 
to the shear force the cell must resist to avoid being dislodged. It is not necessary that 
attachment or detachment should be the exact reverse o f each other. However both 
types of measurement have much in common, that is they coexist in any system in 
which cells are brought to the surface with the possibility o f  attachment. The greater 
the shear force in a system is used, the greater the number o f  bonds o f adhesion 
required before an individual cell can be observed to be attached. Similarly, the 
greater the shear force used the more readily cell detachment occurs from the 
substratum (Bell, 1978).
All the current methodology for the measurement o f cell adhesion revolves around the 
principles stated above. However, there have been substantial variations from 
laboratory to laboratory on the kind o f distractive force which is applied to a 
population of cells adherent to the surface. Conveniently these forces can be 
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In this method detachment forces on cells are applied in the form of gravity or 
a centrifugal force. Many studies quote Dan (1936) the first person who used this 
technique but Easty et al (1960) appeared to develop it further. Later diverse 
modifications in this method have been made to measure cell-cell or cell-substratum 
adhesion. For example McClay et al (1981) made the cell radioactive and brought it 
to the surface for making contact with the monolayer o f cells in a sealed compartment 
by a low  centrifugation force. This assembly was inverted in a centrifuge and a 
centrifugal force applied to detach the probe cell (radioactive cell) from the 
monolayer. By varying the centrifugal force in term o f speed o f centrifuge McClay et 
al were able to measure attachment and detachment o f chicken neural cells.
Goerge et al (1980) determined the adhesion o f  human erthrocytes to glass by 
using this centrifugal technique. A cell suspension was injected into the chamber and 
was allowed to settle for 10 minutes and the chambers were inverted in the centrifuge 
which was spun at 3000rpm. After removing the chamber, adherent and non adherent 
cells were counted. The centrifugal detachment force was calculated as a function of 
cell mass and centrifugal speed. Recently Lotz et al (1989) modified the method o f 
McClay et al (1981). They labelled the cells with -^H-leucine which were added to a 
plate in microtitre well. The second microtitre well was inverted over the first 
micrititre well and were sealed together with a gasket The cells were attached by 
gentle centrifugation onto the plate in the first well. The plate is inverted immediately 
after gentle centrifugation and various known forces are applied to detach the cells 
from the plate. At this stage the top and bottoms o f two microtitre wells were cut and 
the detachment was quantified by scintillation counting (figure 1.9).
The centrifugal method is rather uninformative. Because many cells remain 
adherent in response to the detachment force might represent increased adhesion or a 
change in cell shape which did not allow them to detach In addition, the centrifugal 
technique tends to be time consuming and limited in the range o f forces which can be
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A CENTRIFUGAL FORCE BASED ADHESION ASSAY (Lotz et al, 1989).
MO
FIGURE 1.10
A MICROMANIPULATION BASED CELL ADHESION MEASURING 
DEVICE (Bowers et al, 1989). DIAGRAM SHOWS 
M = Micrppipette 
MO = Microscope objective 
I = An adhering cell under investigation 
C = Other cells
S = Substrate for cell attachment 
A = Aqueous medium surrounding the cells.
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applied to detach the fully spread cells. Often the strength o f the final adhesion is so 
large that it exceeds, technically the ability to measure it by centrifugal method.
Few other methods have been developed by which a known force could be applied to 
an individual cell to break the adhesion. These methods are called 
Micromanipulation and are discussed below.
1.4.2. MICROMANIPULATION
In these systems the adhesion o f a single cell to the substratum or separation 
of pairs of cells can be studied . Coman (1944) introduced this method in its simplest 
form. Coman (1961) used a calibrated microneedle to separate two adherent cells 
from each other and cell from substratum. The position o f the tip of the flexible 
needle just prior to detachment o f the cell was compared to its unstressed position 
when the cell to substrate contact was broken.
A few other workers have modified this method. For instance Evans (1984) 
developed a method on the basis o f Coman's technique. He applied a force which 
sucked cells into a micropipette at known pressure and at the same time the shape of 
cells in response to suction was observed. However, the adhesion zone was not 
directly observed in Evan's experiment. Later, Frances et al (1987) combined the 
elements o f Coman (1961) and Evan's methodology. Frances et al (1987) applied the 
force to the adherent cell via a flexible fine calibrated micropipette. The micropipette 
was attached to the adherent cell into a position so that it can be sucked into the 
micropipette. Measurement of cell adhesion can be made by calculating the applied 
force from the degree o f bending o f  the pipette. The main advantage o f this procedure 
was the direct observation of adherent zone in response to applied force. This was 
done by using interference reflection microscopy (specially designed for observing 
the contact zone). All the experimental information is recorded on a recorder.
Two years latter, a group o f workers (Bower's et al, 1989) came up with a very 
complex new version of the Frances et al' methodology. In a prototype experimental
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design the microscope plays a central role as it supports the cell attached substratum. 
A calibrated vertically oscillating micropipette is also positioned between the 
microscope and the celll bound substrate. The application o f the micropipette is 
manipulated electrically- This assembly is attached with a pressure control system 
which allows the reduction in pressure resulting detachment o f the cell from the 
surface. Measurement o f the pressure and time is continuously displayed on a video 
screen and recorded from a video camera ( figure 1.10).
Although through these refinements on Comans (1961) method avoided puncturing 
and tearing o f a cell, how sad it is that with such a complex, expensive and high 
technology equipped method, only the adhesion o f a single cell out o f millions o f  
cells can be measured at a time. Therefore the complexity and time consuming and 
the fact that relatively small number of cells can be examined in a whole day, 
contributes to the limitations o f this procedure. The limitations o f centrifugal and 
micromanipulated techniques could be avoided by using a hydrodynamic shear force 
on the cells. The brief description o f these techniques is given as follow.
1.4.3. HYDRODYNAMIC SHEAR FORCE METHODS
In these kind o f assays, the cells are first allowed to settle on a substrate and a 
hydrodynamic force is applied parallel to the surface. In attachment studies, the basic 
principle is almost the same in all the techniques developed for this purpose (figure
1.11). A cell containing suspension is passed over the surface and the number o f cells 
which are settled and make contact with the surface at particular flow rate o f  
suspension is measured after a specific time (Weiss, 1961; Mohandas, 1974;
Forresster & Lackie, 1984; Doroszewski & Kiwala, 1988).
For detachment studies adherent cells are exposed to a known shear field, 
usually a laminar flow is claimed to be applied to the adherent cells. In these 
categories the simplest and easiest method is the parallel plate flow chambers. The 
flow through these chambers is supposed to be laminar flow (the flow rate is greatest 
in the centre and least adjacent to the walls).
45
BASE
3 . 5  cm
■GLASS SLIDE 
6  GASKET
f i g u r e  1 . 11





j g 1 Front disc | j m
I •O' rings Back disc




CROUCH ET AL'S (1985) RADIAL FLOW CHAMBER.





A= Stainless steel frame
B= Silicon rubber gasket
D
C= Glass coverslip
D= Recess on the upper face of 
a poly carbonate block.





THE PARALLEL PLATE FLOW CHAMBER (Owens et al, 1987)
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Mohandas (1974) introduced very basic design ;and later number o f other workers 
used this basic design to develop their own paraillel plate chambers. (Doroszewski et 
al, 1979; Owens et al, 1987; Trusky & Pirone, 1990).
It is also appropriate to describe the methodology o f Mohandas et al (1974) (figure
1.11). In this design the upper portion o f a parallel plate flow  chamber contains a cell 
growing slide. The lower portion has a rectangular design. Fluid flows into and out o f  
the channel through two holes drilled in the glass slides. As fluid passes from inlet 
toward outlet the pressure drops and number o f cells which detach from the surface as 
a function of time and applied force are counted. The time and force are used to 
calculate a value below which essentially no cells will detach but above which all 
cells will detach, this is called minimum critical shear value.
Among the latest generation o f parallel plate chambers is the one which 
Owens & Gingell (1987) calibrated for red cells and E. coli adhesion (figure 1.13). 
These workers used a laminar flow which enters the conduit through cylindrical pipe 
integral with the end leading into an elliptical section and then into the rectangular 
conduit. The flow rate through the conduit can be varied by means o f a micrometer 
valves mounted in parallel with the flow line. The response o f cells to the shear stress 
is recorded using a video camera. They found the range o f critical shear values from
2.3 Nm'^ to 5Nm"2 for the red cells and E. coli.
The system is suitable for bacterial and red cells. It could be inefficient in 
measuring the adhesion of mammalian cells which adhere very tightly to the surface. 
Therefore, the measurement o f such cell adhesion could be beyond the ability o f this 
apparatus. Moreover the flow through the conduit is not laminar stabilized which can 
produce misguiding results.
The first attempt to measure the mammalian cell adhesion was by Crouch et al 
(1985). They developed a radial flow chamber, containing two discs separated from 
each other by a very small distance. The fluid is pumped into the centre o f these discs. 
A s it flows radially outwards, its velocity decreases in a way that a shear force 
gradient is generated (figure 1.12). The radial distance between the centre o f  the test
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disc and edge of the zone o f cell attachment can be used to determine the critical 
shear stress o f detachment. Abnormal flow patterns were observed in this set o f  
apparatus. It is also limitted in the range of detachment forces because at higher flow  
rate, the stability of flow can be questioned.
In conclusion, all kind of instruments have been developed for measurement 
of cell adhesion. They all suffer from the need for complex equipment and are further 
handicapped because of limited, and indefinable ranges o f detachment forces.
Having briefly reviewed the methods o f measurement o f cell adhesion, it was realised 
that a simple, reproducible and accurate instrument was required to measure the 
mammalian cell adhesion.
For this purpose, in the present work a simple but highly reproducible technique 
called a Microflow chamber has been developed (chapter 3). It is a cell adhesion 
measurement device in which a convergent channel has been devised. This 
convergent channel is the first o f its kind in the field o f cell adhesion in which the 
channel produces a complete laminar flow throught the chamber. With such laminar 
flow a definable force can be applied to the cell growing surface and the strength o f  
the cell-substrate interaction can be measured in terms o f a critical shear stress of  
detachment (chapter 3).
The present work has also as its objectives to understand the underlying mechanism 
of the adhesion strengthening phenomenon. In this respect, the adhesion strength of 
different mammalian cells has been measured and the possible mechanisms involved 
in this process discussed. Moreover the action o f some major factors have been 
implicated allowing us to explore the complexity of the adhesion strengthening 
phenomena. Among these factors, the role o f serum (different concentrations and 
origin), adhesion proteins (fibronectin & laminin), the recognition sequences o f  
fibronectin and laminin, protein synthesis and secretion on adhesion strengthening 




2 .1 . M A T E R IA L S
2.1.1. GENERAL
All chemicals used in the preparation o f solutions were from Sigma (London), 
Poole, Dorset, BDH Chemical LTD. , Poole, Dorset, Aldrich Chemical Company, 
Gillingham, Dorset, Flow Laboratories, Irvin, Scotland and Fission Scientific 
Apparatus England.
All tissue culture flasks and dishes were from Sterilin LTD. U.K.
2.1.2. CELL LINES
The cell lines tested in present work include: BHK21 (baby hamster kidney 
cells), L929 (NCTC clone) (mouse fibroblasts) , CHL (Chinese hamster lung 
fibroblasts), 3T3 (Swiss albino mouse embryo fibroblasts), Walker rat carcinoma 
cells, Hela B (human cervical carcinoma epithelial cells) and MDCK (Madine Darby 
canine kidney epithelial cells). All these cell types were obtained from Flow  
Laboratories.
2.1.3. CELL CULTURE
PBS (phosphate buffer saline), L-Glutamine, penicillin-streptomycin, non 
essential amino acids, lOx minimum essential medium Eagles (modified with earls 
salt, lOx RPMI 1640 medium without sodium bicarbonate and Trypan blue (0.4% 
w/v) in 0.85% saline solution were purchased from Flow laboratories. DMEM  
(Dulbecco’S modification of Eagles medium was from Gibco Europe LTD. 
HEPES(N-2-hydroxyethyl piperazine- N-2-ethanesulphonic acid was from BDH.
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Trypsin and trypsin inhifbitor(soybean trypsin inhibitor) was from Sigma. Nutidoma 
S.P. (serum free media w as obtained from Boehiringer Mannheim Biochemica.
2.1.4. SERA
Heat inactivated donor horse and donor calf serum were obtained from Flow  
Laboratories. Heat inactivated foetal calf serum was from Globepharm limited Surrey, 
U.K.
2.1.5. MICROFLOW CHAMBER
Peristaltic pump was from Watson Marlowe LTD. Glass slides were 
purchased from Chance Proper Limited. Square plastic dishes (144 cm^) were from 
Sarstetd Ltd. Beaumont Leys, Leicester, U.K. and tissue culture grade round petri 
dishes were obtained from Sterilin Limited U.K.
2.1.6. MODIFICATION OF SURFACES
Human plasma fibronectin and ^^I-fibronectin (human plasma) were from 
Flow Laboratories and laminin (Englebreth Holm- Swarm Mouse Sarcoma) was from 
Sigma.
2.1.7. PEPTIDES
RGDS(arg-gly-asp-ser-) and YIGSR (tyr-ileu-gly-asp-ser-) were purchased 
from Sigma. The YIGSR peptide was also made in our laboratories.
Resin "Fmoc-Arg-PepSyn-KA" and Fmoc-amino acids were obtained from 
MilliGen/BIOsearch U.K. and dimethylformamide, piperidine, 1-
Hydroxybenzotriazole, t-amyl alcohol, dichloromethane, diethyl eather,phenol, ethane 




Emetine dihydrochloride, cycloheximide (crystalline) and monensin sodium 
salt were obtained from Sigma.
2.1.9. RADIOACTIVE COMPOUNDS
^C-Nicotinamide (53mCi/mole, was from Amersham Limited U.K. and 
[•^S]-methionine was purchased from Dupont New England Nuclear).
2.1.10. RADIOACTIVE COUNTING
Scintillation vials were from Packard Instrument LTD. Germany, GF/C discs 
were from Whatman, Maidstone, Kent, trichloroacetic acid was obtained from Fisons 
Scientific Apparatus, England. OptiPhase (ethyl substituted benzene) was used as a 
scintilation liquid and was obtained from LKB.
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2 .2 . M E T H O D S
2.2.1. CELL CULTURE
2.1.1.1 REAGENTS A N D  BUFFERS.
a) Hepes buffer (20m M ):- 12.58 gm o f HEPES was dissolved in double distilled 
water to give final concentration o f 20mM and pH was maintained 7.4 with 0.1M
o
NaOH. The buffer was autoclaved ( under free steam conditions at 130 C temprature 
and 15 lb/in^ pressure for 30 minutes) for sterilization.
b) PBS:- (phosphate buffered saline):- PBS solution was made according to 
instructions of suppliers i.e. five tablets o f PBS were dissolved in 100 mis double 
distilled water and autoclaved.
c) TRYPSIN:- 1% (w/v) trypsin was prepared by dissolving lOmg o f trypsin 
lyophilisate in 1 ml o f pre cooled PBS. 0.1 ml aliquots o f this solution were dispensed 
into sterile storage tubes as quickly as possible, as the trypsin will begin digesting 
itself and stored at -20°C. Trypsin containing aliquot was thawed immediately before 
use and diluted in 2ml MEM or EDTA (0.02% w/v) solution.
d) ED TA 0.02%  (w /v):- 20 mg EDTA was dissolved in 100 ml o f PBS and filtered 
through a 0.2pm filter for sterilization.
e) CULTURE M EDIUM :- To achieve a 10 fold final dilution o f culture medium, 
MEM and RPMI 1640 (10 x concentration) were diluted in HEPES buffer and D  
MEM (10 X concentration) in double distilled water.
To these diluted media other constituents were supplemented as indicated below.
53
2.2.2 MAINTENANCE OF CELL LINES IN CULTURE
All the cell lines tested in the present work were used during the logarithmic 
phase o f growth and maintained in cultures according to the suppliers instructions 
(Flow, 1989). The old spent culture medium was decanted and monolayers were 
washed twice with PBS to remove remaining residues o f serum.
To detach the cells from the flask, 0.05% trypsin (1% stock solution was diluted in 
MEM or EDTA (0.02%)solution.) was added and incubated at 37°C  for 3 to 4 
minutes. Whereas MDCK cells required more extensive incubation with trypsin (15 to 
20 minutes). At this time trypsin was inactivated with serum containing medium 
Cell viability under the conditions used was always typically 99% as was checked by 
trypan blue exclusion method (equal volumes o f cell suspension and trypan blue were 
mixed and the cells were observed under the microscope). The viable cells excluded 
trypan blue. The cell lines were maintained as outlined below.
Hela B, CHL, L929 and MDCK cells were maintained in minimum essential medium 
o f Eagle with Earls salt, supplemented with 20 mM HEPES buffer, 10% v/v foetal 
calf serum, 200 I.U. penicillin, 20 |ig  streptomycin, lOOmM glutamine and 2% non 
essential amino acids.
BHK21 cells were grown in RPMI 1640 medium supplemented with donor calf 
serum. 3T3 cells were maintained in DMEM, supplemented with 10% (v/v) foetal calf 
serum. Walker rat carcinoma cells were maintained in MEM supplemented with horse 
serum, 0.1% sodium pyruvate. Other constituents for BHK, 3T3 and Walker rat 
carcinoma were the same as for other cell lines.
Culture medium was always added according to the volumes o f flasks (25 cm^, 75 
cm^ and 150 cm^) to obtain the cell density o f 1x10^ cells/ml. Cultures were 
incubated in a 5% (X ^/air (v/v) atmosphere and were subcultured twice a week.
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2.3 MEASUREMENT OF THE CELL ADHESION
For the measurement of cell adhesion the Microflow chamber which was devised in 
the present work was used throughout this study. This device is shown 
diagrammatically in figure 3.2& 3.3. The theory, principal and use o f this device is 
illustrated in chapter 3. At this stage it is appropriate to mention that cells are grown 
on glass or plastic substratum for 24 hours and after this time cell growing substratum 
is subjected to the hydrodynamic flow in the Microflow chamber for 10 minutes. 
After this time the Microflow chamber is disassembled and the critical shear stress o f  
detachment was measured by measuring the critical distance and putting its value in a 
shear stress calculation as described in the chapter 3.
2.4 SERUM AS A STIMULANT FOR CELL ADHESION STRENGTH
2.4.1. GROWTH MEDIUM
2.4.1.1. NUTRIDOMA MEDIUM
Nutridoma medium is a serum free medium, the composition and preparation 
of this medium for cell culture is outlined as below;
Nutridoma was diluted 100 fold in MEM containing medium. The final medium 
contained 20mM HEPES, 10% double distilled water, 100 I.U. penicillin, lOOug 
streptomycin, lOOmM glutamine, 2% (w/v) non essential amino acids and 1% 
Nutridoma medium (Boeringer, 1989).
2.4.1.2. PREPARATION OF MEDIUM WITH DIFFERENT CONCENTRATIONS 
OF SERUM AND NUTRIDOMA 1%
The MEM medium in separate containers was supplemented with different 
concentrations of serum, namely 10%,7.5%, 5%, 2.5% 1%, .5% and 0% (v/v). Other 
constituents of these mediums were the same as illustrated in cell culture section
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(2.2), except that these mediums were some tirmes additionally supplemented with 1% 
Nutridpma medium.
2.4.2 DETACHMENT ASSAY IN RESPONSE TO DIFFERENT 
CONCENTRATIONS OF SERUM.
Sub confluent monolayers of L929 and Hela B cells were washed briefly with 
PBS and incubated with 0.01% (w/v) trypsin/.02%(w/v) EDTA at 37°c for 3-4 
minutes. After the cells were detached from the culture flask the trypsin was 
inactivated with 2ml of culture medium containing different concentrations o f serum 
(0% to 10%). The resulting cell suspensions were resuspended in the medium 
containing 0-10% serum.
In some cultures o f L929 and Hela B cells, the trypsin was neutralized by the 
addition of soybean trypsin inhibitor to a concentration o f 0.1% (w/v) in 2ml o f  
Nutridoma -medium. The suspension o f these cells were inoculated into serum free 
medium (Nutridoma 1%). Detachment assays were performed with the old and new  
versions o f the Microflow chamber as described in section 2.3.
2.4.3. GROWTH OF L929 CELLS AND MEASUREMENT OF THEIR 
ADHESION IN SERUM FREE MEDIUM
Nutridoma medium was prepared as revealed above and cryopreserved L929 
cells were adapted to this medium over a period o f 3 weeks This was done by 
lowering the concentration o f foetal calf serum from 10% to 7.5% to 5% to 2.5% to 
1% to 0 %, (v/v) while maintaining the Nutridoma concentration at 1%. The cells 
were always inoculated at concentration o f 2x10^ cells/ml and incubated in a 
humidified atmosphere of 5% (v/v) CC^/air at 37°C. The health o f the cells was 
continually monitored by checking the pH and whenever necessary replacing old 
exhausted medium with new Nutridoma containing medium. The cells were very 
fragile and handled gently. Adhesion strength o f finally adapted L929 cells to glass
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substratum was measured in term of c.s.s. o f  detachment under standard conditions 
outlined in section 2.3.
2.4.4. TH E EFFECTS OF SERA OF DIFFERENT ORIGIN O N  THE  
STRENG TH O F DIFFERENT CELL TYPES.
L929, Hela B, and Walker rat carcinoma cells were seeded in the medium 
supplemented with horse serum or foetal calf serum onto glass or plastic substratum. 
The c.s.s. o f detachment o f these cells was measured under standard conditions 
illustrated in section 2.3.
2.5. THE EFFECT OF FIBRONECTIN AND LAMININ MODIFIED 
SURFACES ON THE ADHESION OF L929 CELLS.
2.5.1. FIBRONECTIN C O ATING  ON PLASTIC SU B ST R A T U M .
Lyophilized human plasma fibronectin was obtained from Flow laboratories.
lm g lyophilisate was dissolved in 1ml of sterilized double distilled water for 30 
minutes at room temperature in laminar flow cabinet. The required concentrations o f  
fibronectin were dissolved in 10 ml o f sterilized double distilled water. The resulting 
solution was poured into 100mm tissue culture grade plastic dishes. Fibronectin from 
this solution was allowed to adsorb on the plastic dishes and the water was evaporated 
overnight. Dried dishes were washed twice with double distiled water and once with 
PBS immediately before seeding the cells. Control dishes were prepared in an 
identical manner except that the first incubation was in 10 ml double distilled water 
without fibronectin (Obrink. 1982).
2 .5 .2 . Q UANTIFICATIO N OF FIBRONECTIN A D SO R PTIO N . 
iZ,JI-fibronectin (5.3|iCi/p,g) in the form of a solution was obtained from Flow
laboratories and the same day this solution was made up to 10 ml with double distilled 
water to give final concentration 1 p.Ci/ml. 0.5 ml o f this solution was added per well
57
of 24 well tissue culture grade dish and allow ed to adsorb overnight. The water was 
evaporated and each well was washed twice with 0.5ml of double distilled water. 
Both washings were pooled together.
The coated ^I-fibronectin  was extracted twice with 0.5ml o f 1M NaOH. 
Each extraction lasted for half an hour. Extractions and washings were counted 
separately for 2-10 minutes on the gamma counter Curtis & Forrester, 1984).
Together the counts per minute and the known specific activity of the *2^I- 
fibronectin allowed calculation o f the number o f molecules adsorbed per cm 2, 
assuming a monomeric uniform distribution. Thus quantity o f ^ I - f i b r o n e c t i n  
adsorbed on the plastic was calculated as illustrated below;
Molecular weight o f fibronectin = 440 Kd
Or 440,000gm/mole
Or ljig  fibronectn/2.3xl0"^m ole
Or 2.3x1 O'^ = 1 2.43x 1 O^counts per minute (cpm)
Observed cpm = A
Thus amount in the observed cpm (Y) = 2.3x10"^ /12 .43x l0^
Avogadro number = 6 x l0 23 
Number o f molecules (B) in Y will be =
B = 2.3x10"12/12.43x106 x  A x  6.02x1023
2.5.3 LAMININ COATING ON THE PLASTIC.
100mm tissue culture grade dishes were coated overnight at room temprature 
with 10 ml of PBS containing 175 pg of laminin. Thereafter unadsorbed laminin was 
extensively (3-4 times) washed with PBS The control dishes were prepared in exactly 
the same way except that they were first incubated with PBS without laminin (Shaw 
et al, 1990).
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2.5.4. MEASUREMENT OF CELL ADHESION ON THE PROTEIN 
MODIFIED SURFACES.
Sub confluent L929 cells were trypsinised, trypsin was inhibited with 10% 
serum containing medium or with soybean trypsin inhibitor. The resulting cell 
suspensions were maintained on fibronectin coated or uncoated plastic dishes in the 
presence or absence o f serum in the medium. Where the serum was absent, the 
medium was supplemented with Nutridoma 1%. The cells were allowed to grow for 3 
or 24 hours and after this time c.s.s. o f detachment was measured as described earlier 
(section 2.3).
The adhesion strength o f L929 and Hela B cells on laminin coated substratum was 
examined in exactly the same way
2.6. EFFECT O F R G D S A N D  Y IG SR  O N  A D H E SIO N  ST R E N G TH  
OF L 929 A N D  H ELA  B CELLS
2.6.1. SYNTHESIS OF YIGSR (tyr-ile-gly-ser-arg)
The peptide synthesis was performed on the MilliGen 9050 automated peptide 
synthesis according to manufacturers instructions (MilliGen/Biosearch, 1990). The 
MilliGen 9050 pepsynthesizer automates the Fmoc polyamide method o f peptide 
synthesis. The specific amino acid derivatives, support and reagents utilized in this 
method are described as below.
2.6.1.1. CHEMISTRY OF THE PEPTIDE SYNTHESIS
a) a-AMINO PROTECTION
In the Fmoc-polyamide method of solid phase peptide synthesis, temporary 
alpha-amino protection is provided by the 9-fluorenylmethyloxycarbonyl (Fmoc) 
group. The Fmoc group is base labile and can be rapidly removed by beta elimination 
with secondary amines such as piperidine (structure 2.1).
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b) SIDE CHAIN PROTECTION
t-Butyl derived groups are used for side chain protection o f L-serine and L- 
tyrosine (structure 2.2). These acid labile groups are stable during the peptide 
assembly and are removed at the end of the synthesis by the action o f trifluoroacetic 
acid. Arginine is a special case. The trifluoroacetic acid labile 
methoxytrimethylbenzenesul-phonyl (Mtr) group is provided for protection o f the 
guanidine function o f arginine (structure 2.3)
c) Fm oc AM INO  A CID  ACTIVE ESTERS
The active esters for the glycine, isoleucine and tyrosine were 
pentafluorophenyl derivatives (-OPfp) (structure 2.4) and dihydro-oxobenzotriazine 
ester derivatives (-ODhbt) for L-serine (structure 2.5).
d) COLUMN PACK
d-1) RESIN
In the Fmoc-polyamide solid phase peptide synthesis the support employed 
was the Fmoc-Arg-pepsyn KA (structure 2.6). This was obtained commercially and 
according to suppliers information it is formed by copolymerizing a 
polydimethylacrylamide gel within the pores of rigid macroporous Kieslguhr 
particles(diatomaceous earth) with cross linking monomers and functinalizing 
compounds to yield a final resin. The latter, sarcosine methyl ester provides the sites 
o f attachment for the growing peptide. To this Fmoc Arginine is esterified.
d-2) PACKING OF COLUM N
The dry resin and DMF were gently mixed until the resin was saturated. The 
column was packed with a fixed length o f slurry. An adjustable length end piece was 
added to eliminate the dead volume and the column was attached to the instrument 
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STRUCTURE 2.3 STRUCTURE OF SIDE CHAIN PROTECTOR Mtr GROUP.
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STRUCTURE 2.6 STRUCTURE OF PepSyn KA RESIN.
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2.6.1.2. REAGENTS A N D  THEIR USE
a) D im ethylfom am ide (DM F)
The general solvent used in YIGSR peptide synthesis was DMF. The solvent 
contained no amines and was HPLC grade (99.9% pure) (according to suppliers 
informations).
b) Piperidine
Peperidine was o f the highest available purity (99%). It was used as a 20% 
solution (v/v) in DMF.
c) 1-Hydroxybenzotriazole (HOBt)
HOBt was used as a catalyst to facilitate formation o f the ester bond.
d) t-A m yl alcohol
It was used to remove DMF from the column
e) Diehloromethane
It was used as a general wash solvent for removal o f t-Amyl alcohol(section ).
f) D iethyl ether
Diethyl ether was used to get rid of Dichloromethane and for shrinking o f the 
column.
g) Phenol
It was used for deprotecting (for removal of Mtr) and as a scavenger
h) Ethane diethyl
It reacts with the Mtr and tertiary butyl and thus acts as a scavenger.
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i) Trifluoroacetic acid (TFA)
It deprotects the peptide and at the same time it cleaves the peptide from the 
support.
j) Petroleum ether
It was used to remove TFA but not scavengers and peptide.
k) Diethyl ether
This ether dissolves scavengers and leaves behind precipitated white peptide 
powder.
2.6.1.3. AUTOMATIC SYNTHESIS OF PEPTIDE
Synthesis was performed on the 9050 automated peptide synthesizer. In this 
system a MilliGen express- peptide program is provided. This program is a text based 
software package designed on a nested- menu format. The main menu displays a list 
o f options that may be selected. By selecting different options the job o f YIGSR 
synthesis was assigned to the system. In this regard the following information to the 
system was provided.
Starting resin = Fmoc-Arg-PepSyn-KA 
Resin quantity = 2.2gm
Target peptide length = 5(NH2-Tyr-Ile-Gly-Ser-Arg-COOH)
Molecular weight of the peptide = 594.678 
Theoretical yield = 0 .1 18gm 
Suggested loop size = 5ml 
Average flow rate = 5ml/min 
Solution volume for .3 molar = 2.64ml
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Estimated reagent usage for synthesis completion:
DMF 524 ml, Piperidine 175 ml and HOBt 11 ml 
Chemistiy o f  amino acids quantit y position on rack 
Gly (Fmoc-Gly-OPfp 0.367gm 2
lie (Fmoc-L-Ile-OPfp 0.41 Igm 3
Ser (Fmoc-L-Ser(But)-ODhbt 0.419 1
Tyr (Fmoc-L-Tyr (BUT)-OPfp 0.495 4
The starting resin was soaked in DMF for 10 minutes at room temperature. The resin 
was washed extensively with DMF to remove fine material. The column was packed 
as illustrated above and was attached to the instrument. The resin on the column was 
thoroughly saturated with DMF. The flow rate was 5ml/min and DMF was run for 
about 2 min. Solvents were further run for 15 minutes to remove air bubbles from the 
system. The amino acid vials were now loaded in the rack according to the position 
indicated above. At this point automatic synthesis was started by pressing the key 
"Run" o f computer attached to the MilliGen instrument.
Though the system is automated, it is appropriate to mention that in the Model 9050, 
a protected Fmoc- amino acid is the starting material. Addition o f soluble activating 
agents (e.g. OPfp & ODHbt) to the amino acids results in the formation o f active 
species. The activated amino acids are transferred to the reaction column for the 
coupling step. Series o f cycles take place. For example, the piperidine, deprotects the 
amino terminus o f a support bound amino acid which in turn reacts with the activated 
carboxyl terminus of the incoming amino acid. The cycle o f deprotection and 
coupling is repeated until chain elongation is complete.
Completion o f the solid phase peptide synthesis results in the generation o f a resin 
bound peptide. The column was removed from the system. The peptide on the resin 
was first thoroughly rinsed in inert organic solvent i.e. t-amyl alcohol. This was 
important because DMF was used during synthesis, since it is non volatile and its 
presence would have interfered with the subsequent cleavage and deprotection 
procedure. FM1 LAB pump (module G150) was used to wash the column with 40-60
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ml of t-amyl alcohol and then to get rid of t-<amyl alcohol the column was washed 
with 20 ml o f dichloromethane. Until this stage the column was still swollen and it 
could still retain some solvents. Thus 20 ml diethyl ether was pumped through the 
column to wash out the dichloromethane and to shrink the resin gel.
2.6.1.4. CLEAVAGE AND DEPROTECTION OF PEPTIDE
With PepSin KA resin, the peptide resin bond is cleaved and most side chain 
protecting groups are removed by the action o f a TFA/  scavenger mixture. For this 
purpose to 900 mg o f resin bound peptide a pre cooled mixture o f TFA and 
scavengers (0.25g phenol, 250pl ethane diethyl and 10 ml o f TFA 95%) was added 
and reaction was left to proceed for 4 hours at room temperature. Peptide plus 
TFA/scavenger mixture was filtered through scintered glass and collected in a round 
bottom flask.The Resin was washed 3-4 times with TFA and the filtrate was collected 
in the same round bottom flask. To remove TFA and stop the cleavage reaction about 
100ml petroleum ether was added to the mixture o f cleaved peptide, scavengers and 
TFA.The peptide was precipitated and filtrate was carefully discarded. To the 
precipitate diethyl ether was added. Diethyl ether dissolved the scavengers leaving 
peptide as a precipitate white powder. The precipitated material was dissolved in 
0.5% B solution (acetonitrile + water(90:10) + 0.1%TFA).The peptide was dried on 
the rotary evaporator and freeze dried overnight.
The goal of cleavage/deprotection was to separate the peptide from the support and at 
the same time to remove the protecting groups from the side chains. This was done 
quickly to minimize the exposure o f the peptide to the acid reagent. The peptide was 
then recovered from the reaction mixture as stated above and analysed on HPLC.
2.6.2. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
a) BUFFERS
BUFFER A: 0.1% (v/v) aqueous TFA
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BUFFER B: acetonitrile in 0.1% (v/v) aqueous trifluoroacetic acid.
2 .6.2.1. ANA LYTICA L HPLC
HPLC appratus was from LKB and in this a reverse phase VYDAC C-18 
column was used for analysis of the collected fractions. The column was 25cm in 
length and 4.9mm in internal diameter. The calculated flow rate was 0.72ml/min. 
0.028 gm of lyophilized peptide was dissolved in buffer B and analytical HPLC was 
performed by using gradient mode o f 5% B and 95% A. The gradient was stopped at 
40% B. The peptide was monitored at 215nm which is closer to the absorbence o f the 
peptide bond (210-214). The peptide started to elute at 27% B gradient. About 20 
fractions were collected on this gradient and analysed on the preparative HPLC as 
described bellow.
2 .6 .2 .2 . PREPARATIVE HPLC
HPLC apparatus was from LKB in which a C18 column o f wide pore(300A°) 
with a particle size o f 10p.m in diameter was used. The column was 25cm long and 10 
mm in internal diameter. The calculated flow rate through this column was 3ml/min. 
Preparative HPLC was performed by using the gradient mode o f 5%B and 95%A. A 
large peak at 25% B was obtained with several small "junk” peaks which were just 
equivalent to the peaks of running reagents. Fractions were collected at this large peak 
and analysed further.A single peak was obtained at 215nm. Whole cleaved peptide 
was purified by using the protocol described above. Solvents were evaporated on the 
rotary evaporator and freeze dried overnight. Lyophilisate was stored at 4°C  until use.
2.6.3 EFFECT OF RGDS & YIGSR O N A D H E SIO N  STREN G TH  O F L929  
CELLS
Immediately after plating the cells on plastic or glass substratum for 
detachment assay, the RGDS or YIGSR (concentrations indicated in the figures 6.1,
6.2 and 6.3) was added. The effect o f these peptides on the adhesion strength o f L929
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cells was analysed by incubating the cells for 24 hours and measuring the c.s.s. of 
detachment with the old or new version of the Microflow chamber.
2.7. ROLE OF PROTEIN SYNTHESIS IN CELL ADHESION
2.7.1. PREPARATION OF DRUG SO LU TIO N S
a) EM ETINE OR CYCLOH EXIM IDE (5mg/ml):- lOOmg emetine or 
cycloheximide was dissolved in 20ml complete medium and sterilized by filtering 
through a 0.2jj.m filter. 1ml aliquots o f this stock solution were dispensed into 
sterilized Eppendorf tubes and stored at -2 0 °  C. The frozen drugs were thawed 
immediately before use and stock solutions were serially diluted to obtain the 
concentration o f drugs indicated in the figures 8.1 to 8.4 and 8.5,8.8 and 8.9.
b) M O N EN SIN  (5mg/ml):- lOOmg monensin was dissolved in 20 ml absolute 
alcohol and kept in freezer. Immediately before use the monensin solution was 
warmed at room temperature for 15 to 20 minutes. lOOp.1 o f alcohol containing 
monensin was added into 100ml o f Nutridoma or complete medium. From this 
solution (5|ig/ml), serial dilution was performed to achieve a final concentration o f  
monensin as indicated in the figures ,8.5,8.6,8.8, and 8.9.. No adverse effects of 
alcohol(ljLtl/ml) without monensin on the growth or viability o f L929 cells were 
observed, as was checked by trypan blue exclusion method.
2 .7 .2  DETERM INATIO N OF EFFECTIVE D O SE  OF D R U G S FOR  
INH IBITION OF GROW TH OR PROTEIN SY N T H E SIS.
To determine the specific dose o f monensin, emetine or cycloheximide to 
work with, the response o f L929 cells to these drugs(in term of their growth or/and 
protein synthesis) was examined as described below.
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2.7.2.1. GROWTH:
Sub confluent cells were trypsinized and trypsin inhibited as stated earlier 
(section 2.2.2 ). The resulting cell suspension (1 x 10^cells/ml) was inoculated with 
these drugs (concentrations are indicated in the figures (8.1 to 8.4). Cell counting was 
continued with heamocytometer at different intervals for 96 hours. The measurement 
o f population doubling time was used to quantify the response o f L929 cells to these 
drugs.
2.7.2.2. PROTEIN SYNTHESIS INHIBITION.
For the protein synthesis inhibition following steps have been taken
a) DILUTION OF L-[35S]METHIONINE (8.5mCi/ml):-
L-[ SJmethionine was obtained from Dupont. The septum o f the vial was 
pierced with a syringe needle and touching o f the frozen product was avoided.The 
vial was vented in the fume hood and thawed at room temperature. Any pressure 
developed could vent through the syringe needle. The needle was removed and 
thrown in the radioactive waste bag. The contents o f the vial was diluted with 10 ml 
o f mercaptoethanol (20mM) and aliquotd equally into 10 ependorf tubes and stored at 
-80° C. Immediately before use this stock solution was diluted in complete medium. 
The final concentration of radioactivity which was added per well o f 24 well plate 
was always 0.51pCi.
b) DETERMINATION OF PROTEIN SYNTHESIS
L929 cells were placed in a 24 well plate in the presence, or absence, o f drugs 
and the cells were allowed to attach to the wells for 2 hours and metabolically 
labelled by adding 0.51 pci o f the [^SJmethionine to each well. The incorporation 
was followed over a period o f 8 hours. At times ranging from 0 to 8 hours, the 
labelled medium was carefully removed and each well was washed twice with PBS. 
The cells were then dissolved in 0.5ml o f 0.1 M NaOH which instantly digested the
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cells. To this mixture 2 to 3 ml o f ice cold 10% TCA was added and the reaction was 
left to proceed overnight at 4°C. The precipitated samples were then passed through a 
GF/C disc (previously washed with 2ml ice cold 5% TCA) on an ultrafiltration tower. 
The discs were then washed with 3 aliquots o f  ice cold 5% TCA (5ml) and finally 
with 95% ethanol (2-3ml). The discs were placed in a scintillation vial and dried at 
60° C . After drying, 2-3ml scintilant (OptiPhase) was added to each vial. The 
samples were counted in a Packard Tri- carb liquid scintillation counter.
2.7.3 SECRETION OF PROTEINS
Sub confluent L929 cells were sub cultured into 24 well plates and were 
metatabolically labelled with [^S]methionine (lpC i/w ell) overnight in serum 
containing medium. After this time, the labelled medium was decanted and [^ S ] -  
methionine incorporated cells were carefully washed 3 times with Nutridoma medium 
(0.5ml). To each well 1ml Nutridoma (1%) medium with monensin or without 
monensin was added. At different time points (as indicated in figure 8.6) the 
conditioned medium was collected, centrifuged and precipitated with ice cold 20% 
TCA. The precipitate was processed for counting as illustrated in protein synthesis 
section.
2.7.4 SECRETION OF NICOTINAMIDE-14C
The Nicotinamide- C (53mCi/ml) was from Amersham LTD U.K. and was 
diluted with 50% ethanol to give 25jiCi/ml. 20jil o f nicotonamide (25|iCi/ml) was 
added to 250ml of complete medium and out of this labelled medium 10ml was added 
to each flask (25cm ^ ) at the time o f inoculation o f L929 cells. The incorporation o f  
labelled nicotinamide in the L929 cells was allowed to occur for 48 hours. At this 
time labelled medium was carefully removed and the cells were washed with PBS 2-3 
times. To the labelled cells 10 ml Nutridoma medium(l%) with and without
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monensin was added. The conditioned medium was collected at different time 
intervals (see figure 8.7). and after adding scintillant (OptiPhase) counted in a 
Packard Tri-carb liquid scintillation counter.
2.7.5. EFFECT OF ENDOGENOUS PROTEINS ON THE ADHESION 
STRENGTH OF L929 CELLS
The following approaches have been developed to examine the effect of 
inhibition of protein synthesis or secretion on adhesion strength o f L929 cells:
a):-
The conditioned medium of sub confluent L929 cells growing on glass or 
plastic substratum was replaced with or without drug containing new medium (serum 
or without serum). After this cells were further incubated for 3 or 6 hours and c.s.s. o f 
detachment was measured at this each time point (figure 8.5)
b):-
The overnight growing L929 cells were treated with drugs and further incubated for 
24 hours. After this time the c.s.s. o f detachment was measured as described earlier 
(section 2.3). The concentrations are indicated in the figure 8.8.
c):-
Sub confluent L929 cells were trypsinized and after inhibiting trypsin with 10% 
serum containing medium, the cells were subcultured on glass or plastic in presence 
or absence of drugs (figure 8.9). The c.s.s. o f detachment was measured by using the 
old or new version of the Microflow chamber.
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d):-
L929 cells in their logarithmic phase were trypsanised with 0.05% trypsin in 0.02% 
EDTA and trypsin was inactivated with 0.1% soybean trypsin inhibitor in Nutridoma 
medium. The cells were plated on glass or plastic in the presence o f serum free media 




THEORETICAL BACKGROUND OF THE MICROFLOW 
CHAMBER 
3.1. TERMINOLOGY
Before illustrating the theoretical background o f the Microflow chamber (a 
cell adhesion measuring device developed in present work) it is appropriate to discuss 
some terminology involved in the design of this device.
3.1.1. INERTIAL FLOW
In this kind o f flow the inertial force (fictitious force) acts on the fluid i.e. a 
flow in which no external forces are exerted on a fluid is called inertial flow.
3.1.2. REYNOLDS NUMBER
A dimensionless number which is significant in the design o f a model o f any 
system in which the effect o f viscosity is important in controlling the velocities or the 
flow pattern of a fluid; equal to the density o f a fluid, times its velocity, times a 
characteristic length, divided by the fluid viscosity.
3.1.3. LOW REYNOLDS NUMBER
When the Reynolds number is much smaller than unity the viscous force 
dominates over the inertia force so much that the latter plays a negligible role in the 
flow dynamics i.e. the flow will be smooth.
3.1.4. HIGH REYNOLDS NUMBER
At high Reynolds number viscous force is so small compared with the inertia 
force that it can be neglected and the flow will not be smooth.
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3.1.5. LAMINAR FLOW
Streamline flow  o f an incompressible, viscous fluid; that is all particles o f the 
fluid move in distinct and separate lines without turbulence. In other words each 
element of a fluid travels smoothly along a simple well defined path called Poiseuille 
flow. That is each element starting at the same place (at different times) follows the 
same path.
3.1.6. TURBULENT FLOW
Motion o f fluids in which local velocities and pressures fluctuate irregularly, 
in a random manner and producing a turbulent boundary laver in which the Reynold 
stresses are much larger than the viscous stresses.
3.1.7. CONVERGENT CHANNEL
When a change occurs as a decrease in width, relative to the direction o f flow, 
the transition length is referred to as a convergent channel. Flow through a convergent 
channel is accelerating.
3 .2. THEORY OF THE M ICROFLOW  CHAM BER
The theory of the Microflow chamber is dependent on the fact that the flow o f  
a viscous incompressible fluid between plane parallel plates is governed by a 
parabolic velocity distribution (so called Poiseuille flow) (Millsaps & Pohlhausen, 
1953). The velocity profiles o f fluid in the parallel plate chamber is given in the figure 
(3.1). An obvious inspection o f this velocity profiles show that each o f these profiles 
is more sharply curved in the middle o f the channel than the Poiseuille parabola, 
which is valid for parallel flows.
The velocity profiles also show that as the Reynold numbers increases to still 
larger values, back flow regions will appear along each wall. In a divergent 
(widening) channel the profile is not parabolic even at low flow rates and becomes 
worse as the flow rate is increased until back flow occurs near the walls (curves 5, 6
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and 7). However, in the convergent channel, where each o f values leads to a 
symmetrical profile with jets and back flow, the lowest Reynold number or the largest 
value o f K (a parameter which is inverse of the Reynold number) leads to the normal 
symmetrical profile. In convergent channel, provided the design is correct, the curves 
3 to 2 to 1 show that increasing the velocity gives increasingly smooth flow. 
Moreover it should be noted that Poiseuille flow  is smooth parabola (the dotted line o f  
curve 4) and is known as laminar flow. Thus in a convergent channel a wall on both 
sides o f this parabola can be constructed to yield a laminar flow.
The dimensions o f the Microflow chamber are given in this section (see later) 
and are designed on the basis of theoretical predictions that in a convergent channel, 
turbulent boundary layer becomes laminar, when values o f a parameter K (an inverse 
o f Reynold number) exceeds about 2x10'^ the phenomena which is referred to as 
"laminarisation". Even if  there is turbulence at the entrance to the channel, it becomes 
laminar very quickly. This is "flow re-laminarisation" and an essential feature o f  the 
design o f the Microflow chamber. The theoretical studies (Launder & Lockwood, 
1969) also show that if  the design is correct the values o f  K increases as the flow is 
accelerated along the convergent channel. This means flow  will be increasingly 
laminar at higher flow rates.
This laminar flow o f a fluid is used as a hydrodynamic shearing force to 
detach the cells from the surface. It may be argued that cell growing surface is not 
smooth and the laminarisation of the fluid on the cell growing surface could be 
turbulent. Again on the basis o f the theoretical and experimental evidences (Cebeci & 
Smith, 1974) it is clear that if  the roughness o f the surface is reasonably small, 
nothing unusual will happen to the mean velocity distribution. This is because if  the 
free stream velocity increases rapidly, there is not time for the turbulence to respond 
very much. In convergent channels, the turbulence fluctuations remain nearly the 
same in "metere/sec" but the mean velocity in "metre/sec" increases so that the 
dimensionless turbulence intensity decreases. Thus the flow  remains largely laminar. 
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FOGURE 3.1
VELOCITY DISTRIBUTION IN A CONVERGENT AND A DIVERGENT 
CHANNEL AFTER MILLSAPS AND POHLHAUSEN (1953)
CONVERGENT CHANNEL 
Curve 1 = 5,000 
Curve 2 = 1342 
Curve 3 = 684
DIVERGENT CHANNEL 
Curve 5 = 684 
Curve 6 = 1342 
Curve 7 =5,000
Curve 4 refers to a channel with parallel walls (Poiseuille parabolic velocity 
distribution)
This graph shows the velocity profiles of fluids flowing in channels. With parallel 
walls it is smooth parabola ( the dotted line of curve 4) and is known as laminar flow.
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and use o f the Microflow chamber are given as below.
3.3 INTRODUCTION OF THE MICROFLOW CHAMBER.
The Microflow chamber (a cell adhesion measuring device) is shown, 
diagrammatically in the figures 3.2 and 3.3. A convergent channel is accurately 
developed in this chamber, in which a complete laminar flow is achieved for 
hydrodynamic detachment o f the cells from the surfaces. At present two versions o f  
this device exist. The old version is suitable for glass slides and the plastic o f  the size 
of the glass slides. The new version is suitable for glass and plastic petri dishes. Both 
versions are easy to handle and are described below.
3.3.1. OLD VERSION
The Microflow chamber consists o f two parallel plates (made by machined 
perspex') separated by a small distance as illustrated in figure2.1. The convergent 
channel is designed in the upper part o f the chamber. Cell growing plastic or glass 
slides are inserted into the recess which constituents the lower part o f  the device. Prior 
to the channel there is a lead in section (figure 3.2). The two halves o f  the chamber 
are assembled and are clamped tight. To ensure the tight sealing a gasket (silicon) is 
placed around the convergent channel. The Microflow chamber is connected on one 
side with a reservoir containing running medium and on other side with a peristaltic 
pump. The device was tapered by (Quatro Biosystem Ltd. U.K.
3 .3 .2 . NEW  VERSION
The geometry of this version is exactly the same as the old version. The 
convergent channel for the new version is tapered in the round shaped aluminium cast 
and coated with nvlon. The cell growing 100mm plastic dish is assembled with this 
lower part as an upper part o f the chamber. The whole assembly is clamped with a 
metal lid. The inlet and outlet o f this version are also connected with a peristaltic 
pump and reservoir containing medium respectively, (figure 3.3 ). Actual convergent 
channel in the new version is
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Figure 3.2 Dimensions of the Microflow chamber
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FIGURE 3.3 B Side view of the assembled Microflow chamber
Cell M onolayer 
Clamped T ightly  |
l r
T issue  C ulture D ish






Figure 3.3 The new version of the Microflow chamber
10"""PICTURE 3.1
The Microflow chamber (old version) before assembly
Assembled Microflow chamber
m ***»PICTURE 3.2
New version o f  the Microflow chamber
Cell adhesion assay ol the cells growing in 100mm petri dish.
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exactly the same as in the old version. Dimensions o f the Microflow chamber are 
shown in the figure 3.2 & 3.3 and are described below.
3.4 DIMES IONS OF THE MICROFLOW CHAMBER 
The old version o f the Microflow chamber is 151mm long and consists o f two parallel 
plates. Each plate is 20mm thick (picture 3.1). A convergent channel is devised in the 
upper part o f the Microflow chamber. There are two major sections of the Microflow 
chamber, a lead in section (30mm) and a convergent channel i.e the test section which 
is 76mm long (figure 3.2). The inlet area o f the lead in section is 20mm^ and is 
constant up to the test section inlet which is also 20mm^. After the test section inlet, 
the convergent channel starts, which is tapered by keeping constant depth (1mm). The 
outlet of the Microflow chamber is 3mm wide.
The new version o f the Microflow chamber is 99mm in diameter (picture 3.2).The 
lead in section in this device is 20mm (figure 3.3).The rest o f the dimensions are 
exactly the same as o f the old version.
3.5 . D ETACH M ENT A SSA Y
(1) PREPARATIONS OF SAMPLES:-
Sub confluent monolayer cells are trypsinized with 0.05% (v/v) trypsin and 
the action of this proteolytic enzyme was stopped by serum containing culture 
medium. The resulting cell suspension, at the concentration o f 2x10^ cells/ml, was 
inoculated into complete growth medium. This cell containing medium was poured 
into 144cm^ plastic dishes already containing five sterilized microscope slides or in 
tissue culture grade plastic dishes (100mm). The cells were allowed to grow for 24 
hours in a 5% CC^/air atmosphere at 37°c.
(2) RUNNING MEDIUM:-
MEM or RPMI 1640 growth medium was diluted in 20 mM HEPES buffer to 
give final concentrations of growth medium 10% (v/v). The pH was maintained 7.4 
with 0.1M NaOH.
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(3) PRINCIPLE AND EXPERIMENTAL PROCEDURE OF THE 
DETACHMENT ASSAY.
In the old version,the cell growing slide is inserted into the recess which 
constituents the lower part o f the chamber and in the new version,the cell growing 
dish (100mm) is assembled as the upper part o f the chamber. After the assembly o f  
the chamber the running medium from the reservoir is pumped through it at a 
predetermined flow rate for ten minutes. The flow rate can be controlled by simply 
varying the RPM o f the peristaltic pump (figure 3.4 & 3.5).
As soon as medium enters into the chamber,the lead in section (figure 3.4) 
reduces the turbulence and stabilizes the flow. As medium enters the test section 
(figure 3.2 to 3.5) due to the convergent channel, it travels with a tapering width but 
constant depth, thereby accelerating the flow from the inlet toward the outlet o f the 
chamber. The increasing fluid velocity results in an increase in hydrodynamic shear 
stress along the cell growing surface (figure 3.6). At a certain critical point, near the 
outlet, the surface shear stress becomes sufficiently large to cause the detachment o f  
the cells. The critical distance from the inlet to this attachment/detachment boundary 
is used as a direct measure o f critical shear stress (c.s.s.) o f detachment in terms of  
Nm"^ (calculation and figure 3.7). The flow rate was calculated by measuring the 
volume o f liquid pumped per minute at a specific speed o f the peristaltic pump.
The following equation is derived for the calculation o f the critical shear stress of  
detachment.
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FIGURE 3.6 SCHEMATIC REPRESENTATION OF THE HYDRODYNAMIC 
CELL DETACHMENT
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3.6 CALCULATION OF THE CRITICAL SHEAR STRESS
According to Owens et al(1987) critical shear stress (x) between two parallel plates
can be calculated by using the following equation:
x = (X x dv/dy
\i = viscosity o f the fluid
dv = change in the velocity
dy = change in the depth
In the calculation for the critical shear in the Microflow chamber the viscosity and
depth are kept constant. Therefore:
Viscosity = \1 = 0.012 Poise = 0.0012 Mms'^
Depth = y  = 0.5mm = 0.0005m
The third factor in the critical shear calculation is the change in the velocity. By using 
the dimensions o f the Microflow chamber the change in the velocity can be 
determined as follows:
The fluid enters into the channel through an inlet area (20mm with a velocity called 
the inlet velocity.
Inlet velocity = Volumetric flow rate (f) /inlet area 
Flow rate = fml/cm ^ s" ^
Inlet area = 20mm^ = 0.2cm^
Thus the inlet velocity = f/0.2 = f/.2 ml cm"^s'^
As the fluid travels toward the outlet, the velocity increases in a linear fashion, with 
an acceleration the ratio of which can be measured as below  
Acceleration ratio over the whole test section = Inlet width/outlet width = 20/3 =6.67 
The length o f the test section is = 7.6cm
The acceleration ratio at any point D will be = 6.67 x D/7.6 = 0.877 x D
There are various streamlines o f the fluid which travels with different velocities. The
mean of these velocities can be determined.
Mean velocity = Inlet velocity x acceleration ratio at point D ml cm'^s"^
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Thus by putting the values of these factors in thte mean velocity equation:
Mean velocity = f/0.2 x 0.877 x D ml cm"* s'* == f/.2 x 0.877 x D/100 ml m"* s"^
The estimates given by Zachara & Doroszewski (1979) based on the movement of 
small particles indicate that the velocity o f the fluid in the centre will be maximum. 
and 1.5 times more than the mean velocity. Therefore the maximum velocity can be 
calculated.
Maximum velocity = 1.5 x mean velocity = 1.5 x f/0.2 x 0.877 x D/100 ml m"^s"  ^
Assuming that the velocity has changed from the inlet velocity to the maximum 
velocity at any point D, the values of the viscosity, depth and maximum velocity 
(change in the velocity) can be inserted in the equation, for the critical shear stress 
NnT2
x = H x dv/dy = 0.0012 x 1.5 x f/.2 x 0.877 x D/100 /0.0005 NnT2 
x = D  x f  x 0.15786 NnT2
Where point D is the critical distance from the test section inlet to the cell 
attached/detached boundary and f  is the volumetric flow rate for practicle purposes.. 
The derived factor 0.15786 can be approximated to 0.158.
Thus the final equation can be written as
Critical shear stress o f detachment (c.s.s.) = D x f x  0.158 Nm*^
SAMPLE CALCULATION
Some examples o f the measurement o f critical distance and c.s.s o f detachment are 
given in figure 3.6. An example o f the calculation o f c.s.s. o f detachment is given 
below.
For a critical distance (D) = 60mm = 6cm and a 
Flow rate per second (f) = 51 ml
The critical shear stress o f detachment (c.s.s.) = critical distance x flow rate x 0.158
= 6 x  51 x 0.158 = 48.3 NnT2
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db ca
A = Beginning o f the test substratum 
+ = Attachment/detachment boundary
Critical distance = (from A to +)
Flow rate = lOOOml/minute = 16.7ml/sec
Critical shear stress Nm'^ = flow rate/sec x critical distance x 0.158






Diagram to show the critical shear stress of detachment at different points 
(attachment/detachment boundary) along the surface of a cell growing test substratum 
in the Microflow chamber, at a constant flow rate of 1000ml minute"
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3.7 D ISC U SSIO N
As it mentioned earlier in chapter 1, due to inadequate standard quantitative 
techniques, the measurement of cell adhesion o f  different cell lines has been limited 
and often remained qualitative . Some quantitative studies have been proposed but 
they all suffer from the need for complex equipment (Horbert et al, 1988; Bowers et 
al, 1989). Moreover, the lack of reproducibility o f previous techniques render them 
inefficient and incompetent methods (Owens et al, 1987). This necessitated the 
development o f a simple and reproducible quantitative technique for the measurement 
of cell adhesion.
In the present work these requirements have been met when a simple but reproducible 
technique for the measurement of cell adhesion has been developed. The heart o f  this 
technique is a specially designed Microflow chamber (U.S. patent 4831869).
This Microflow system is the first o f its kind in which a complete hydrodynamic 
laminar flow is achieved through a convergent channel. The convergent channel is 
designed by keeping a constant depth but tapering the width o f the chamber. Prior to 
the channel, there is a lead in section which stabilizes the flow and reduces turbulence 
(figure 3.2 & 3.3). The convergent design o f the chamber accelerates the liquid flow  
as it passes from the inlet to the outlet. An increasing hydrodynamic shear stress is 
generated over the surface of the test substratum (figure 3.2 ). At a critical distance 
from the inlet the cells would be detached due to the shear stress they experience. 
This distance is used to measure critical shear stress of detachment (NnT^) (see 
calculation and figure 3.7)).
Since the flow is laminar, the fluid velocity near the walls o f the flow channel is 
assumed to be zero. Estimates given by Zachara and Doroszewski (1979) based on the 
movement of small particles through a parallel plate chamber, indicate that the 
velocity o f the fluid close to the walls is approximately one fifth o f the magnitude of 
the velocity o f the centre. Therefore, the velocity profiles across the chamber is 
calculated as 1.5 x the average velocity (section— ). This assumption is of 
considerable importance in the estimation of the strength o f cell adhesion.
88
While fluid velocity plays a crucial role in the measurement o f cell adhesion 
the viscosity of this fluid is also an important parameter. In all the experiments 
described the viscosity was 1.2 centi poise and kept constant throughout the present 
work (see equation 3.1).
The measurement o f cell adhesion while quantitative also needs to be rapid and 
reproducible. As in the presently designed chamber, the critical distance is measured 
with a millimetre scale and the resulting critical distance inserted into a simple 
equation (see calculation in section 3.9.1).
The novel design and principle o f the Microflow chamber, make it almost 
impossible to compare with previously designed hydrodynamic shearing techniques. 
However it is worthwhile outlining the deficiencies o f previously developed methods 
and explaining the advantages of Microflow chamber for this research work.
Firstly, it is clear that the strength o f adhesion o f a fully spread mammalian cells 
(monolayer) to the surface is so large that it exceeds the shear forces generated in 
previous methods (McClay et al, 1981; Owens et al, 1988). Shiga et al (1985) realized 
this deficiency in their device and found that red blood cell adhesion on glass and 
plastic was too great to be measured by their hydrodynamic shearing method. 
Considering this situation, any method developed for quantitative measurement o f  
adhesion must produce a range o f shear forces that are likely to be encountered in 
cells. That is; if cells are only weakly attached low shears will be needed whereas for 
tightly attached cells very high shears will be needed. In the device described here 
these requirements are fulfilled by having the accelerated flow, described earlier, and 
a pump which can provide both low and high volumetric flow rates. Thus the final 
strength o f adhesion o f any mammalian cell line on any surface can be assessed easily 
and accurately with the help o f this Microflow chamber.
It is important that at very high volumetric flow rates the fluid flow should remain 
laminar. For example Hela cells have a critical shear o f up to 62.0 Nm'^ on glass 
substratum. This figure does not illustrate the erroneous fluid velocity over the cells. 
For example at 62.0 Nm"^ the volumetric flow rate is 3000 ml/minute. At the cell
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attachment/detachment boundary the liquid velocity over the cells is 3.9m/sec (see 
calculation3.9.1). The flow at this velocity is still completely laminar because the 
theoretical predictions given earlier show that the liquid flow becomes increasingly 
laminar as the velocity is increases (Millsaps & Pohlhausen, 1953). Thus the adhesion 
of very tightly bound cells can be determined. Thousands o f measurements have been 
made within a cell line and the standard deviation is remarkably low for a biological 
system ( see chapter 4).
The converging channel avoids any shear forces except those introduced by laminar 
flow. This permits the measurements of the force necessary to detach the cells from 
the surface in a reproducible and quantitative manner. It would be fair to say that the 
present work would not have been carried out with any existing hydrodynamic 
system. It would not be immodest to suggest that this quantitative system outperforms 
any thing published to date. Therefore, the Microflow chamber has opened an 
enormous vista o f possible work in cell adhesion. In the following chapters, the 
reproducibility, accuracy and validity o f this chamber will be discussed in detail and 




COMPARATIVE ADHESION OF DIFFERENT MAMMALIAN 
CELL LINES ON GLASS AND PLASTIC SUBSTRATUM.
4.1. INTRODUCTION
Despite extensive research concerning the adhesion o f  different mammalian 
cells to various types o f substratum, the molecular requirements and mechanism by 
which cells adhere to surfaces has not yet been elucidated. However considerable 
progress has been made in the identification and characterization o f the parameters 
that are important in the adhesion mechanisms o f all cell lines. Such parameters 
include adhesion proteins, the ability o f a surface to adsorb proteins, receptors for 
adsorbed proteins and finally stabilization and strengthening o f cell adhesion by 
recruiting cytoskeletal elements in and around the adhesion plaques (Bum et al,
1988). Certain evidence suggests that the requirements for adhesion o f fibroblast and 
epithelial cells to surfaces differ in terms of the cell requirement for different 
extracellular matrix proteins (Terranova et al, 1986). Some studies attributed the 
differences in adhesion o f various cell lines to the ability o f a surface to adsorb 
adhesion proteins. (Grinnell et al, 1977; Knox & Griffiths, 1980).
It should be stressed that these differences in cell adhesion were demonstrated 
in the attachment and spreading on a qualitative basis. However, the reasons for the 
differences in adhesion strength o f different cell lines remained obscure. Moreover, as 
far as present knowledge is concerned, quantitative comparison o f cell adhesion o f  
different mammalian cell lines has not been possible before this work. As will be 
revealed in the following discussion, the research described in this thesis shows that 
cell adhesion is a phenomena which occurs in two phases: the first phase involves an 
interaction between cell surface receptors and their appropriate ligands which are 
deposited on the substratum. This requires no metabolic energy from the cell.
In second phase . cells spread and gain attachment strength to their 
substratum. The first phase has been studied extensively but the second phase is still
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very poorly understood. In the present work, an effort has been made to resolve the 
mysteries o f the underlying mechanism of the second phase o f cell adhesion. For this 
purpose the adhesion o f various mammalian cell lines on glass and plastic substrata 
was measured quantitatively with the help o f the Microflow chamber (chapter 3). 
Furthermore, to help understand the underlying mechanism, the basis o f subsequent 
differences in adhesion strength o f different cell lines is discussed in the following 
section.
4.2. RESULTS & DISCUSSION
During the development o f Microflow chamber, the reproducibility o f the 
device was analysed, during which work the molecular basis o f  adhesion 
strengthening phenomena was studied. For this purpose it was o f initial interest to 
determine whether or not various cultured mammalian cell lines showed similar or 
different critical shear stress ( c.s.s.) o f detachment.. The greater the critical shear, the 
tighter the cells are attached to their substratum. The cells listed in figure 4.1 were 
grown under the conditions as illustrated in materials and methods. The c.s.s. o f  
detachment of each cell line was measured according to the conditions outlined in 
materials and methods. It was o f  interest to note that the cells presented in figure 4.1 
show a wide range o f critical shear from 2.2 ±  1.04 Nm'^ in Walker rat carcinoma to 
62.0 ±1.2Nm'2 in Hela B cells on a glass substratum. It was encouraging that a high 
degree o f reproducibility within the particular cell line was observed. That is when 
any cell line removed from liquid nitrogen storage (cryopreserved) and the grown for 
72 hours, the measured c.s.s o f detachment was always within the value as illustrated 
in figure (4.4).
At present it is not known why the c.s.s. o f detachment is different in different cell 
lines. Moreover, these values can not be compared as such with other published 
research work because quantitative data about phenomena o f cell detachment by 
controlled shear force is almost impossible to come by in the literature. However, 












Hela MDCK L929 CHL BHK 3T3 WRC
Cell lines
FIGURE 4.1
COMPARATIVE ADHESION STRENGTH OF DIFFERENT CELL LINES ON THE GLASS 
SUBSTRATUM
Hela B, MDCK, L929, CHL, BHK, 3T3 and Walker rat carcinoma cells (WRC) were grown on glass 
slides as outlined in materials and methods and adhesion strength of these cells in terms of the critical 
shear stress (cs.s.) of detachment was measured by using the Microflow chamber.
Each data point is the mean of 5 experiments each of which contains 20 measurements of cs.s. of 
detachment.














Hela MDCK L929 CHL BHK 3T3 WRC
Cell lines
FIGURE 4.2
THE CRITICAL SHEAR STRESS OF DETACHMENT (C.S.S.) OF VARIOUS 
CELL LINES CALCULATED BY BELLS (1978) THEORETICAL FORMULA 
LAW AND WITH THE FORMULA DEVELOPED FOR THE MICROFLOW 
CHAMBER.
Hela, MDCK, L929, BHK, 3T3 and Walker rat carcinoma cells (WRC) were 
subjected to a defined fluid force (i.e. a known maximum velocity) in the Microflow 
chamber. The c.s.s. was measured by using the flow rate and the critical distance as 
illustrated in materials and methods. The c.s.s. of detachment was also measured by 
inserting the maximum velocity experienced by a cell (lOjim^) in the theoretical 
formula given by Bell (1978). Each bar is the mean of 5 independent experiments in 
each of which 20 calculations were made. The error bars indicate the standard error of 
that mean. Further details may be found in the text.
|  = U icro flo w  ch am ber  formula  
rV i  - S to k e s  formula
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-anism of cell detachment (Bell, 1978; Evams, 1985; Cozens-Roberts et al 1990). At 
present the results presented in figure 4.1 can only be interpreted by speculations and 
comparing with these theoretical studies. For example Bell (1978) revealed that if  a 
cell o f radius r is exposed to a fluid stream o f  a fixed velocity v the force on the cell 
can be calculated by Stokes law as described below.
F= 6ITnrv where r\ is the fluid viscosity and it is assumed that the flow is laminar. By 
assuming the area of each cell line tested in this work 10 |im^ and the maximum 
velocity they experienced in the Microflow chamber the c.s.s. o f  detachment o f each 
cell line is calculated. As seen in the figure 4.2, the c.s.s. o f detachment calculated 
according to Stokes law is remarkably close to the critical shear values determined by 
the formula developed for the Microflow chamber in present work. An acknowledged 
weakness o f this comparison is that the area o f every cell line could not be detected in 
the present work. However, every cell line detached at a specific velocity and this 
helped to calculate the c.s.s. o f detachment (by keeping the area o f each cell line 
lOjim^).
Although the values calculated by Stokes law are slightly lower than the values 
calculated by the formula for the Microflow chamber, it is o f great interest that 
entirely different formula o f specific design (Microflow chamber) gives similar 
results to that o f theoretical predictions of Bell (1978) about Stokes law. Since both 
types o f calculations proved that every cell line tested with Microflow chamber has its 
specific critical shear value, the possible reasons for this specificity are given as 
below.
According to theoretical studies (cited above) , the adhesion force between 
cell and a surface is the result o f the net contribution o f the biochemically specific 
forces. Almost all o f these studies are agreed that non specific forces ( Van der waals, 
electrostatic repulsion and steric stabilization) play a negligible role in the adhesion 
strength o f a cell line.
The biochemical forces are believed to largely arise from the level o f surface 
complexes formed from receptors/ligands. These include extracellular ligands
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supplied in the serum which are also produced and deposited by the cells themselves, 
receptor numbers, cell to substrate contact area and increased cell spreading. These 
parameters are overlapping and crucially interdependent. For the sake o f simplicity 
and ease the role o f individual factors in present study will be considered separately.
4.2.1. LIGAND-RECEPTOR BONDS
Theoretically it has been known for some time that the number o f  bonds 
between adhesion proteins and their receptors are involved in the adhesion 
phenomena (Bell, 1978). An unsophisticated but working hypothesis is that the 
adhesion o f a cell for its substratum will increase as the number o f receptors increase. 
This will lead to an increased resistance to hydrodynamic shear. This seems to be the 
case with the cells bearing higher critical shear values. If it is true, exactly opposite 
phenomena may be operative in the case o f cells which detach at very low critical 
shear value (e.g. Walker rat carcinoma in figure 4.1). The interactions between 
adhesion proteins and their receptors may be affected by various factors such as 
receptor numbers, the density of ligands (adhesion proteins), the affinity o f receptors 
to such ligands and provision o f the suitable surface for the formation o f bonds.
Apart from these considerations the molecular conformations o f the entities 
taking part in the attachment process are also expected to affect the apparent 
adhesiveness o f the cells. Therefore, variations in c.s.s. o f detachment o f cell lines 
listed in figure 4.1 could be attributed to various quantities and qualities o f receptors 
and their ligands (adhesion proteins). For example the variation in c.s.s. might be 
predicted to be due to interactions with different strengths because the various 
proteins involved in the interaction may recruit different class o f receptors (Dejana et 
al, 1988). That is the strength o f binding o f different adhesion receptors e.g. 
vitronectin inegrin or fibronectin integrin will vary in the same way as the binding 
strengths o f immuonoglobulins to their antigens. In fact the complex multipoint 
binding between antibody and its antigens might be a good model, at least as an aid to 
visualise the mechanisms o f binding o f adhesion proteins and their receptors i.e. some
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bind very tightly and some only weakly. Thius the total adhesion strength o f a cell for 
a surface will be the sum of a very wide range o f receptors- proteins complexes.
An added complexity is that, for example, vitronectin receptors from different 
cell types differ in their affinity for vitronectin, yet no chemical difference was found 
between such functionally different receptors (Languino et al, 1988). It is likely that 
differences in glycosylation levels o f the receptors could explain the above.(Kitagaki- 
Ogawa et al, 1990). However the spreading o f BHK cells on vitronectin isolated from 
different animal sera was indistinguishable from that on human vitronectin. This 
point will be further discussed in chapter 5. At present it is appropriate to mention that 
although vitronectins from different sources equally induced spreading in BHK cells, 
it could well be that the strength o f adhesion o f BHK cells varied according to the 
source o f vitronectin. It has not been possible to measure such differences until the 
Microflow chamber was developed, these differences might now be recognised.
Taken together these observations and results presented in figurem 4.1 it is a 
general impression that a particular cell adhesion protein may be mediating adhesion 
strength within the particular cell line, but with different proteins for different cell 
lines. It is possible that some other proteins also make an important contribution to 
the adhesion strength by cooperating with this main adhesion protein. It is convenient 
to call the former the principal adhesion proteins and the latter reinforcing proteins.
There are two possibilities: first, the principal adhesion protein is different in 
different cell lines or is expressed differently, that is either qualitatively or 
quantitatively. The second possibility is that reinforcing proteins are different in 
different cell lines. They may also be expressed in various amounts or in different 
conformations. In both of these situations bonds o f different strengths w ill exist and 
thereby, assign a specific adhesion strength to an individual cell line.
One o f the simplest systems is the receptor-adhesion protein bonds. Bell(1978) 
suggested that if multiple bonds underneath the cells had to be detached as a unit, 
there would be a critical force per bond at which the cells will suddenly detach. This 
force for a typical antigen-antibody bond was estimated as lxl0'~* dynes per bond.
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Therefore the total force for the detachment o f a cell would be 1x10"^ times the 
number o f  bonds in the contact area. It is not possible to compare this force with the 
force which is applied to the cells in the Microflow chamber. The force provided in 
the Microflow chamber has a vector while Bell (1978) estimated perpendicular force 
for breakage o f bonds. However,it seems clear that there must be a relationship 
between the critical shear stress o f detachment o f a cell and the number o f bonds in 
the contact area. The data presented in this thesis (chapter 8) shows that this might be 
an oversimplified model. That is the actual measured critical shear o f detachment can 
not only be ascribed to the number o f bonds. There must be other factors involved in 
the final adhesion strength o f cells. Thus the theoretical suggestions made by Bell and 
those published recently (Wattenberger et al. 1990) may not be representing the active 
process o f cell adhesion. It may be that initial binding o f adhesion proteins and 
receptors is only causing the first phase o f adhesion which leads to the second phase 
and collectively both o f these phases are responsible for the adhesion strength o f a 
cell. Therefore, there can be little doubt that receptors and ligands are actively 
engaged in cell adhesion, but the final strength o f cell adhesion can not be ascribed 
solely to ligand- receptor binding.
As was indicated earlier, cell adhesion can be thought o f as a two step process. 
The first step is an initial binding, followed by a substantial strengthening o f  that 
binding. The initial binding may represents the attachment of cells to the substrate 
components under conditions where cytoskeletal events are prevented from 
participation. In the present work the final strengthened adhesion measured after 
growing cells for 24 hours represents the initial adhesion plus what seems to be the 
consequences o f coupling o f the adhesion receptors to the cytoskeleton. This idea 
gains support from experiments cited in chapter 7, whereby there is considerable 
difference between adhesion strength gained by the cells after 3 and 24 hours o f 
growth.
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4.2.2. PO SSIBLE INVO LVEM ENT OF THE CYTO SK ELETO N
From the data described here and in the chapter 7 the following theory could 
be developed to understand the underlying mechanism o f the final adhesion strength 
of a cell.
Normally functional cells are able to recognise and measure trace 
concentrations o f adhesion proteins (ligand-receptor), then store and process the 
information obtained from ligand- receptor bonds to make a decision on further 
adhesion on the basis o f this information. In other words, after binding with the 
adhesion protein(s) the intracellular portion o f the receptor could also bind with the 
cytoskeleton and thus convey positional information to the cell machinery. This 
thought is strengthened by the findings that the cytoskeletal protein, actin, provides 
the structural support to the cell (Burridge et al, 1988). Now, vinculin interacts both 
with talin and a-actinin which in turn has an additional affinity for actin fibres. In fact 
a series o f protein- protein interactions can be mapped out extending from the 
extracellular matrix through adhesion plaques to the actin fibres. Although not 
certain, these events could increase the strength of cell adhesion. Since the actin fibres 
provide structural support for the cell and in response to shear stress these fibres were 
found reorganising themselves, actin is thought to participate in the stabilization o f  
adhesion of a cell.(Wechezak et al, 1989). This process may be varied from cell to 
cell in present study. Thus resulting in the variation of c.s.s. values among the cells 
shown in the figure 4.1. If the involvement o f cytoskeletal events are taken into 
account, the force required to break the adhesion bonds would be far greater than 
predicted in the theoretical studies discussed earlier (Bell, 1978).
4 .2 .3 . PARTICIPATION OF THE A DH ESIO N  PLA Q U ES
Adhesion plaques are sites where cytoskeletal events take place. Although 
focal adhesion is not essential for cell attachment and spreading, its presence is 
correlated with increased strength o f cell adhesion (Burridge et al, 1988). In these 
regions the surface o f the cell comes closest to the substratum, the plasma membrane
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is specialized for anchoring stress fibres and microfilaments. Therefore the adhesion 
plaques might be functioning by preventing the uplifting of the upstream cellular edge 
, thus, minimizing the hydrodynamic shear traction forces in the Microflow chamber. 
It is possible that the cells with higher shear values possess adhesion plaques in which 
stress and microfilament fibres are highly organised. In these cells the distance 
between substratum and cell membrane at adhesion plaques is expected to be lower 
compared to the distance o f the cells with lower shear values. How cells regulate the 
information o f adhesion plaques and coupling o f the cytoskeletal proteins to the 
protein- receptor complex in and around the adhesion plaques is simply not known. It 
is unlikely that this type o f binding between cytoskeleton and protein-receptor 
complex is simple "glue" type binding, rather it is likely that there must be something 
complex going on in the cytoplasm which regulates all the events involved in 
strengthening the cell adhesion.
4 .2 .4 . SIG NALLING  M ECH ANISM
My impression is (as seen from the fibronectin experiments in chapter 7) that 
receptors first undergo membrane clustering and then concentrating in focal contacts 
in a ligand controlled way. Thus the signal is generated by adhesion protein(s)- 
receptor(s) complex and unknown second messenger(s) receive it and control the later 
events in a sophisticated manner. The next point to make is to question which 
molecule acts as a second messenger. At present this is not known but cAMP and 
phosphatidyl inositol can be included in the list o f suspected messenger molecules. 
There are some indications for the participation o f cAMP in the strengthening o f cell 
adhesion (Pastan & Willingham, 1978 ; Cheung & Juliano. 1985). That is the 
treatment o f fibroblast cells with cAMP can alter morphology with apparently 
adhesive cells. It could be that a ligand-receptor complex on the cell surface triggers a 
short lived increase in the intracellular cAMP In turn the cAMP , activates a cAMP 
dependent protein kinase system. Protein kinases are thought to be involved in 
stabilizing the receptor- cytoskeletal coupling (Issaad et al, 1989). Although little is
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known about the other functions of cAMIP and protein kinases in cell adhesion 
system, many lines of evidence point to a role for protein kinases in cell adhesion. 
Phosphorylation is an attractive hypothesis where cAMP dependent kinases regulate 
the affinity o f integrin receptors for ligands or cytoskeletal components (Freed et al,
1989). On one hand phosphorylation is expected to increase the affinity o f receptors 
for the cytoskeleton and stimulate the cells to gain the greater adhesion (Suzuki et al, 
1987) on other hand phosphorylation of the fibronectin receptor was shown to induce 
disruption o f cellular adhesion and actin orgnisation (Hirst, et al, 1986). Taken 
together, these observations suggest that both positive and negative controls are 
operative. It is possible that the cells use both these controls in concert to allow itself 
to grow and migrate. Nevertheless it seems apparent that adhesion is perturbed or 
manipulated by the cell using various mechanisms.
There are other factors which may increase or decrease the adhesion strength o f cells. 
Some o f these are listed below.
4.2.5. PROTEASES
An additional cause o f variability in the cells responses to critical shear may 
be attributed to the degree o f activation o f cell surface proteases in an individual cell 
line. The proteases may be involved in the degradation o f extracellular matrix 
components and/or cytoskeletal proteins (Fox et al, 1985) Thus resulting in the 
disruption of binding of integrin receptors to the extracellular cytoskeletal proteins. In 
fact a specific example is the cleavage of talin or vinculin by Ca^+ dependent 
proteases which represents a potential mechanism for regulating adhesion plaque 
organisation and thus the subsequent strength o f cell adhesion (Beckerele et al, 1987). 
Again proteases are themselves believed to be activated by phosphorylation. It is 
possible that adhesion proteins send a signal to the cell machinery to activate these 
proteases by a greater amount in those cells which are only loosely adhered (e.g. 
Walker rat carcinoma(2.2±1.04 Nm'^)., conversely a lower degree o f proteases
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activation will occur which are tightly attached to the substratum (e.g. Hela B 62.0 
Nm'2).
4 .2 .6 . A N TIA D H ESIO N  PROTEINS
In contrast to the adhesion proteins there are some secreted glycoproteins e.g. 
tenascin and SPARC (secreted protein acidic and rich in cystine) which exert an 
antiadhesive effect on the cells (Villarreal et al, 1989; Faissner and Kruse et al, 1990). 
The mechanism o f their anti adhesive action is yet to be determined. There is 
considerable speculation as to how these antiadhesive molecules work. For example, 
antiadhesive function was attributed to an interference with focal adhesion 
(Mosher, 1990) or modulation o f protease activity (Hasselaar et al, 1991). Several 
investigators have in fact presented a strong case for functional antagonism between 
fibronectin and tenascin (Chiquet-Ehrismann et al, 1988). In my study, the relative 
amount o f each o f these proteins may determine the specific adhesion strength to each 
cell line. These studies suggest that the cells with lower critical shear value (poorly 
adhesive) might be expressing tenascin or tenascin like molecules in relatively high 
amounts. For example the antiadhesive molecules might be acting as a blocker or 
inhibitor o f binding of cellular receptors with other extracellular components, thus 
interfering in receptor-ligand bond formation. This event perhaps blocks the signal 
generated by adhesion proteins on the cell surface. This might explain the weak cell 
adhesion strength o f Walker rat carcinoma cells. On the other hand it might be that 
L929, Hela B and MDCK cells are negative in tenascin and therefore showed high 
critical shear value. The role o f antiadhesive molecules and their various mechanisms 
is yet to be determined. If it is true, tenascin or tenascin like molecules are probably 
working under the control o f cellular negative signalling.
4 .2 .7 . DEGREE OF SPR EA D IN G  A N D  A D H ESIO N  STRENG TH
There is reason to believe that the critical shear force is not entirely dependent 
on the degree o f spreading. The morphological studies carried out in the present work
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have substantiated this idea. For example, MDCK cells are more spread (have a large 
surface area) than the Hela B cells on a glass substratum yet their c.s.s. value (55.2 
±0.84 Nm"2) is lower than that o f Hela B cells (62.0 ±1.2 Nm'^). This idea also gains 
support from the findings that the flattened morphology o f a adhesion defective 3T3 
mutant could be restored by the treatment o f cAMP and yet their adhesiveness to the 
substratum decreased (Pouyssegur & Pastan, 1976). Taken together these findings and 
the morphological studies in the present work suggest that adhesion strength may not 
be solely determined by the spread area o f the cell. However, one must not imply that 
spreading is irrelevant to the adhesion strength.
The role o f the substratum in cell adhesion has been studied in cell adhesion for many 
years since the poineering work o f Curtis (1960). It is clear that a cell adhesion to a 
surface depends on the wettability o f that surface. In other words its hydrophobic and 
hydrophilic nature (Grinnell, 1978; Hattori et al, 1985). However there has never been 
a quantitative study relating adhesion strength o f a cell to the properties o f the 
surface. With this in mind a study was carried out to examine the c.s.s.. o f detachment 
o f different cells on different surfaces. For this work, tissue culture grade plastic was 
selected and adhesion strength of different cell lines was analysed on this surface.
4.3. COMPARATIVE CELL ADHESION ON PLASTIC 
SUBSTRATUM.
The cell lines shown in the figure 4.3 were subcultured in round tissue culture 
grade plastic dishes (100mm) (see materials & methods) and c.s.s. o f detachment was 
measured with a new version o f the Microflow chamber as described in materials and 
methods. It was exiting to find that like glass a wide range o f  c.s.s. o f detachment was 
found, which varied from 10.2 ±1.5Nm"^ in Walker rat carcinoma to 70.5 ±1.9 Nm‘^ 
in MDCK cells (figure 4.3). However, it is clear that all the cell lines tested with the 
exception o f CHL cells, stuck better to plastic than glass. That is, the c.s.s. values 
ranged from 9.5% increase in glass c.s.s. values for Hela B to 70% increase in glass 
c.s.s. values for Walker rat carcinoma cells, (figure 4.1 & figure 4.3). As can be seen
MDCK HELA B L929 BHK CHL WRC
Cell lines
FIGURE 4.3
COMPARATIVE ADHESION STRENGTH OF DIFFERENT CELL LINES ON THE PLASTIC 
SUBSTRATUM.
MDCK, HELA B, L929, BHK, CHL, and Walker rat carcinoma cells (WRC) were grown on tissue 
culture grade plastic dishes (100mm) as outlined in materials and methods. The adhesion strength of 
these cells in terms of the critical shear stress (c.s.s.) of detachment was measured by using the 
Microflow chamber.
Each data point is the mean of 5 experiments each of which contains 20 measurements of c.s.s. of 
detachment The error bars indicate the standard error of the mean. Further details may be found in the 
text
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in these figures the c.s.s. value for CHL cells unexpectedly dropped by 34%. Once 
again this emphasises the underlying differences in adhesion in different established 
cell lines.
A pleasing aspect o f this adhesion analysis is the remarkably good reproducibility 
within a particular cell line. Moreover the c.s.s. value within a particular cell line was 
always (within a small standard deviation) close to that cell lines value whenever it 
was measured. At present the underlying mechanism o f detachment is uncertain and 
equally unclear are the mechanisms which cause different surfaces to have different 
strengths. However, it is possible to make realistic speculations from the results 
obtained. These are described below.
It is clear from early work (Curtis, 1960; Baier & Dutton, 1969) that when a 
clean (virgin) surface is wetted with a solution containing protein(s) the first, very fast 
reaction is the adsorption o f the protein onto the surface. Such adsorption leads to 
complete denaturation into a spread out 2 dimensional sheath. After a monomolecular 
layer is formed a subsequent build up o f more protein layers occurs, the thickness o f  
which depends on the nature o f both the surface and the protein (Castillo et al, 1986). 
It is extremely difficult, if not impossible, to determine the resulting protein- 
substratum structure. However it is possible to adsorb radiolabelled proteins (chapter 
7) and to calculate what the protein concentration is on the surface. Furthermore, by 
making assumptions about the size o f the denatured protein one can predict with some 
confidence, how many layers there are adsorbed. O f coarse the situation is more 
complex if a mixture o f  proteins (e.g. serum) is adsorbed to the surface. It is probably 
a reasonable assumption that a cell does not, in fact, adhere to the surface but to the 
adsorbed protein layer on that surface. The resulting layer will also vary greatly in its 
structure varying widely from totally denatured to structurally intact proteins. Thus 
the cell receptors will have an enormous repertoire o f ligands (surface proteins) to 
which they may bind. O f course a further complication is that the resulting receptor- 
ligand complexes will have widely different affinities for each other, which will be 
reflected in the final strength o f adhesion.
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Furthermore as stated earlier there must be a complicated signalling system between 
the cell- substratum interface and internal cellular mechanisms, such as protein 
synthesis. The hypothesis put forward in this thesis is that there is a signalling system 
which controls not only the secretion o f proteins to their correct location within the 
cell- substratum interface but also determines the structural relationship between this 
interface, the extracellular matrix, the cell membrane, the cytoskeleton and 
metabolism. The signalling thus makes the cell adhere to the surface with a strength 
that seems to be genotypic though there is no direct evidence for this.
A discussion o f the first step in the process now follows, that is the adsorption 
o f the proteins to the substratum and the possible exchange o f  proteins within the 
adhesion interface. The latter comment implies that once the cell- substratum 
adhesion is made then there is a continuing import export o f proteins between the cell 
and the adhesion interface. It must also be made clear that once the cells adhesion is 
formulated then the process does not stop there. At some stage in the cells growth 
cycle it will need to "round up" for division, a process which involves a complete 
change in the cell adhesion to the rounded up less adhesive mode.
In the present work the two surfaces or substrates o f interest are glass and 
plastic.. The former is quite hydrophilic, contains no aromatic residues and is weakly 
ionic. The latter (styrene) is more hydrophobic, contains a large amount o f aromatic 
molecules, and is probably more ionic than glass. That is the plastic is treated during 
manufacture with high voltage (plasma), which introduces -OH and COOH groups 
(Klebe et al, 1981). It is clear that the protein adsorption will be very different on both 
of these surfaces (e.g. plastic & glass).
Apart from controlling the amount of protein(s) which mediates cell adhesion, 
different substrates might be inflicting conformational changes in different proteins in 
different ways (Klebe et al, 1981; Van Oss et al, 1981). The receptors on different 
cells seem to be able to recognise these conformations with varying degree o f  
affinity, thereby resulting in bonds o f various affinity in each cell type. It seems that 
receptors of CHL cells make relatively weak bonds with protein(s) adsorbed on the
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plastic compared to proteins adsorbed on the glass. One should keep in mind that 
these bonds might be responsible for sending signals to produce cells own proteins. 
Thus it is possible that the bonds that formed between receptors on CHL cell surface 
and proteins adsorbed on the plastic caused poor production o f intracellular protein(s) 
and thus resulted in poor adhesion compared to the adhesion o f the CHL cells on glass 
substratum. This idea gets support from the findings that extracellular matrix 
production is substrate dependent (Varani et al, 1989). Again this phenomena may 
depend on the responsiveness o f different cells to the various substrata. This may be 
the reason that CHL cells showed poorer adhesion on plastic than glass. However the 
cellular and molecular basis o f this phenomena cannot be confirmed at present
4.4. AGEING IN RESPECT OF C.S.S. OF DETACHMENT.
Some cell lines also show ageing with respect to their critical shear value. For 
example when BHK cells were taken from liquid nitrogen storage and their growth 
maintained in 25cm^ flasks for a large number o f passages the c.s.s. o f detachment 
was found to slowly decrease from the original value o f 25.9 ±  3.9 Nm’^ (figure 4.4). 
After 24 weeks from zero time the c.s.s. o f detachment had dropped by 90% o f the 
original value o f the BHK cells, (figure 4.4). While the cell viability was found to be 
intact (98.8%) and not to decrease, there was a marked decrease in the adhesion 
strength of BHK cells as the passage number increased. On the other hand no 
difference in adhesion strength o f L929 and Hela B cells was found from 0 time to 24 
weeks (figure 4.4). The decrease o f c.s.s. of detachment o f BHK cells may be due to 
genetic instability of these cells which might easily alter many aspects o f cell 
adhesion. These alterations includes perturbation o f the biosynthesis o f adhesion 
protein(s), integrin receptor(s) or an increase in proteolysis o f normally expressed 
proteins. Moreover, the sensitivity of BHK cells to c.s.s. o f detachment might reflect 




£ 3  -  BHK c a l ls
Passage number
FIGURE 4.4
EFFECT OF AGEING ON THE C.S.S. OF DETACHMENT OF BHK, L929 AND HELA B CELLS.
BHK, L929 and Hela B cells were taken from liquid nitrogen and were passaged routinely after 3 days. 
The critical shear stress (c.ss) of detachment of every cell line was measured weekly for 24 weeks.
The ageing effect on the cs.s. of detachment of BHK cells is shown in figure A. Figure B represents 
the comparison of ageing effect on the c.s.s. of detachment of BHK, L929 and Hela B cells.
Each data point is the mean of 25 different determinations. The error bars represents the standard error 
of the mean. Further details may be found in the text.
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explore these possibilities more information will be required on the biochemistry o f  
extracellular and cytoskeletal proteins throughout their ageing period. Such 
information is currently not available.
At present an alternatively spliced fibronectin may be considered to be one 
cause for a change in adhesion because splicing may produce biologically active or 
inactive polypeptides o f fibronectin. This speculation is supported by the study o f  
Chandrasekhar et al, (1983). They demonstrated that human diploid fibronectin from 
young cells can make an old cell more adhesive, while old cell fibronectin was less 
effective in the adhesion o f old cells. It was further suggested that the young cell 
fibronectin when compared to old cell fibronectin was more supportive to adhesion 
plaque formation. These observations may be implied similar to that which occurs in 
the ageing o f BHK cells described above.
It is possible that due to defective fibronectin or other unknown molecules, the 
actin and microfilament fibres were not fully organised. It is also possible that the 
secretion system for endogenous extracellular matrix production was turned to a 
lower efficiency. These changes may have contributed to the basis for altered 
metabolism or altered biophysical properties. These altered properties o f BHK cells 
may account for the decrease in their c.s.s. o f detachment with increasing passage 
numbers.
4.5. CONCLUSION
In conclusion, a range o f c.s.s. o f detachment o f various mammalian cell lines 
on glass and plastic was found. Every cell line has a specific and constant shear value 
with respect to the substratum. The tremendous versatility in adhesion strength o f  
mammalian cell lines may become particularly evident with regard to the qualitative 
or quantitative expression of adhesion proteins and their receptors. Theoretical studies 
predicted the adhesion strength dependent on protein-receptor bond numbers. 
Whereas in the present work adhesion bonds are speculated to activate unknown 
second messenger which in turn regulate the activities o f cytoskeletal proteins in
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different cell lines in different fashions. Such mechanisms may cause each cell line to 
possess a different strength.
The Microflow chamber is validated in this cell adhesion research at receptor 
level and it has proved to be a useful tool for the characterization o f cell-substratum 
interactions. For example, even though the qualitative attachment o f different cell 
lines on the same or different surfaces may appear to be the same, the difference in 
c.s.s. will predict various proteins and class o f receptors in each cell line. Which 
otherwise would have gone undetected. Thus a fundamental quantitative 
understanding o f  adhesion of cells to a substratum could lead us to understand the 
complexity o f the cell adhesion phenomena.
These points are made in introducing the appropriate tools for understanding 
the mechanism o f detachment under the effect o f  hydrodynamic force. It has been 
necessary to speculate about this phenomena because nothing is known about this 
aspect o f cell adhesion. However, a start has been made to analyze the interaction that 
occur between a cell and its substratum. In this context the most obvious start point is 
with the adhesion molecules. That is, the adhesion proteins and the receptors involved 
in cell adhesion. These molecules are for convenience divided into three categories.
1 Exogeneously added as a mixture i.e. the serum component in the culture medium.
2 Exogeneously supplied purified adhesion proteins.
3 Endogenous adhesion molecules i.e. extracellular proteins and their receptors, 
produced by the cell.
The effect of each o f these on the hydrodynamic detachment was examined. 
Thus the rest of this thesis will consist o f the findings o f this research.
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CHAPTER 5 
ROLE OF SERUM IN CELL ADHESION STRENGTH.
5.1 . INTR O D U CTIO N
It is generally accepted that the growth o f virtually all types o f cells in culture 
requires the presence o f added serum in the culture medium. Such serum is a complex 
mixture and some o f its components are directly involved in cell adhesion. O f course 
many serum components are as yet poorly characterised. Recently rapid progress has 
been made in the identification and characterisation o f  the proteins which mediate cell 
adhesion. Serum contains fibronectin, vitronectin, laminin, thrombospondin and many 
poorly studied proteins which mediate cell adhesion (Underwood & Bennet, 1989). 
However, there have also been reports that serum interferes with cell attachment and 
spreading (Witkowski & Brighton, 1972; Unhjem & Prydz, 1973 ). Curtis & Forrester 
(1984) demonstrated that components o f serum that is alpha-1 antitrypsin and albumin 
both cause low adhesiveness o f BHK cells to surfaces.
Considering these two contrary findings for the role o f serum it was desirable to 
discover how serum effects cell adhesion. The approach made in the present chapter 
is based on attempts to understand what functions serum as a whole is serving in 
adhesion strength.
5 .2 . R ESULTS & D ISC U SSIO N
To define the quantitative role of serum in the adhesion strength the following 
strategies were adopted.
1  Firstly the c.s.s. o f detachment o f two cell lines i.e. L929 cells (fibroblasts) and 
Hela B cells (epithelial cells) was measured by simply varying the concentration of 
serum in the culture medium. The total absence o f serum was also used as the starting 
point in the c.s.s. o f detachment.
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2 Secondly, great effort has been made to continuously grow L929 cells in serum free 
medium (Nutridoma medium) and to measure their adhesion strength.
1  The third and the last approach was to determine the effect o f sera o f different 
origins on the c.s.s. o f detachment o f L929, Hela B and Walker rat carcinoma cells. 
L929 and Hela B cells were selected because they are easy to grow and are taken as 
representatives o f two different origins, i.e. fibroblasts and epithelial cells 
respectively. Walker rat carcinoma cells were selected because o f very low adhesion 
strength (2.2±1.04 Nm'^ on glass and 10.2±1.5 Nm'^ on plastic) in the presence o f  
horse serum. Therefore it was of interest to examine the effect o f other sera on the 
adhesion strength o f these cells. The details o f the approaches (stated above) are given 
as follows.
5.2.1. EFFECT OF DIFFERENT CONCENTRATION OF FOETAL 
CALF SERUM ON THE ADHESION STRENGTH OF L929 & HELA 
B CELLS.
Here the experiments were based on the idea that one o f the main functions o f  
serum in adhesion studies is to provide a mixture o f essential adhesion proteins e.g. 
fibronectin and vitronectin. These proteins are considered necessary for the 
attachment and spreading. It is clear that there are a large number o f proteins present 
in the serum which may reinforce the stabilization o f the initial attachment or vice 
versa. Prior to this study it has been impossible to measure cell adhesion 
quantitatively. That is why the quantitative role o f serum has not been established. 
While now we can put a number to the adhesion strength o f cells (with the 
development of Microflow chamber in present work) the first step is to construct an 
adhesion "response" curve for serum. To set this up L929 and Hela B cells were 
grown in 10%, 7.5%, 5%, 2.5%, 0.5% and 0% serum (v/v) in the culture medium 
supplemented with a good growth medium (Nutridoma 1%) and the c.s.s. o f  
detachment was measured as illustrated in Materials & Methods.
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The data are presented in the figures 5.1 & 5.2. It can be seen that there is a large 
decrease in adhesion strength o f both cell lines between 0.5% to 0% serum containing 
medium. The adhesion strength o f L929 cells remained constant when the 
concentration o f serum was lowered from 10% to 0.5%. At 0% serum in the medium 
(supplemented with Nutridoma 1%) there was a sudden and statistically highly 
significant (p=0.0001) drop in the adhesion strength o f L929 cells.
For Hela cells it is clear that there is a slow, but significant (p=0.0032) drop in 
the adhesion strength when the serum is lowered from 2.5 to 0.5% and then a very 
sudden loss o f adhesion from 0.5% to 0% serum.
As it is seen in the figures 5.1 & 5.2, when serum was totally eliminated from 
the culture medium, a sudden drop in the adhesion strength o f both cell lines was 
noted inspite o f supplementation o f good growth medium (Nutridoma 1 %). Thus it 
was logical to use culture medium in which serum should be diluted from 0.5% to
0.05%. The culture medium was also prepared without serum. This was done but 
without supplementing Nutridoma 1% (due to financial restrictions). In this condition 
L929 cells retained their adhesion when serum was diluted from 10% to 0.25%. These 
cells growing in culture medium containing 0.1% serum still showed a considerable 
adhesion strength (40.5 ± 5.5Nm"^). However, without Nutridoma 1% medium, these 
cells did not survive in the culture medium containing 0.05% and 0% serum (table 
5.1).
Hela B cells appeared more dependent on a good growth medium (Nutridoma 
1%) as compared to L929 cells. That is Hela B cells did not survive in culture 
medium (without Nutridomal%) containing less than 0.5% serum. Even at 0.5% 
serum (without Nutridoma) the adhesion strength (24.0 ±  5Nm-^) of Hela B cells was 
just equivalent to the adhesion strength of these cells in serum free medium 
supplemented with Nutridoma medium (23.0 ± 8.5Nm-^). These results indicate that 
a good growth medium which could fulfil the nutritional requirements o f  the cells 
was necessary not only for the stabilization o f adhesion o f cells but also for the 
survival of the 1929 and Hela B cells in serum free medium.
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FIGURE 5.1
EFFECT OF VARIOUS CONCENTRATIONS OF SERUM ON THE ADHESION STRENGTH OF 
L929 CELLS ON PLASTIC OR GLASS SUBSTRATUM.
Sub confluent L929 cells were subculuired and maintained in the culture medium which was 
supplemented with 10 to 0% (v/v/) serum. These cultures (containing different concentrations of 
serum) were additionally supplemented with 1% Nutridoma. The adhesion strength of the L929 cells 
growing in these mediums is measured in terms of the critical shear stress (c.s.s.) of detachment.
Each data point represents 6 experiments in each of which 20 measurements were made. The error bars 
represent the standard error of the mean.
A t test indicates an insignificant difference (p=0.25) in the adhesion strength of cells growing in the 
medium containing 10% to .5% serum. Whereas this difference is highly significant (p= 0.0001) 
between .5% and 0% serum. Further details may be found in the text The t test also indicates that in 
the absence of serum the difference between the adhesion strength of L929 cells on plastic and glass 
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FIGURE 5.2
EFFECT OF VARIOUS CONCENTRATIONS OF SERUM ON THE ADHESION STRENGTH OF 
HELA B CELLS ON PLASTIC OR GLASS SUBSTRATUM.
Sub confluent Hela B cells were subcultured and maintained in the culture medium which was 
supplemented with 10% to 0%(v/v) serum. These culture (containing different concentration of serum) 
were additionally supplemented with 1% Nutridoma.
The adhesion strength of the Hela B cells growing in these mediums is measured in terms of the critical 
shear stress (c.s.s.) of detachment. Each data point represents 6 experiments in each of which 20 
measurements were made. The error bars represents the standard error of the mean.
A t test indicates slightly insignificant (p=.003) difference among the adhesion strength of cells 
growing in the medium containing 7.5% to 2.5% serum. Whereas a highly significant (p=0.0001) 
difference was found from 2.5% to 0% serum. Further details may be found in the text. The t test also 
indicates that in the absence of the serum the difference in the adhesion strength of Hela B cells on 
glass and plastic is insignificant (p= 0.47).
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FIGURE 5.3
PROTEIN SYNTHESIS IN THE PRESENCE OF CULTURE MEDIUM WITH OR WITHOUT 
SERUM.
L929 cells were plated at a density of 5x10  ^ cells/cm ^ and were allowed to grow overnight in the 
culture medium containing serum. The old medium was replaced with the [35$]-methionine labelled 
serum free medium or labelled culture medium containing serum. At different time intervals (indicated 
on the x-axis of the figure) the medium was carefully decanted and the cells were sequentially prepared 
for scintillation counting as illustrated in materials and methods.
Each data point represents 3 experiments in each of which every sample has been 
counted 3 times. The  ^error bars indicate the standard error of the mean. Where error 
bar does not appear, it is smaller than the symbol. Further details of the experiment 
may be found in the text
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Now the discussion of serum effect on the adhesion strength o f these cells in presence 
of Nutridoma 1% follows. It is o f interest that at 0% serum there is still a measurable 
and reproducible adhesion strength. However, in the absence o f serum the cells are 
not growing in the sense that they do not go through cell division even a good growth 
medium was supplemented in the absence o f added proteins. The effects o f 0% serum 
will be discussed later, for the present, serum results are now discussed and 
conveniently divided into following major sections.
1. Effect o f lowering the serum concentration from 10% to 0.5% on the adhesion 
strength o f L929 cells.
2. Effect o f lowering the concentration o f serum from 10% to 0.5% on the adhesion 
strength o f Hela B cells.
2  Growth o f L929 cells in serum free media
4 Effect o f 0% of serum on the both L929 and Hela B cells.
5  Possible mechanism by which serum exert its effects on the adhesion strengthening 
process.
5.2.1.1. EFFECT OF LOWERING THE SERUM CONCENTRATION 
FROM 10% TO 0.5% SERUM ON THE ADHESION STRENGTH OF L929 
CELLS.
As seen in the figure5.1, in response to lowering the serum concentration from 
10% to 0.5%, L929 cells appeared to maintain their normal adhesion strength. That is 
the difference between adhesion strength o f L929 cells in presence o f 10% to 0.5% 
serum is statistically insignificant. In fact it is equivalent to the adhesion strength of 
L929 cells in presence o f 10% serum (53.0 Nm'^ on glass and 66.0 Nm'^ on plastic). 
The explanation of these results is given as below.
If serum is considered the only source o f proteins for cell adhesion, it is likely 
that foetal calf serum even at 0.5% contains sufficient ligands to assign the final 
adhesion strength to L929 cells. There appears to be very strong support for this idea. 
That is foetal calf serum is reported to contain 300|ig/ml o f vitronectin and 30|ig/ml
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of fibronectin, which at 10% serum is sufficient to support cell adhesion (Hayman et 
al. 1985). If the concentration o f fibronectin and vitronectin is simply diluted by 
lowering the serum concentration from 10% to 0.5%, the actual amount o f fibronectin 
and vitronectin at 0.5% is thus 54.5ng/cm^ and 545 ng/cm^ respectively.
Now considering the co-distribution of fibronectin and vitronectin on the surface, 
while 545ng vitronectin/cm^ is insufficient for attachment and spreading, 54.5ng 
fibronectin/cm^ is adequate for attachment and subsequent stabilization o f the cell 
adhesion. This point is made on the basis that the threshold level o f  vitronectin for 
attachment and spreading is quoted as 6.5|ig/cm^ (i.e.6545ng/cm^ ( Whateley & 
Knox, 1980) and in this work in chapter 7 it was found that 18ng/cm^ o f fibronectin is 
sufficient for L929 cells to attain final adhesion strength.
Grinnell and Feld (1982) and recently Underwood & Bennett (1989) found 
that adsorption o f fibronectin to tissue culture plastic was minimum at 10% and 
maximum at 1% serum from the culture medium. The adsorption o f  vitronectin at 
10% and 1% serum containing medium was exactly opposite to that o f  fibronectin 
(Underwood & Bennett, 1989). No reason for these observations is given in their 
studies, apart from that it was considered unknown phenomena. It may be that non 
specific proteins are hindering the adsorption o f fibronectin by some means when 
culture medium containing 10% serum is used. Nevertheless, taken together these 
adsorption studies and findings of the present work (i.e. c.s.s. at 10% & 0.5% is the 
same ) it can be suggested that at 10% foetal calf serum, it is vitronectin that is the 
effective molecule for adhesion strength o f L929 cells and at 0.5% serum it is 
fibronectin that assumes this role.
Of course this interpretation is just speculation which is based on the protein 
adsorption studies carried out by others (Underwood & Bennett, 1989; Knox, 1984). 
However if this is true there must be biphasic phenomena in operation in the L929 
cell adhesion strengthening process. This suggestion is consistent with the qualitative 
findings of Knox (1984) who suggested that at different serum concentrations 
spreading occurs via different mechanisms. That is different effectors o f  spreading
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were proposed to become significant to a greater or lesser extent at higher or lower 
concentration o f serum.
5.2.1.2. EFFECT OF LOWERING THE SERUM CONCENTRATION
FROM 10% TO 0.5% ON THE ADHESION STRENGTH OF HELA B 
CELLS
As indicated in the figure 5.2 it is clear that there is a slow, but significant 
(p=0.0032) drop in the adhesion strength when the serum is lowered from 10% to
0.5% and thus a very sudden loss o f adhesion in 0% serum (0% serum will be 
discussed later).
For the Hela B cells at 1% and 0.5% the c.s.s. o f detachment was considerably 
reduced (15% and 30% respectively of the control value). Considering above different 
published reports it seems unlikely that the decreasing amount o f adsorbed fibronectin 
is instrumental for decreasing the c.s.s. o f detachment o f  Hela B cells, since sufficient 
fibronectin was shown to adsorb even at 0.5% serum. Further, there are reports that 
Hela B cells neither spread on a fibronectin substrate nor react with antibody specific 
for mammalian fibronectin receptor (Lu, et al, 1989). It is also reported that they do 
not produce fibronectin and fibronectin receptors (Becham & Jacobson, 1990). This 
indicates that Hela B cells use some protein(s) other than fibronectin for their 
adhesion. This protein (unknown) may be substantially diluted beyond its effective 
concentration at 1% & 0.5%.
It means that certain number o f receptor-ligand bonds are needed to stimulate 
the events o f adhesion strengthening phenomena. On the other hand at 1% & .5% 
serum L929 cells showed no decrease in adhesion strength perhaps the threshold level 
of adhesion bonds was achieved by using the adsorbed fibronectin. Whereas Hela B 
cells might be different in regard to their requirements for adhesion compared to L929 
cells, nevertheless, these results suggested a significant role for serum (perhaps by 
providing adhesion protein(s)) in adhesion strengthening phenomena. This idea was 
further investigated by measuring the cell adhesion in the total absence o f serum. For
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this an attempt was made to grow L929 cells in serum free media. The difficulties 
faced are discussed below .
5.2.2. GROWTH OF L929 CELLS IN SERUM FREE MEDIUM
An effort was made to grow L929 cells in serum free media. The continuous 
growth o f L929 cells was desired to see the effect on adhesion strength when 
adhesion proteins are totally excluded from the cell adhesion system. Moreover, it 
was tempted that once cells are adapted to serum free medium, different parameters 
involved in the cell adhesion could be examined. To fulfil the trophic requirements o f  
the cells a medium was needed which provides nutritional elements (other than 
adhesion proteins) to the cells. To this end, L929 cells were grown in the serum free 
media (Nutridoma 1%) according to the instructions o f the suppliers (Boehringer, 
1989). Nutridoma was selected because it does not contain any adhesion proteins.
Firstly, L929 cells were inoculated directly in the serum free medium 
(materials & methods). The cells attached and remained attach to the culture vessel 
for 72 hours. Thereafter, they detached from the surface and were found floating in 
the culture medium. Their growth was determined by quantifying the number o f cells 
at different intervals during 72 hours. Their number remained the same, indicating the 
cells did not grow at all. However, they were viable while they remained attached to 
the surface. After losing their adhesiveness (i.e. after 72 hours) the cells were found 
dead as was checked by trypan blue exclusion method. Therefore, it appeared that 
they needed some time to adapt to the new serum free medium. This was done 
according to the suppliers instructions. That is L929 cells were grown on serum free 
medium by gradually lowering the concentration o f foetal calf serum from 10% to 0% 
(materials and methods).
For this purpose cryopreserved L929 cells were used in the earliest stage o f  
their life. The cryopreserved cells maximise the genetic microavailability for 
adaptation of cells to the serum free media (Katsuta & Takaoka, 1973). This strategy 
was adapted because variations in each lot o f serum cause an adaptation o f  the cells to
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the specific serum. Thus cells which could adapt most quickly to the new conditions 
will become the prominent cells in the culture. There may not be a sub population o f  
cells able to adapt quickly to a serum free environment. Considering this situation, it 
was logical to use the cells which were liquid nitrogen stored prior to use.
For the continuous growth o f L929 cells in serum free medium the precautions which 
were outlined in suppliers information were carefully followed (Boehringer, 1989). 
The observations which were noted during the attempted adaptation o f L929 cells are 
given as below.
1. The serum free derived cells were extremely sensitive to trypsin and only brief 
exposure to a little amount (0.01% w/v) compared to normal amount o f trypsin 
(0.05%) was found sufficient. Moreover due to their sensitivity, they were handled 
gently.
2. Due to unknown reasons, bovine serum albumin, fraction V (0.1%) was helpful to 
maintain culture when supplemented into Nutridoma medium.
1. It is appropriate to maintain cell culture at high cell density (3x10^ cells/ml), since 
only 25% cells were surviving at low inocula (lxlO^cells/ml).
Their growth curve was determined. While the doubling o f L929 
cells in serum was found to be 20 to 22 hours, the cells which were grown in the 
serum free medium doubled every 35 to 40 hours. However it is not out o f place to 
mention that their doubling was not frequent and these cells could only be grown for 2 
passages and in third passage they lost their adhesiveness. It took 3 weeks to bring 
these cells to this stage. Using the trypan blue exclusion method it was shown that 
these detached cells were viable (95%). The morphological studies o f these cells 
showed that the cells were absolutely abnormal (picture 5.1 compared with picture 5.2  
& 5.3). Their abnormality was also shown when their c.s.s. o f detachment was 
measured, in first and second passages. In first passage their critical shear was 13.0
PICTURE 5.1
Normal L929 cells growing on the plastic substratum
Sn is
Picture 5.2
Normal L929 cells growing in the serum free media
picture 5.3
Abnormal L929 cells growing in serum free media in their second passage
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±5Nm"2 (normal) and in second passage their critical shear value was 30.5 ±18 Nm' 
^(abnormal). The value of second passage was not stable (10-32 Nm*^). The cells in 
their second passage repeatedly appeared abnormal as they were tried to adapt for 6 
months. After 6 months extensive efforts it was concluded that continuous growth o f  
L929 cells in Nutridoma was not possible. Therefore, it was decided to grow cells just 
for 24 hours or less (according to the requirements o f the experiments) at the time o f  
experiment, since at this time their c.s.s. o f detachment is a constant value.
Thus in the connection of the effect o f serum on the adhesion strength o f L929 and 
Hela B cells, it was decided to check the effect o f complete absence o f serum proteins 
(adhesion) while cells had been growing for 24 hours in the serum free media. The 
effect of 0% serum on the adhesion strength o f L929 and Hela B cells is discussed in 
the following section
5.2.3 THE EFFECT OF 0% SERUM (SERUM FREE MEDIA)
L929 and Hela B cells were trypsinized from their surface and trypsin was 
inactivated using soybean trypsin inhibitor (a 3xM stoichiometric excess). The cells 
were then inoculated simultaneously on plastic and glass substrata. To provide cells 
other essential nutrients (except adhesion proteins) in the absence o f serum a good 
growth medium (Nutridoma l%(v/v), see materials & methods) was supplemented for 
the culture medium. The c.s.s. o f detachment was measured as illustrated in the 
methods (chapter 2). It is clear from the figure 5.1 & 5.2 that both cell lines showed a 
basal level of adhesion that is in 0% serum L929 cells have an adhesion strength (in 
terms of the c.s.s. of detachment) 9.1 ±3 Nm"^ on plastic and 13.0±4.5 Nm"^ on glass. 
Hela B cells on the other hand have a strength o f 16.0 ±3.8 Nm"^ and 27.0 ± 7 N n T ^  
on glass and plastic respectively (figure 5.1 & 5.2). Although, in the absence o f serum 
adhesion strength on glass and plastic is different but it is statistically not significant 
However, according to the trend, in the absence o f serum, L929 cells comparatively 
stick better to the glass than plastic. Whereas Hela B cells attached better on plastic.
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It is likely that this difference is due to cell type difference i.e. L929 are 
fibroblastic and Hela B are epithelial cells. However, what ever is the case, in both 
cell lines (on plastic and glass), the adhesion strength is substantially decreased 
(figure 5.1 & 5.2). It was o f interest to note that in the absence o f serum as compared 
to in its presence, the c.s.s. of detachment of both cell lines was obtained with 
unexpectedly large standard deviation. This observation might reflect the variation 
which may exit at sub-population level within the same cell line (Hurum et al, 1982; 
Connor et al, 1983)
5.2.3.1 POSSIBLE MECHANISMS OF SERUM EFFECT
5.2.3.1.1. ADHESION PROTEINS IN THE SERUM
The decreased critical shear in the absence o f serum may be due to deficiency 
o f adhesion proteins since considerably lower protein synthesis was observed in this 
case compared to the protein synthesis in the presence o f serum (figure 5.3). Thus 
serum may be acting as a stimulant for protein synthesis and secretion. Since this 
stimulant was no longer provided, the cells might fail to carry on full scale adhesion 
protein synthesis and subsequently a low amount o f protein deposition on the 
substratum took place. This is just speculation because adsorbed proteins were not 
analyzed in the present work. However, if  it is the case, a minimum number o f bonds 
might be formed to give the basal c.s.s. o f 9.1Nm“^  (in case o f L929 cells) and 
27.0Nm"2 (in case of Hela B cells). Therefore, it is possible that in the absence of 
serum, the number of adhesion bonds underneath the cells responsible for final 
adhesion strength remained well below than required for this complex phenomena. It 
is not clear whether in the absence of serum the synthesis and secretion o f all proteins 
decreased in a coordinated fashion or whether certain proteins are depressed 
preferentially. Thus it is my feeling that serum is providing vital ligands (proteins) for 
the cell surface receptors. These ligands bind with their receptors and
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send fully developed informational signals (perhaps for protein synthesis) to the 
interior o f cells so that cells attain final adhesion strength. In fact in the absence o f  
actual adhesion proteins, serum has been considered necessary for cytoskeletal 
orgnisation (i.e. binding of actin to the talin and vinculin which in turn bind to the 
receptors) and adhesion plaque formation. These structures may play a role in the 
stabilization o f adhesion process (Burridge et al, 1988). If proteins are provided then 
even when serum is absent cells achieve their final adhesion strength, (findings o f 
chapter 7).
5 .2 .3 .1 .2 . PROTEOLYSIS
In the absence o f adhesion proteins in the culture medium enhanced secretion 
o f hydrolases has been observed (Werb et al, 1989). These enzymes may be acting on 
receptors, adhesion proteins or cytoskeletal proteins. The end result will be fewer 
bonds and subsequently lower adhesion strength. Together, deficiency o f adhesion 
proteins and enhanced secretion of hydrolases might render the cells less adhesive in 
the absence of serum in the culture medium.
5.2.4. EFFECT OF SERA OF DIFFERENT ORIGIN ON THE 
ADHESION STRENGTH OF L929, HELA B AND WALKER RAT 
CARCINOMA CELLS
After examining the different aspects o f the role o f foetal calf serum on two 
very different cell types, it was o f interest to know whether or not sera from different 
species exerted similar or different effect on the adhesion strength o f cells. 
Particularly, considering the c.s.s. o f detachment o f Walker rat carcinoma when 
grown in horse serum (figure 4.1 & 5.4), it was necessary to examine the effect o f  
foetal calf serum on the adhesion strength o f walker rat carcinoma. Also it was 
necessary to examine the effect o f horse serum on the c.s.s. o f detachment o f L929 
and Hela B cells. Therefore experiments were carried out to examine the
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Cone, o f serum L929 C.S.S.(Nm~2) Hela C.S.S.(Nm"2)
10.0% 63.8 ±2.5 66.5 ±2.8
7.5% 64 411.5 65 112.3
5.0% 63 012.7 65 011.7
2.5% 64 212.4 64.512
1.25% 63 312.1 45 513.5
0.5% 62 712.5 23 018.5
0.25% 63 612.8 0  (not suvived)
0 .1% 40515.5 0 (not survived)
0.05% 0  (not survived) 0 (not survived)
0% 0  (not survived) 0 (not survived)
TABLE 5.1
L929 and Hela B cells were grown in the medium with different concentrations of 
serum (without Mutridoma 1%). The critical shear stress of detachment of these cells 
was measured as illustrated in materials and methods. Each value in the table is the 
mean of 20 detemninations.
125
j | ■ FCS glass 
£/]«FC S plastic 
|  *HS glass 





EFFECT OF FOETAL CALF (FCS) AND HORSE SERUM (HS) ON THE 
ADHESION STRENGTH OF L929, HELA B AND WALKER RAT CARCINOMA 
CELLS (WRC).
S  r  ^  in medium ■ « *
I^hT laStrength ° f th“ e Ce"S ^ termS ° critica^shL d^Tchm^.reprcSenlS Ule
c ^ e S T *  mean ° f 5 differem Each ™ c o n S t e a s ™ .  of
■me error bars indicate the standard error of the mean. Further details may be found in the text.
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responsiveness o f L929, Hela B cells and Walker rat carcinoma to both horse and 
foetal calf serum. The results are presented as below.
L929, Hela B and Walker rat carcinoma cells were grown in foetal calf serum or 
horse serum as illustrated in materials and methods. The c.s.s. o f detachment o f each 
cell line was measured according to the detachment assay described in materials and 
methods. The c.s.s. of detachment o f L929 and Hela B cells, in presence o f horse and 
fetal calf serum was not significantly different ( figure 5.4). That is for example the 
c.s.s. o f detachment o f L929 cells in presence o f foetal calf and horse serum on 
plastic was 66.0± 2.3Nm"^ and 65.2±2.5 Nm"^ respectively (figure 5.4). Similarly the 
c.s.s. o f detachment of Hela B in presence o f foetal calf serum on glass and plastic 
was not significantly different than that in the presence o f horse serum (figure 5.4). 
Surprisingly this was not the case for Walker rat carcinoma cells. In fact there was a 
dramatic increase in the c.s.s. o f detachment o f this cell line from both plastic and 
glass in response to foetal calf serum (40.0Nm'^ and 50.1Nm"^ on glass and plastic) 
compared to that o f horse serum (2.2Nm-  ^ on glass and 10.5Nm"^ on plastic).
This horse serum-foetal calf serum difference is very exciting, though difficult to 
interpret in detail. Firstly, it shows that Walker rat carcinoma cells have a stable 
adhesion constant in each serum. For example in horse serum the c.s.s. o f detachment 
o f walker rat carcinoma cells is 2.2Nm'^ and in fetal calf serum it is 40.0Nm'^. 
Furthermore these very widely different critical shear values are not reflected by 
measurable difference in growth rates. From an applied point o f  view this is further 
good evidence that the adhesion strength of a cell line is a suitable value that could be 
used as a quality control parameter. It is not easy to see how this adhesion strength 
difference arises. Ehrismann et al (1982) characterized the major adhesion protein 
"fibronectin" in horse serum and showed that in respect to its structure and functions 
it was similar to foetal calf fibronectin. So the different response is unlikely to be due 
to different fibronectins in horse and foetal calf serum. It is also unlikely that the 
structure o f vitronectins is different in horse and foetal calf serum, since overall this is
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also a quite highly conserved protein. However this difference can be attributed to the 
following speculations
1  Involvement o f protein(s) other than fibronectin and vitronectin
2 Horse vitronectin
(i) Glycosylation
(ii) Different receptors o f vitronectin 
(ii) Proteolysis
2  Transferrin
Now these points will be discussed individually as below.
5.2.4.1 PRO TEINS OTHER T H A N  FIBRONECTIN A N D  VITRO NECTIN
It is likely that the differences lie in the many other proteins present. If this is 
the case, the unknown adhesion protein(s) present in the foetal calf and missing from 
the horse serum may have a little significance for Hela B and L929 cells, whereas 
they may be crucial for strengthening the adhesion o f Walker rat carcinoma cells. It is 
also possible that these unknown adhesion proteins may be present in abundance in 
horse serum and could have low affinity toward receptors on the Walker rat 
carcinoma cell surface. On the other hand , foetal calf serum may contain proteins 
with high affinities for Walker rat cell surface receptors. These results indicate that 
Walker rat cells may attach and spread in similar way to Hela B and L929 cells but 
they probably attain their strength under entirely different mechanisms. The other 
possible mechanisms involved in the adhesion strengthening phenomena o f Walker 
rat and other cells is given below.
5 .2 .4 .2 . HORSE VITRONECTIN
Kitagaki-Ogawa et al (1990) published results that vitronectin o f  different 
serums may show variations with respect to its glycosylation sites . The most 
remarkable difference was found in D-galactosamine content, where horse vitronectin
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contained one residue and bovine vitronectin contained 8 residues o f this molecule. In 
addition, other quantities o f carbohydrate e.g. mannose and galactose on horse serum 
vitronectin are considerably lower compared to bovine vitronectin. It is known that 
carbohydrate generally stabilizes the protein structure and may be a protection against 
proteolysis (Rademacher et al, 1988). Therefore, it may be suggested that vitronectin 
in horse serum mediates attachment and spreading but due to lack o f  carbohydrate 
content was more prone to proteolysis than calf serum vitronectin. It may well be that 
extracellular proteolysis o f vitronectin disturbed the vitronectin-integrin-cytoskeleton 
complex and affected the formation of adhesion plaques, thereby, reducing the 
adhesion strength of Walker rat carcinoma cells. It could be argued that if  this is the 
case then horse vitronectin should be equally target o f proteolysis in case o f L929 and 
Hela B cells. In this regard the following factors must be considered.
Firstly, the proteolytic activity may be different in Walker rat carcinoma cells 
and other two cell types. Secondly, horse serum vitronectin may be equally facing 
proteolysis in L929 and Hela B cells but fibronectin and/or some other proteins are 
still there to compensate for this loss. If it is true then Walker rat carcinoma cells may 
be using vitronectin for its attachment and subsequent adhesion strengthening 
phenomena. While it can be speculated that different vitronectins show different 
binding affinities for the cell surface receptors, it can also be suggested that highly 
glycosylated foetal calf vitronectin may be providing more resistance to proteolysis, 
thereby , increasing adhesion strength o f Walker rat carcinoma cells.
Apart from adhesion proteins horse serum may be deficient, quantitatively or 
qualitatively in one or more components essential for the adhesion strength o f Walker 
rat carcinoma cells and non essential for L929 and Hela B cells. These components 
may include the molecules such as transferrin and growth hormones which are 
described below.
1 2 9
5.2 .4 .3 . GROW TH HORM ONES
Some hormones can alter the expression or affinity o f receptors for proteins 
and in this way might be expected to affect cell adhesion. For example, for some cell 
types it has been established that the amount o f fibronectin they produce can be 
modulated by glucocorticoids (Oliver et al, 1983), cyclic AMP (Dean et al, 1987) and 
epidermal growth factors (Baltt et al, 1988). These hormones are effective at 
extremely low concentrations (pico molar basis) which might vary between horse and 
foetal calf serum and thus would make difference between the effectiveness o f horse 
and foetal calf serum. If it is the case they are much more important for Walker rat 
carcinoma cells but not for L929 and Hela B cells.
5 .2 .4 .4 . TR AN SFER RIN
In the hormone category, there is a protein called transferrin. As with insulin, 
virtually every cell type examined has been found to respond to transferrin in serum 
free media (Barens and Sato, 1980). Iron saturated transferrin is essential for 
maintenance o f cells in culture. The stimulatory activity o f transferrin may also be 
due to the binding of this molecules to other metal ions which are toxic and which 
may be present in the culture medium (Mather and Sato, 1979). It is possible that each 
cell type has a different requirement for transferrin to cause effective adhesion as was 
shown for the growth o f some human carcinoma cell lines (Allegra & Lippman, 
1978). Recently it has been shown that proliferation of chick embryo neuroblast 
growth in the presence o f horse serum requires exogenous transferrin (Barakatwalter 
et al, 1991). Since the growth o f Walker rat carcinoma cells in horse serum is perfect, 
transferrin is either irrelevant to the growth o f these cells or it may only be affecting 
their adhesion strength.
5.3 CONCLUSION
In conclusion, adhesion proteins which are present in the serum are 
responsible for the adhesion strength of cells. In 0% serum containing culture
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medium, cells remained confined in first phase. That is they never gain their final 
adhesion strength. Moreover, the results presented in this chapter show that spreading 
is one aspect o f cell adhesion but does not represent the final adhesion strength as was 
found in the case of Walker rat carcinoma cells. That is they spread equally well in 
the presence o f horse and foetal calf serum but they are unable to gain their final 
adhesion strength in presence o f horse serum. Thus in presence o f  horse serum they 
never entered into the second phase o f cell adhesion (final adhesion strength). 
Whereas in presence of foetal calf serum they go through from first (attachment +/- 
spreading! to second phase (final adhesion strength).
While these findings and their interpretations are valuable information for the future 
research, the emphasis on these findings must be that the adhesion value o f  a cell line 
is constant value under constant conditions. It is not out o f place to mention that the 
main objective o f this study was to check the potential o f the Microflow chamber 
(developed in the present work) for evaluating the adhesion strength in different type 
of environments. It is very pleasing about this device that it is able to take account o f  
the environmental adhesion potentials o f the system. Therefore, now it is possible that 
the data obtained by the Microflow chamber can be interpreted according to the 
requirements of the work (research, clinical and biotechnological).
From the speculations in the previous chapter that specific adhesion protein(s) 
are responsible for cell adhesion strengthening phenomena, created the immediate 
thought that they might be doing so by binding with the integrin receptors. The 
adhesion proteins might be sending signals to the interior o f cells via integrin 
receptors. This is only speculation because nothing is known about it. Nonetheless 
this is not the subject o f this study, rather this speculation can be considered as a 
suggestion for future work. Thus the attention was focused on the protein receptor 
complex. It was thought that if protein-receptor bonds were involved, by blocking 
receptors with some agents, these bonds can be prevented from forming and in this 
way the adhesion strength o f a cell can be reduced or abolished completely. One 
approach was to use small peptides (e.g.RGDS) which are known to have the active
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binding sites o f fibronectin and other adhesion proteins (see chapter 1). These ought 
to bind to the integrin receptors thus competing out the respective protein(s)- 
receptor(s) binding, and adhesion strength of a cell can be purturbed. The following 
chapter is based on this strategy
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CHAPTER 6 
INHIBITION OF ADHESION STRENGTH IN RESPONSE TO 
RGDS(Arg- Gly-Asp-Ser) & YIGSR (Tyr-Ile-Gly-Ser-Asp). 
6.1. INTRODUCTION
Synthetic peptides containing the sequences RGDS and YIGSR have been 
shown to inhibit the adhesion o f various cells to several extracellular matrix protein(s) 
(Saiki et al, 1989). While the former inhibits adhesion mediated by fibronectin, 
vitronectin, laminin, collagen, the later specifically inhibits the laminin mediated cell 
adhesion (Skubitz et al, 1990). The RGDS sequence was first mapped as the main 
interaction site for the cell surface fibronectin binding receptor a 5 p l (Pytela et al, 
1985b). Since then RGDS has been used to inhibit the function o f the cx5pl and other 
integrins in several experimental models (Ruoslahti & Giancotti, 1989; Reinbolt et al,
1990)
The YIGSR a laminin derived peptide has also been reported to bind to a 
67Kd laminin receptor(Terrenova et al,1983). In the present study, RGDS and YIGSR 
were used to block the receptors and the resultant effects on the adhesion strength o f  
L929 and HELA B cells were examined. It was in mind that if  prior to the 
detachment measurement, the fibronectin active binding site peptide RGDS was 
added, a measurable decrease in adhesion strength might be seen.
6.2. RESULTS & DISCUSSION
6.2.1. EFFECT OF RGDS ON THE ADHESION STRENGTH OF L929 
CELLS
The effects o f RGDS on the critical shear stress of detachment o f  L929 cells 
from glass and plastic substrata were examined by incubating the cells with this 
peptide in varying concentration for 24 hours.
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As seen in figure (6.1), the depression of adhesion in presence o f RGDS to some 
extent was concentration dependent, however, by increasing the concentration from 
7.5}ig/ml to 15|ig/ml, the adhesion strength was not further perturbed. The maximum 
reduction noted on glass and plastic substrata was 44% and 41% of the control values 
respectively The effect due to RGDS did not appear to be due to toxicity rather, it 
seemed to be quite specific. This specificity was demonstrated by the fact that the 
control peptide i.e. YIGSR ( materials & methods) had no observable effect on the 
adhesion o f L929 cells. Lack o f toxicity was also evidenced by the observation that no 
cell death was detected by the trypan blue exclusion method, where the RGDS was 
present in the growth medium o f the cells.
As seen in figure 6.1 the reduction o f adhesion strength was only partial at the 
maximum concentration o f RGDS used in this study. The reason may be that the 
concentration used in this study was far lower than the amount o f peptide used in 
previous studies published by the other workers (Ylanne, 1990). That is the maximum 
concentration utilized in this study was 15(ig/ml compared to 1000}ig or more/ml in 
other studies (Hautanen et al, 1989 and Massia & Hubble, 1990). However one must 
make distinction between the effect o f RGDS either on attachment o f the cells or on 
the strength of cell adhesion. Here in this study it was never the aim to stop the cells 
attaching to the substratum.
It is not clear, at the present time, how the adhesion functions are perturbed by 
this peptide. It is likely that vitronectin and fibronectin are both implicated because 
both o f these adhesion proteins are present in the serum for growing these cells. 
Moreover Hayman et al (1985) have shown that serum proteins play a role in cell 
adhesion. The reduction in adhesion strength seen in the figure (6.1) is significant 
when one realizes that the RGDS interaction is, by no means the only receptor—ligand 
bindings present (Farsi et al, 1985 and McCarthy et al, 1990). Even within fibronectin 
there are other adhesion domains (Komoriya et al, 1991). Thus the partial reduction o f  
adhesion strength either may be due to RGDS independent molecules or to domains
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FIGURE 6.1
PERTURBATION OF ADHESION STRENGTH OF L929 CELLS IN RESPONSE TO RGDS (arg-
gly-asp-ser).
L929 cells were plated on glass or plastic substratum with or without RGDS peptide at the 
concentrations indicated on the x-axis of the above figure. Adhesion strength of these cells in terms of 
the critical shear stress (c.s.s.) of detachment was measured by using the Microflow chamber as 
described in materials and methods.
Each data point represents 3 experiments, each of which contains 20 measurements of c.s.s. in response 
to different concentrations of RGDS peptide. The error bars indicate the standard error of the mean.
A t test indicates that the depression of adhesion strength of L929 cells even at lower concentrations 
(2.5|ig/ml) of RGDS is highly significant (p=0.0001). Further details may be found in the text
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other than RGDS (arg-gly-asp-ser).It is also quite likely that RGDS binding was less 
than 100%. That is, it is a competitive reversible binding event whose quantitative 
affinities or disassociation constant is not known. In the present study in 
correspondence to maximum concentration (15|ig/ml) 1 .8 x 1 0 ^  molecules o f  
RGDS/ml were calculated, where as maximum number o f receptors on the cell 
surface are estimated as lx  10^ (Codongo et al, 1987). The total volume in the 
adhesion assay plate (55cm^) was 20 ml thus the total number o f RGDS molecules 
per plate can be calculated as 1 .8 x l0 ^ /m l x 20 = 3.6x10^/plate. Whereas total 
number o f cells in the plate (55cm ^ ) were 4x10^, therefore, number o f receptors per 
plate were 4x10^ x 10^receptors/cell = 4x l0^ /p la te . From this calculation it seems 
that sufficient molecules o f RGDS were present to compete out receptor-ligand 
binding but one must keep in mind that it is competing with much larger molecules of  
both serum and secreted proteins.
One body o f evidence suggested that the treatment o f mouse 3T3 fibroblasts 
with RGDS not only perturbed binding o f adhesion proteins to their receptors but also 
induced disassociation o f cytoskeletal proteins from the sites o f adhesion plaques 
(Stickel & Wang, 1988) The cytoskeletal proteins and adhesion plaques both are 
considered necessary for the stabilization of cell adhesion (Burridge et al, 1988). Thus 
it seems likely that RGDS used in present study affected adhesion strength by 
disturbing the adhesion plaques or by interfering in the formation o f adhesion plaques. 
As it is also possible that the binding of RGDS with the receptors might have 
enhanced the expression o f proteases which caused the reduction o f adhesion strength 
(Werb et al, 1989)
In response to RGDS the partial reduction in adhesion strength o f L929 cells 
can be explained from another point o f view. That is all the previous published studies 
with the RGDS were carried out for short time periods ( Pierschbacher & Ruoslahti, 
1987; Ruoslahti & Pierschbacher, 1987). This is the first study to date in which 
functions of RGDS are determined for a longer period in serum containing medium. 
Thus similar effects noted in response to all concentrations at or above 7.5|ig/m l may
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be suggesting the reversibility o f RGDS-receptor interaction over the longer period 
(24 hours) due to, perhaps, internalisation o f peptide. The term internalisation is just 
speculation because at present nothing is known about it. It is also possible that the 
effect o f RGDS would have been more than observed because the long incubation 
might have degraded some o f the peptide. However it can not be ruled out that all the 
sites that can bind with peptide bound it at 15|ig/ml i.e. the sites are saturated.
The combined result o f all the effects outlined above is that RGDS ensures that the 
adhesion strength never reaches its maximum due to competitive binding.
6.2.2. EFFECT OF YIGSR (tyr-ile-gly-ser-asp ) ON THE ADHESION 
STRENGTH OF L929 AND HELA B CELLS
The control peptide for this experiment was the laminin active site peptide 
YIGSR which had no effect on adhesion strength at any o f the concentration used 
(figure 6.2 & 6.3). This also gives the interesting findings that since it has no effect, 
thus it is unlikely that L929 or Hela B cells utilise laminin to any great extent 
However the laminin has been shown to increase the strength o f L929 and Hela B cell 
adhesion considerably in serum free medium (chapter 7).
It must be kept in mind that the experiments here, were carried out in serum 
containing medium. In presence o f serum, L929 and Hela B cells might have used 
fibronectin, vitronectin and vitronectin and collagen respectively instead o f laminin. 
This notion may not be completely true, because laminin may have reinforced the 
adhesion strength o f these cells. If this is to be believed, the YIGSR should depress 
the adhesion strength o f these cells, at least to some measurable extent which it did 
not. This simple explanation of this failure may be put in the context o f rather a large 
number o f proposed recognition sequences reported to date in laminin. That is apart 
from the YIGSR sequence, at least 8 others have been reported so far (Yamada,
1991). Moreover, in general the peptides derived from laminin appear to have 











o  _ «
o _
f  -  Plastic 
[ 3  -  Glass
LI LI
0 2JS 5 7.5 10 12JS 15
Concentration of  YIGSR (/jg/ml)
FIGURE 6.2











0 2.5 5 7.5 10 12.5 15
Concentration of YIGSR (jjg/ml)
EFFECT OF YIGSR (tyr-ile-gly-ser-arg-) ON THE ADHESION STRENGTH OF HELA B CELLS.
L929 or Hela B cells were plated on glass or plastic substratum with or without YIGSR peptide at the 
concentrations indicated on the x-axis of the above two figures (A & B). Adhesion strength of these 
cells in terms of the critical shear stress (c.s.s.) of detachment was measured according to the standard 
conditions outlined in materials and methods.
Each data point is representative of 3 experiments. In each experiment, 20 measurements of c.s.s. were 
made at each concentration of YIGSR. The error bars indicate the standard error of the mean.
A t test indicates the difference in adhesion strength of untreated and YIGSR treated L929 cells is not
significant (p=0.45).
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higher molar amounts of these peptides compared to laminin for adhesion assays 
(Sephel et al, 1989). While YIGSR is inefficient in depressing the adhesion strength 
of both L929 and Hela B cells, o f course it might be active in some other cell types. 
That is each binding site in laminin may be playing a specific role in different cell 
types.
The findings o f the present study are favoured by the work in which it has 
been shown that a laminin derived peptide RYVVLPR (arg-tyr-val-val-leu-pro-arg-) 
when coated on the substratum, directly promoted cell adhesion, but when present in 
solution could not significantly depressed the adhesion (Skubitz et al, 1990). The 
situation in the present work became very complicated because o f the presence o f  
other serum proteins in the culture medium. With these present (fibronectin, 
vitronectin, collagen lv) it is unlikely that laminin contributed a measurable part in 
adhesion o f L929 and Hela B cells.
6.3 CONCLUSION
In conclusion, the addition o f exogenous RGDS peptide to the serum 
containing culture medium, perturbed to a significant extent protein-receptor 
complexes and had a profound effect on the adhesion strength o f L929 cells, despite 
the fact that alternative determinants are present. The main finding o f this chapter is 
that the Microflow chamber appears to be highly sensitive because it can sense a 
minor change in the environment o f the cell adhesion system. This sensitivity is a pre 
requisite for a competent quantitative technique. It is pleasing that the Microflow  
chamber not only can detect the changes in the environment o f the attached cell but 
the results obtained with the help o f this device can also be used to interpret the 
biochemical events involved in the cell adhesion. For example RGDS is suspected to 
block the formation of the protein-receptor bonds. This idea (participation o f  
proteins) was checked by coating the surface with specific adhesion proteins and 
measuring the adhesion strength of cells growing on this surface with the help o f the 
Microflow chamber as described in the following chapter.
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The RGDS might have suppressed adhesion strength by blocking some signals 
generated by the adhesion proteins. Thus it is suggested in the present and chapter 5 
that serum enhances the adhesion strength via adhesion proteins present in it. To 
check whether adhesion proteins are actually responsible for adhesion strength, 
surfaces are coated with specific adhesion proteins and adhesion strength measured as 
described in the following chapter.
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C H A P T E R  7  
THE ROLE OF SUBSTRATUM PRE-ADSORBED PROTEINS IN 
ADHESION STRENGTHENING PHENOMENA
7.1 . INTRO DUCTIO N
In previous chapters, the focus was on the adhesion proteins adsorbed directly 
from the serum onto the surface. These adsorbed proteins might be encountered by 
cells in the usual serum supplemented culture medium (Edwards et al, 1987). 
Attention was also drawn to possible mechanisms by which cells could use one or 
more protein(s) from serum containing culture medium (chapter 5). Some o f these 
adhesion proteins are now commercially available in their purified form. Taking 
advantage o f their availability, studies were planned to modify the normal tissue 
culture grade plastic with a specific protein and then find out how this affects cell 
growth and adhesion. For this purpose the plastic surface o f tissue culture was coated 
with fibronectin or laminin and the effects o f this on the adhesion strength o f L929 
and Hela B cells was examined. Fibronectin and laminin were chosen because it is 
widely believed that these proteins function with the widest variety o f cell types 
(Couchman et al,1983), with the emphasis that the former has many binding sites on 
both fibroblasts and epithelial cell surfaces (Dufour et al, 1986). Whereas, laminin 
binds most favourably with epithelial cells. (Kleinman et al, 1985). The L929 and 
Hela B cells were selected because the former are fibroblasts and the latter epithelial 
cells. The results and their interpretations are presented in the following section.
7 .2 . RESULTS A N D  D ISC U SSIO N
7.2.1. RESULTS
To evaluate the role of specific protein (fibronectin) in the adhesion 
strengthening phenomena, tissue culture grade plastic dishes (55cm^) were coated 
with fibronectin (l-175jig/55cm^ dish) overnight as described in materials and
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methods. After this time the dishes were washed three times with double distilled 
water and air dried in a laminar flow for fifteen minutes before seeding the L929 cells 
on them. At this time four experiments were performed.
1  L929 cells were seeded on fibronectin coated or non coated (control) dishes in the 
presence o f serum in the culture medium and the c.s.s. o f detachment was measured 
after 3 hours.
2 L929 cells were seeded on fibronectin coated or non coated dishes (control) in the 
absence o f  serum in the culture medium (Eagles medium plus Nutridomal%) and the 
c.s.s. o f detachment was measured after 3 hours.
In the next two experiments the cells in NO. 1 & 2 were incubated for 24 
hours and c.s.s. o f detachment was measured.
When the L929 cells were grown on fibronectin coated dishes in the presence 
or absence o f serum in the culture medium and were observed under phase contrast 
microscopy, they were found slightly more spread (picture 7.1) compared to the cells 
growing on non coated plastic in the presence of serum (picture 7.2). The cells grown 
on non coated dishes in serum free medium were found with round morphology 
(picture 5.2 in chapter 5).
The results of these experiments are given as below.
1  It was o f interest to note that when L929 cells were grown on fibronectin coated 
dishes in the presence o f serum and c.s.s. o f detachment was measured after 3 hours, 
the adhesion strength was increased by 15% over the control value. That is adhesion 
strength on fibronectin coated surfaces in the presence o f serum was 60.0 ±  l^N nT^  
and on non coated dishes it was 52.1 ± 1.5Nm"^ (figure 7.1).
2 When the L929 cells were grown on fibronectin coated dishes in the absence o f  
serum and c.s.s. of detachment was measured after 3 hours it was increased by 7 fold 
(700 %) o f the control value. That is on the coated dishes in presence o f serum free 
media (Nutridoma 1%) the critical shear was 61.0 ±1.4Nm'^ and on control dishes it 
was 7.0 ± 3Nm-  ^(figure7.1).
PICTURE 7.1
L929 cells growing on the plastic substratum
PICTURE 7.2
L929 cells growing on the fibronectin pre-adsorbed substratum
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2 After 24 hours in the presence o f serum on fibronectin coated dishes the c.s.s. was 
increased by 30% of the control (non coated dishes) value (figure 7.2).
4 After 24 hours in the serum free media on fibronectin coated dishes the adhesion 
strength was increased by 800% o f the control (non coated dishes) value (figure 7.2).
It is clear from the results presented in the figures 7.1 & 7.2 that whether 
serum is present in the culture medium or not the fibronectin coated dishes enhanced 
the critical shear value to a maximum o f 82.5Nm'^. Furthermore, one important 
finding is that the dramatic sensitivity o f L929 cells in response to a fibronectin 
coated substratum appears to require a minimum surface density o f  fibronectin 
molecules l|ig/55cm ^ dish, above this level (25-175|ig/55cm^ dish) the adhesion 
becomes independent o f the added fibronectin concentration.
Now the discussion o f these findings follows.
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FIGURE 7.1
a d h e sio n  Streng th  of L929 cells o n  the fibronectin  pre  a d so r b e d  plastic
The tissue culture grade plastic dishes (55cm2) were incubated with (0-175 f ig ^ m 2) human 
fibronectin. Fibronectin coating was proceeded as illustrated in materials and methods. L929 cells were 
grown on fibronectin pre-adsorbed dishes for 3 hours. The adhesion strength of these cells in terms of 
the critical shear stress (c.s.s.) was measured by using the Microflow chamber. Each data point 
represents the mean of 30 different determinations, the error bars indicate the standard error of that 
A 1 test ^dicates that the difference between the adhesion strength of cells growing on uncoated 
dishes (in presence of serum or serum free medium) and fibronectin pre-adsorbed dishes (in presence 
of serum or serum free medium) is highly significant (p=0.0001).
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FIGURE 7.2
ADHESION STRENGTH OF L929 CELLS ON THE FIBRONECTIN PRE ADSORBED PLASTIC 
SURFACE.
The tissue culture grade plastic dishes (55cm^) were incubated with (0-175p.g/55cm^) human 
fibronectin. fibronectin coating was proceeded as illustrated in materials and methods. L929 cells were 
grown on fibronectin pre-adsorbed dishes for 24 hours. The adhesion strength of these cells in terms of 
the critical shear stress (c.s.s.) was measured by using the Microflow chamber.
Each data point represents the mean of 30 different determinations, the error bars indicate the standard 
error of that mean.
A t test indicates that the difference between the adhesion strength of cells growing on uncoated dishes 
(in presence of serum or serum free media) and fibronectin pre-adsorbed dishes (in presence of serum 
or serum free medium) is highly significant (p=0.0001).
^49955
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7.2 .2  D ISC U SSIO N
The results obtained in response to pre-adsorbed fibronectin were very 
exciting. Particularly the finding that a very low concentration o f fibronectin acts like 
a catalyst and increases adhesion strength by 9 fold (i.e. 82.5Nm'^) o f the control 
value (i.e. 9.1Nm"^). Since fibronectin was simply adsorbed but not chemically 
coupled to the plastic, the next question was how much o f it remained adsorbed on the 
surface after extensive washing. For this, iodinated fibronectin was used to find out 
the number o f molecules adsorbed per unit area of the tissue culture grade plastic. The 
details o f the procedure are given in materials and methods , however, it is 
worthwhile to mention that ^^I-fibronectin was coated on tissue culture plastic 
overnight and proceeded exactly the same way as non iodinated fibronectin coating, 
(see above and materials & methods). The coated ^^I-fibronectin was extracted 
twice with NaOH (1M) and counted on the Gamma counter. The counts per minute 
and radio specific activity o f ^^I-fibronectin was used to calculate the number o f  
fibronectin molecules/pm^.
According to the ^ I - f i b r o n e c t i n  adsorption experiment, in fact 70% of the 
added fibronectin was adsorbed to the surface (table 7.1 & 7.2)) For example, when 
55cm^ (3 x l0 ^ p m^) dishes were coated with lp g  and 150 pg, the number o f  
molecules which remained adsorbed were calculated as 200/pm^ and 30,000/pm^ 
(table 7.1). Interestingly, 200 molecules/pm^ and 30,000 molecules/pm^ enhanced 
the same amount of adhesion strength of L929 cells. Therefore, it was necessary to 
find out whether 200 molecules/pm^ are covering the surface underneath the cell or 
not. For this purpose the following assumption was made.
The fibronectin molecule is a rod shaped molecule with a length o f 60-70 nm 
and a width o f 2-3nm (Ito et al,1991). Assuming that fibronectin acquires a flat 
rectangular shape after its adsorption onto the surface, the area which this molecule 
will cover can be calculated as 180nm^. Therefore, to cover the area o f lpm ^  
completely, 5500 molecules are required (see also table 7.2). Thus it is clear that at 
lpg/3xl0*  lp m  ^the fibronectin molecules (200/pm^) do not completely cover the
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Applied FN per 3x10^ Molecules/cell C.S.S. (Nm '2
Opg 0 9.1 ±3.5
in g 2,000 82.5 ±1.5
25 pg 50,000 82 0±1.4
50 pg 100,000 81.7 ±1.5
75 pg 150,000 82 1±1.3
100 pg 200,000 82.5 ±1.2
125 pg 250,000 83 0±1.3
150 pg 300,000 82 2±1.2
175 pg 350,000 81.5 ±1.2
TA BLE 7.1
^I-fib ron ectin  was coated on the tissue culture grade plastic as illustrated in 
materials and methods. The number of adsorbed fibronectin (FN) molecules/cell 
(lOfim2) w as calculated as described in materials and methods. The critical shear 
stress of detachment (c.s.§.) o f L929 cells growing on this adsorbed fibronectin was 
measured in terms of Nm . Further details may be found in the text and in the figures
7.1 & 7.2.
L (nm) W (nm) A (nm2) Molecules required/cell
60 3 180 55,000
Table 7 .2
On the basis o f theoretical estimated size o f adsorbed fibronectin, number of 
molecules required to cover the underneath o f the cell surface w as calculated by 
assuming the size o f cell lOfim . Further details may be found in the text.
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whole surface. As indicated above and making the assumption on the size o f the 
surface bound fibronectin molecule, there are 5x10^ molecules needed per cell 
(assuming that the area o f L929 cell is lOjim^). However, the maximum cell adhesion 
is found at 2x1 (P molecules per cell, a value 30 times lower than expected. Moreover, 
the L929 cells gained maximal adhesion (82.5± 1.5Nm‘^) on these minimal 
fibronectin molecules. That is, 2x10^ fibronectin molecules caused the cell adhesion 
to increase from 9.1 ± 3.5 Nm'^ to 82.5 +  1.5Nm"^, a nine fold increase.
Intuitively the addition o f 2000 fibronectin molecules to a cell could not increase the 
critical shear stress by the factor o f nine seen in figure 7.1. Some workers have tried 
to develop mathematical models which describe adhesion o f a cell to a substratum. 
One of these (Bell, 1978) calculates that an "average" receptor-ligand bond, such as 
that which occurs between a lectin and its target protein, has a strength o f 0.4x10"^ 
dynes. An immediate problem is that this figure is valid only for cells which are 
pulled in a perpendicular manner, away from their substratum. In the hydrodynamic 
Microflow chamber the liquid force applied to the cell is parallel to the cell's 
substratum. In other words the cell can be likened to a small submarine anchored to 
the bottom o f a fast flowing river (the Microflow chamber). The moving water exerts 
a force on the leading edge or front o f the submarine with little or no force exerted 
along its length including its trailing edge. The same applies to a cell in the Microflow  
chamber where the leading edge o f the cell takes the whole force. Imagine now an 
idealised rectangular cell with regularly spaced ligand-receptor binding this cell to the 
substratum (figure 3.5). At one time the only important binding sites are at the leading 
edge. Once sufficient force has been applied to peel these bonds away from the 
substratum, all the force is taken on the second row, then the third row and so on 
while the cell rolls off the substratum. It is not possible, therefore, to calculate the 
actual quantitative force to disrupt the added 2000 fibronectin molecules. One can 
however make an educated or qualitative estimate.
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It is probably reasonable to suggest that at most, 10% of the receptor-ligand 
sites are at the cells leading edge,that is, 200 molecules o f fibronectin. Intuitively it 
seems improbable that these 200 molecules can increase the overall adhesion o f the 
cells by a factor o f 9 or so (figure 7.1). This being the case, it is reasonable to suggest 
a strong possibility that the fibronectin molecules are acting as a signalling system. 
This possibilityis described in detail below.
7.2.2.1. SIGNALLING MECHANISM
As stated above it seems likely that there must be some signalling mechanism 
involved in the fibronectin enhanced adhesion strength. At present nothing is known 
about this signalling mechanism, therefore, the topics discussed below are 
speculations. It is not out o f place to mention that the object o f this work is not to 
explore the signalling mechanism, thereby, the emphasis on these findings must be 
that the Microflow chamber (developed in present work) is a device which is able to 
determine the effect o f 200 molecules/pm^. It is pleasing that this device can be used 
at the molecular level. This statement no way detracts from the importance o f the 
findings o f the fibronectin enhanced adhesion strength. Thus coming back to the 
signalling mechanism the following possible speculations concerning this mechanism 
can be considered.
1  Involvement o f the adhesion bonds.





2 The distance between cell and the surface
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7.2.2.1.1. INVOLVEMENT OF THE ADHESION BONDS
A theory o f an adhesion signalling system was put forward in the chapter 4. 
The signal might be triggered by the fibronectin-integrin bonds and acts as a 
stimulator o f biochemical and cytoskeletal events involved in gaining the adhesion 
strength. It is likely that a certain number o f initial bonds are required to initiate this 
process. These specific bonds somehow send a signal to the interior o f the cell 
machinery to recruit the cytoskeletal proteins to produce more stable and compact 
adhesion.. It is also possible that this triggering low level o f fibronectin (2000 
molecules/cell) stimulates the synthesis and secretion o f endogenous fibronectin or 
other protein(s) which later bind with their respective receptors thus contributing to 
the final adhesion strength. These speculations may be oversimplifying the situation. 
It could be that a variety o f stimuli are involved by which cell adhesion is 
strengthened. Some o f these possible stimuli are discussed as below.
72.2 .1 .2 . ADHESION STRENGTHENING VIA FORMATION OF THE 
ADHESION PLAQUES AND THE CYTOSKELETAL ORGNISATION
Once the initial bonds have formed, these bonds must be triggering the 
biochemical events responsible for the formation o f the adhesion plaques (see chapter 
1) and the cytoskeletal orgnisation (the coupling o f the cytoskeletal proteins with each 
other and with integrins, see chapter 1)). At present these biochemical events are not 
known. However, some o f the possible mechanisms are discussed below.
(a) cAMP
cAMP could be suspected to play a role as an adhesion signalling system in 
the activation o f adhesion phenomena. This molecule may be affecting this process 
through cAMP dependent protein kinases. It has been known for some time that cell 
adhesion can be strengthened by raising the intracellular level o f cAMP (Johnson & 
Pastan, 1972). Although qualitatively, they were able to show that the detachment of 
the cells was retarded by artificially raising cAMP inside the cell. Still qualitative,
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many studies showed that virally transformed cells responded to elevated cAMP by 
adhering more tightly to their substratum (Leader et al, 1983).
Nevertheless if  the cAMP is involved it must be acting through the protein kinases. 
Here the possibility is that the binding of fibronectin with its receptor may induce 
conformational changes in the cytoplasmic portion o f the fibronectin receptors which 
may lead the events which elevate the cAMP level in the cell and in turn the protein 
kinases may be activated. The protein kinases may be stabilizing the adhesion 
protein-receptor-cytoskeleton complex via the phosphorylation o f some o f  the 
participant in this complex as stated below.
(b) PHOSPHORYLATION
The protein kinases can phosphorylate the cytoplasmic portion o f the receptor 
or some o f the cytoskeletal proteins. In fact phosphorylation appeared to stabilize 
integrin-cytoskeleton interactions (Suzuki et al, 1987). This stabilization in turn may 
stabilize the fibronectin-integrin complex and thereby contribute to the formation o f  
the stable adhesion plaques. These adhesion plaques may be an important factor in 
gaining the final adhesion strength of a particular cell line ( e.g. L929 cells). Apart 
from phosphorylation, proteolysis could be another aspect o f regulation o f cell 
adhesion strength which I propose is under the control o f fibronectin activation 
system as is illustrated below.
(c) PROTEOLYSIS
Werb et al (1989) found that the blockage o f fibronectin receptor by using 
monoclonal antibodies actually enhanced the expression o f two extracellular 
degrading enzymes, collagenase and stromolysin. It is possible that in my work, apart 
from sending a signal for cytoskeletal orgnisation and thus adhesion plaque 
formation, fibronectin suppressed the expression o f proteolytic enzymes and thereby 
increasing the adhesion strength (by protecting the extracellular proteins).
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7.2.2.1.3. THE DISTANCE BETWEEN THE CELL AND THE SURFACE
. It is generally believed that focal adhesions are sites, the presence o f which 
may be correlated with increased adhesion strength (Norton & Izzard, 1982). This 
suggestion was made on the basis of qualitative observations. However, In the 
presence o f fibronectin precoating, the average distance o f 20nm between the cell and 
the substratum was classified as an adhesion plaque. Whereas, in the case o f an 
uncoated substratum, but in the presence o f serum, a distance o f 50nm was defined as 
an adhesion plaque (Schakenraad et al, 1989). Thus it can be implied that, the smaller 
the distance the stronger the adhesion. Therefore, in the present experiments 
involving the surface precoating with fibronectin, the critical step might be the 
determination of adhesion strength via decreasing the distance between the cell and its 
substratum. This decreasing distance system must be under the control o f  the 
fibronectin activation system.
7.2.3 EFFECT OF PR EA D SO R BED  FIBRO NECTIN O N  THE A D H ESIO N  
STR ENG TH  OF L 929 CELLS IN PRESENCE O F SER U M
Another important finding in this work was that once the surface is coated 
with fibronectin, the presence o f serum does not play any further role in strengthening 
the adhesion. Here the situation is puzzling concerning the proposed fibronectin 
removal from adhesion plaques. This is because Grinnell (1986) found that adsorbed 
fibronectin could only be removed from beneath the focal adhesion in the presence of  
serum. Except that Grinnell speculated mechanical desorption o f fibronectin, no other 
explanation about this finding was given In my study the fibronectin was coated onto 
the surface and L929 cells were seeded in the culture medium containing serum. 
Interestingly the adhesion strength was not perturbed and no difference in the c.s.s. of 
detachment from fibronectin substratum was noted in the presence or absence o f  
serum.
In the present work the desorption of fibronectin underneath the cell was not 
checked, since it was not the main object of this study. However, the results obtained
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in the presence o f serum indicate that once fibronectin activated initial events occur 
and the sequence o f events leading to final adhesion strength is started, then adhesion 
strength is independent of the presence of serum. In context o f  the serum experiments, 
one could argue that on non coated plastic, fibronectin which is present in the serum 
does not increase as much adhesion as was observed in response to the pre-adsorbed 
fibronectin. This argument further strengthens due to the fact that about 38ng/cm^ 
fibronectin adsorbed on the plastic when it is incubated with the medium containing 
10% foetal calf serum (Steele, et al, 1991). This amount is double the amount o f pre­
adsorbed fibronectin in the present study. That is in present study 18ng/cm^ was 
adsorbed when lp.g was used for adsorption on the 55cm^ dish.
The simple answer might be that fibronectin adsorbed from the serum is not as 
biologically suitable as was the precoated fibronectin substratum. Serum is a complex 
mixture o f proteins and other molecules. 38ng fibronectin/cm^ is such a small amount 
compared to other molecules that other proteins do not allow fibronectin to alter its 
conformation to a suitable form for full activation o f adhesion strength. This idea 
gains support from the other lines o f evidence which suggest that not only is the 
quantity o f protein adsorbed on the surface important but also their conformation is a 
determinant for cell adhesion (Fabrizius- Homan & Cooper, 1991).
After establishing the fact that fibronectin acts as an activator rather than mediator in 
cell adhesion, it was desirable to know whether other adhesion proteins play similar 
roles in this complex process. It was with this question in mind that laminin was 
selected so that its role in strengthening the cell adhesion could be examined.
7 .2 .4  EFFECT OF PR E -A D SO R B E D  L A M IN IN  O N  THE A D H ESIO N  
STRENG TH OF L929 A N D  HELA B CELLS
Laminin was obtained from Sigma and coating o f plastic petri dishes with this 
protein was proceeded with as stated in the materials and methods. Briefly, l-175|J,g 
laminin was dissolved in PBS and the 55cm^ dishes were coated overnight. 
Thereafter, immediately before use, unadsorbed laminin was extensively removed
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with PBS. It is not known how much laminin was adsorbed on the surface. For this 
purpose laminin needed to be iodinated and the adsorption determined as illustrated in 
case o f fibronectin. However, financial considerations ruled this out. Nevertheless on 
laminin coated dishes the following experiments were performed.
1  L929 and Hela B cells were seeded on laminin coated (l-175p.g/ 55cm ^ dishes) or 
non coated (control) dishes in the absence o f serum and c.s.s. o f detachment was 
measured after 24 hours (see materials and methods).
2 L929 and Hela B cells were seeded on laminin coated (l-175jig/55cm ^  
dishes) or non coated (control) dishes in the presence o f  serum (55cm^) and c.s.s. o f  
detachment was measured after 24 hours (see materials and methods)
The following results were obtained. It was o f interest to note that like 
fibronectin, laminin too, at lower or higher concentration increased adhesion strength 
substantially. For example, the laminin coated substratum enhanced the c.s.s. o f  
detachment o f L929 cells 7 fold (65.0 ±1 Nm'^) o f the control value (9.1±3.5 Nm“^ ) 
whereas the increase in Hela B cells was 2.5 fold (63.1 ±2.3Nm-^) o f the control 
value 23.0±6Nm"2 (figure7.3)
Unlike fibronectin, laminin did not increase adhesion strength o f L929 and 
Hela B cells in the presence o f serum. That is, in the presence o f serum the adhesion 
strength o f these cells on laminin coated (e.g. 65.0± 1.4 Nm'^ for Hela B and 64.1 ±  
1.2Nm'2 for L929 cells) and non coated plastic dishes (e.g. 66.0 ±2.5 Nm"^ for Hela 
B and 66.1±1.6Nm"^ for L929 cells) was the same. In contrast fibronectin activation 
caused a 30% increase in the c.s.s. o f detachment o f L929 cells compared to an 
uncoated substratum in the presence o f serum (figure 7.3).
In numerous studies, laminin is considered best for epithelial cells (Klein et al, 
1988). It was expected that laminin would enhance adhesion strength favourably for 
Hela B cells (epithelial cell line) compared to L929 cells (fibroblasts). Surprisingly 
the adhesion strength o f L929 cells (65.0Nm-^) was more enhanced compared to Hela 
B cells (63.1Nm'2). Thus the observations that led to these findings were unexpected.
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However, the main difference was found to be between fibronectin and laminin 
activation o f  the adhesion phenomena.
At present no specific reason concerning the different behaviour o f L929 cells 
toward these proteins is available. However, the number o f receptors on the L929 
cells which might bind selectively to fibronectin and laminin may account for the 
difference in the enhancement o f adhesion strength caused by these proteins.
As stated earlier, from the results presented in figure (7.3) it is noted that 
laminin, like fibronectin (though not equivalent to fibronectin) at low concentrations 
(lpg/55cm ^ dish) substantially increased the adhesion strength o f L929 cells (7 fold). 
It implies that at lower concentrations o f laminin a similar phenomena is operative as 
was seen for fibronectin . Therefore, it is likely that laminin too, is signalling to the 
interior o f cells for activating the events leading to the final adhesion strength o f  cells. 
According to this speculation a small number o f laminin molecules might have 
initiated the signalling for intracellular development o f the full adhesion strength, via 
a signalling system. Thus the discussion about fibronectin may also be valid for 
laminin.
7.3 CONCLUSION 
The results imply that fibronectin and laminin participate in adhesion as 
activator molecules rather than only attachment factors. It is seen in the figures7.1 to 
7.3 that L929 and Hela B cells possess a specific critical shear value with regard o f  
uncoated plastic, fibronectin coated plastic and laminin coated plastic. Therefore, the 
major finding of this chapter is that the c.s.s. o f detachment is not only specific for 
specific cell line but also is specific for substrates.
A specific value in response to pre- adsorbed specific proteins can be 
implemented in a variety o f biomedical and biotechnological processes and thus may 
be a breakthrough in mammalian cell technology, where rather than guessing, a 
specific critical shear value can be used confidently before proceeding with any 
process. As revealed in the discussion, the feeling that adhesion strengthening
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FIGURE 7.3.
ADHESION STRENGTH OF L929 AND HELA B CELLS ON THE LAMININ PRE-ADSORBED 
PLASTIC SURFACE IN THE ABSENCE OF SERUM
The tissue culture grade plastic dishes (55cm^) were incubated with (0-175|ig/55cm^) Englebreth 
Holm-Swarm mouse sarcoma laminin. Laminin coating was proceeded as illustrated in materials and 
methods. L929 or Hela B cells were grown on laminin pre-adsorbed dishes for 24 hours. The adhesion 
strength of these cells in terms of the critical shear stress (cs.s.) of detachment was measured by using 
the Microflow chamber.
Each data point represents the mean of 20 different determinations. The error bars indicate the standard 
error of that mean. A t test indicates that the difference between the adhesion strength of both cell lines 
growing on uncoated or laminin coated dishes is highly significant (p=0.0001).
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phenomena is under the control of signalling mechanisms became more strong when 
only a.few molecules were found to be enhancers o f the maximum adhesion strength. 
However, as stated earlier, it must be emphasized that the aim o f this work was not to 
dissect the second messenger system, if indeed it exists. Intuition suggests that there is 
a way at least to implicate a second messenger. The approach taken was, to see if  cell 
adhesion and adhesion strengthening could be linked to protein synthesis. The 
detailed arguments will be given later (results and discussion o f the following 
chapter). In start, if  protein synthesis affects cell adhesion and its strengthening then 
they must be linked. This link must be a feedback mechanism whereby the level o f  
protein synthesis (of cell adhesion proteins) is tied to the adhesion state o f the cell. 
That is protein synthesis is up and down regulated as adhesion proteins are required or 
not.
The protein synthesis experiments are described in the next chapter.
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CHAPTER 8 
ROLE OF ENDOGENOUS PROTEIN(S) IN STRENGTHENING THE 
ADHESION OF L929 CELLS.
8.1 IN TRO D UCTIO N
In the previous chapters it has been proposed that the first phase is receptor 
driven which leads to the activation o f my proposed second phase via an unknown 
control system. While for the first phase, the serum used in the culture medium may 
provide most o f the adhesion proteins initially deposited on the substratum, the cells 
themselves are responsible for synthesizing extracellular adhesion protein(s). 
(Grinnell & Feld, 1980). The endogenously synthesized matrix components are 
secreted by the cells and incorporated into the developing matrix. This process might 
lead them into second phase. The cells that produce the extracellular matrix protein(s) 
also express surface receptors for these components to make adhesion bonds. Recent 
studies have shown that the continued adhesion of cells to the substratum is dependent 
on endogenously produced matrix molecules (Couchman et al, 1983). Therefore cell- 
extracellular matrix interactions change continuously in the expression o f the 
extracellular matrix protein(s) and their receptor(s).
Despite these findings, a direct relationship between expression o f cell 
adhesion proteins and cell adhesion has been difficult to establish due to the lack o f  
quantitative studies. That is to say, cells in the presence o f serum or purified adhesion 
protein(s) will attach and probably spread normally even in the absence o f  protein 
synthesis (Neumeir & Reutter, 1985), However, qualitative studies can not detect any 
difference between cell adhesion in the presence or absence o f protein synthesis. Once 
again, credit goes to the Microflow chamber, developed in this present work. That is, 
it is possible to distinguish between the contribution o f exogenous and endogenous 
protein(s) to cell adhesion.
For this purpose, by using Microflow chamber, the possible role o f on going 
protein synthesis which is controlled by a second messenger in cell adhesion
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strengthening can be established. To achieve these goals in the present chapter, 
metabolic inhibition was employed to evaluate the participation o f endogenous 
proteins in the cell adhesion process. Inhibition o f protein synthesis was accomplished 
by treating L929 cells with emetine and cycloheximide while the secretion o f  some 
adhesion protein (s) (fibronectin) was perturbed by employing the sodium ionophore, 
monensin (materials & methods). The results presented in the following pages suggest 
the beginning o f an enormous breakthrough in establishing the mechanism of  
strengthening adhesion by an adhesion protein activated second messenger system. 
The results and discussion o f these studies now follows.
8.2 RESULTS & DISCUSSION.
8.2.1. DETERMINATION OF EFFECTIVE DOSE OF EMETINE OR 
CYCLOHEXIMIDE FOR PROTEIN SYNTHESIS INHIBITION
To determine the concentration o f emetine and cycloheximide which 
effectively arrests the growth o f cells, a family o f curves has been obtained (figures
8.1 & 8.2). It was determined that although O.lpg/ml and 0.5|ig/m l o f cycloheximide 
and emetine substantially inhibits the growth o f L929 cells, it is lp.g/ml o f these drugs 
which almost completely stopped the growth o f the L929 cells (figures 8.1 & 8.2). 
When L929 cells were labelled with [^S]-m etionne, inhibition o f protein synthesis in 
response to emetine and cycloheximide was noted to be 97.5% and 95% respectively. 
Surprisingly it was found that even after 8 hours, 3% and 5% protein synthesis was 
still going on in response to 1 jig/ml of emetine and cycloheximide respectively 
(figures 8.3 & 8.4). Coupling o f growth experiments with this biosynthetic labelling 
study showed that lpg/m l o f these drugs is an appropriate concentration to work 
with. To look at the effects o f protein synthesis inhibition bythese drugs on the 
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FIGURE 8.1
EFFECT OF CYCLOHEXIMIDE ON THE GROWTH OF L929 CELLS..
Sub confluent L929 cells were tiypsinised and inoculated in the tissue culture flasks (25 cm2). The 
dose of cycloheximide which effectively inhibited growth of these cells was determined by adding 
different concentrations of this drug (indicated in the frame of figure) at the beginning of the 
experiments which lasted for 96 hours. Each data point represents 6 experiments in each of which cells 
were counted for 10 times. The error bars indicate the standard error of the mean. Where error bar does 
not appear, it is smaller than the symbol. Further details of the procedure may be found in the text
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EFFECT OF EMETINE ON THE GROWTH OF L929 CELLS.
Sub confluent L929 cells were trypsinised and inoculated in tissue culture flasks. The dose of emetine 
which effectively inhibits growth of these cells was determined by adding different concentrations of 
this drug(indicated in the frame of Figure) at the beginning of the experiment which lasted for 96 hours. 
Each data point represents 6 experiments in each of which cells were counted for 10 times. The error 
bars indicate the standard error of the mean. Where error bar does not appear, it is smaller than symbol. 
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FIGURE 8.3
PROTEIN SYNTHESIS IN L929 CELLS IN RESPONSE TO CYCLOHEXIMIDE.
Adherent cultured L929 cells were plated at a density of 5x10^ cells/cm^ in the presence or absence of 
cycloheximide (concentrations are indicated in the frame of this figure) and allowed to attach to the 24 
well plate for 2 hours. At this stage these cells were metabolically labelled with (35 $]-methionine. The 
incorporation was followed over a period of 8 hours. At time ranging from 0 to 8 hours, the cells were 
sequentially prepared for scintillation counting as illustrated in materials and methods. The results are 
presented in terms of cpm/hour/lx 10  ^cells.
Each data point represents 5 different experiments in each of which the effect of differe.i* 
concentrations of cycloheximide was examined in triplicate. The error bars indicate the standard errxx 
of the mean. Where error bars are not apparent, they are smaller than the symbols. Further details may 
be found in the text.
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PROTEIN SYNTHESIS IN L929 CELLS IN RESPONSE TO EMETINE.
Adherent cultured L929 cells were plated at a density of 5x10^ cell s/cm  ^  in the presence or absence of 
emetine (concentrations are indicated in the frame of this figure) and allowed to attach to the 24 well 
plate for two hours. At this stage these cells were metabolically labelled with [35§] methionine. The 
incorporation was followed over a period of 8 hours. At times ranging from 0 to 8 hours, the cells were 
sequentially prepared for scintillation counting as illustrated in materials and methods. The results are 
presented in terms of cpm/ hour/lxlO^ cells.
Each data point represents 5 different experiments in each of which the effect of different 
concentrations of emetine was examined in triplicate. The error bars indicate the standard error of the 
mean. Where error bars are not apparent, they are smaller than the symbol. Further details may be 
found in the text.
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8.2.2. EFFECT OF EMETINE, CYCLOHEXIMIDE OR MONENSIN ON THE 
ADHESION STRENGTH OF SUB-CONFLUENT L929 CELLS
In the initial experiments, ljig  o f emetine or cycloheximide per ml o f  medium 
were employed to inhibit protein synthesis in the L929 cells which had already been 
growing for 24 hours. This was carried out by replacing the old medium (containing 
serum or serum free) with or without drug and further incubating the cells with these 
drugs for 3 or 6 hours. After this time, the critical shear stress o f detachment was 
measured. There were no observable effect o f these drugs on the critical shear values, 
either in the presence or absence o f serum in the medium. That is the control 
(untreated) and the drug treated L929 cells showed the same detachment values for 
the adhesion strength (figure 8.5).
One explanation o f this finding is that the cells were carrying on traces o f  
protein synthesis (3-5%), even after substantial protein synthesis inhibition (figures 
8.3 & 8.4). This protein synthesis at lower level (3-5%) might not be sufficient for 
cell division as the number o f cells did not increase in presence o f ljxg/ml o f these 
drugs. However, even 3-5% protein synthesis was found to be supportive for the 
adhesiveness o f L929 cells. The synthesis of which protein (adhesive or others) was 
inhibited remains to be determined It might be the part o f the cells internally retained 
pool of adhesion proteins, is they secreted later, the end result being no change in 
adhesion strength. The insensitivity o f L929 cells after 3-6 hours o f drug treatment 
(figure 8.5) indicates that the binding sites o f the proteins involved in the adhesion 
process may have a long half life and therefore, were not affected by the relatively 
brief drug treatment.
Alternatively, before protein synthesis inhibition occurred, the adhesion 
proteins from the serum plus the cell secreted proteins might have sent a signal to the 
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FIGURE 8.5
ADHESION STRENGTH OF SUB CONFLUENT L929 CELLS TREATED WITH EMETINE (EM) 
OR CYCLOHEXIMIDE (CHX) OR MONENSIN (MN) OR EMETINE PLUS MONENSIN 
(EM+MN) FOR 3 OR 6 HOURS.
The old culture medium of sub confluent L929 cells was replaced with fresh medium containing 
lpg/ml of emetine or cycloheximide or monensin or emetine plus monensin. The treated (EM, CHX, 
MN, EM+MN) or untreated (Q  cells were further incubated for 3 or 6 hours. After this time adhesion 
strength was measured and the results are presented in terms of the critical shear stress (c.s.s.) of 
detachment A t test indicates insignificant difference(p=0.53) in the adhesion strength of treated or 
.untreated cells.
1 6 5
transduced by these adhesion proteins and are transmitted to inside the cell, then no 
matter whether protein synthesis is going on or not, the cells will strengthen their 
adhesion in the presence o f exogenously supplied (serum) adhesion proteins. This 
argument in no way detracts from the fact that cell adhesion is an active phenomenon. 
Some workers have reported observations that can be interpreted as supporting to the 
above notion. For example Grinnell & Feld (1979) found a small pool o f adhesion 
proteins inside the cells even after protein synthesis inhibition. Taken together these 
observations and findings o f this experiment (where cells were treated for 3-6 hours) 
it can be concluded that simply stopping protein synthesis at the time o f the adhesion 
experiments may not be sufficient. That is the small internal pool o f adhesion proteins 
retained by the cells most likely will serve as a source o f proteins needed in the rest o f  
the events involved in strengthening the cell adhesion.
To abolish this possibility, the next experiment was designed to examine the 
combined effects o f emetine and monensin on the adhesion strength o f L929 cells. 
The monensin was used because o f its reported effects on the secretion o f some 
adhesion protein(s) from the cells (Uchida et al. 1979). However even in these 
experiments, the critical shear values remained unaltered in both the presence or 
absence o f serum in the culture medium (figure 8.5). It is not out o f place to mention 
that the morphology o f the cells was not changed in either o f the experiments 
described above. One could argue that monensin should stop secretion o f adhesion 
protein(s) from this internal pool and thereby prevent participation of adhesion 
protein (s) in cell adhesion. This possibility could be ruled out on the basis that among 
the known adhesion proteins, it is only fibronectin, secretion, which is impeded. The 
fate o f other adhesion molecules in response to monensin has yet to be determined. In 
addition, this short term treatment with monensin might not be sufficient to 
completely block the secretion of fibronectin. In fact, contrary to other reports 
(Mollenhauer et al, 1990) the overall secretion was enhanced in the presence o f  
monensin used in the present study (figure 8.6). This enhanced secretion was not 
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FIGURE 8.6
MONENSIN ENHANCED SECRETION OF ACID INSOLUBLE MATERIAL 
FROM THE L929 CELLS.
L929 cells were metabolically labelled with (35$] methionine far overnight. The labelled medium was 
replaced with the fresh serum free media (with or without different concentrations of monensin) as 
described in materials and methods. The conditioned medium was collected at different time intervals 
(indicated on the x-axis of the figure) and proceeded for the scintillation counting as illustrated in 
chapter 2.
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^NICOTINAMIDE (NM) SECRETION FROM L929 CELLS IN THE PRESENCE OR 
ABSENCE OF MONENSIN (1 mg/ml).
L929 cells were metabolically labelled with M^-Nicotinamide for 48 hours. At this time the labelled 
medium was carefully replaced with fresh serum free media(with or without monensin) as described in 
materials and methods. The conditioned medium was collected at different time intervals (time is 
indicated in the above figure) and scintillation counting was performed. Values on the y-axis are 
expressed as the percentages of the total uptake of the radioactivity by the cells (lxlO6 cells). Further 
details may be found in the text
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did not take up trypan blue. Moreover, when these cells were labelled with 14C- 
nicotinamide and the leakage from both control and monensin treated cells was 
examined, (materials & methods) there was no observable difference in the case o f  
nicotinamide loss from either treated or untreated cells (figure 8.7). That is the 
monensin does not cause the cells to be leaky.
The enhanced secretion o f [^S]-labelled material was an unusual finding, since 
monensin is considered a useful inhibitor of protein secretion without directly 
affecting protein synthesis (Mollenhauer et al, 1990). The enhanced secretion was not 
analyzed further, but would be an interesting subject to follow up at a late date. 
Nevertheless, the short term treatment with these drugs was not sufficient to impair 
the strength o f L929 cell adhesion 
At this stage four questions were asked:
First, does monensin inhibit only fibronectin secretion while the other adhesion 
proteins were being secreted. Second, is fibronectin secretion only partially inhibited 
and third, once the final cell adhesion strength is acquired, is it possible to perturb it 
by simply depriving cells o f protein synthesis and secretion. Fourth, do endogeneous 
proteins play any role if serum is totally eliminated from the culture medium. The 
following experiments were designed to answer these questions. Thus the second, 
third and fourth questions were resolved by performing the following experiments.
8.2.3. EFFECT OF PROLONGED TREATMENT OF L929 CELLS WITH
EMETINE OR CYCLOHEXIMIDE OR MONENSIN ON THE ADHESION 
STRENGTH OF THESE CELLS 
This experiment was designed for prolonged treatment o f L929 cells with the 
drugs. The object was to eliminate the existing pool of adhesion proteins after protein 
synthesis inhibition (with emetine/cycloheximide) and completely block the 
fibronectin secretion (with monensin). At the time of drug treatment cells had been 
growing for 24 hours (materials and methods).
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ADHESION STRENGTH OF L929 CELLS ON GLASS OR PLASTIC SUBSTRATUM IN 
RESPONSE TO EMETINE (EM) OR CYCLOHEXIMIDE (CHX) OR MONENSIN (MN) OR 
EMTINE PLUS MONENSIN (EM+M).
L929 cells had been grown for 24 hours and the culture medium was replaced with new culture 
medium (serum or serum free ) containing drugs indicated on the x-axis of this figure. The untreated 
(C) or treated cells (EM, CHX,MN,EM+MN) were further incubated for 24 hours. At this stage their 
adhesion strength was measured in terms of the critical shear stress (c.s.s.) of detachment.
Each data point represents the mean of 10 different experiments, in each of which 20 measurements of 
the c.s.s. were made. The error bars indicate the standard error of that mean.
A t test indicates a significant difference (p=0.0001) in the adhesion strength of drug treated or 
untreated cells. The difference between adhesion strength of L929 cells treated with emetine or 
cycloheximide is significant (p=0.0027). However, the difference between adhesion strength of 
untreated or treated (with emetine or cycloheximide) is highly significant (p=0.0001).
Likewise there is no significant difference (p=0.21) in the adhesion strength of L929 cells treated with 
monensin alone or together with emetine, whereas compare to control the depression of adhesion 
strength in response to these drugs is highly significant (p=0.0001). Further details may be found in the 
text.
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When L929 cells which had been growing for 24 hours were treated with monensin 
(ljLtg/ml) alone the c.s.s. was inhibited 27% o f the control c.s.s. value o f  the L929 
cells. When the L929 cells were treated with monensin together with emetine 
(ljig/m l) the critical shear was inhibited 30% of the control shear values o f these cells 
(figure 8.8).As indicated in the figure 8.8 monensin alone significantly affected the 
adhesion strength o f L929 cells over this longer period. That is, it depressed 27% 
normal adhesion strength o f L929 cells. The effect o f monensin might be due to the 
impairment o f fibronectin secretion. It is possible that small residual pools o f 
endogenous fibronectin may have been dispatched from the cells before the monensin 
effectively inhibited secretion o f this molecule. This may be the reason that the 
adhesion strength was not as depressed as expected. This idea gains support from the 
findings o f  Curtis (1987) that very small pools o f endogenous fibronectin was the 
minimum requirement for cell adhesion and my results on catalytic quantities of 
fibronectin (chapter 7).
Although not equivalent to the monensin effect, some reduction in adhesion 
strength was noted in response to cycloheximide and emetine. As shown in the figure 
8.8, emetine and cycloheximide significantly (p=0.0001) reduced critical shear values 
of L929 cells. For example emetin (1 fig/ml) depressed 15% and 14% control shear 
values from plastic and glass substrata respectively. Cycloheximide being less potent 
than emetine only depressed the adhesion by 8% and 7% of the control shear values 
from plastic and glass substrata. This may be reflecting the different extent o f protein 
synthesis inhibition in response to these drugs (figure 8.3 & 8.4).
The minor depression in adhesion strength might represent the direct effect of  
long term protein synthesis inhibition by these drugs. These effects may include the 
synthesis of adhesion protein(s), receptor(s) and the inability o f the cells to complete 
generation of F-actin stress fibres. (Flinckinger & Culp, 1990). Further this minor 
reduction does support the idea that once cells acquire their final adhesion strength, 
protein synthesis in the presence o f serum, plays little role in the adhesion o f L929 
cells.. However, secretion of protein(s) from the cells continues even after protein
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synthesis inhibition (Grinnell & Feld, 1979). As stated earlier, this is because o f the 
long cellular half life of fibronectin and fibronectin receptors. For example Ryseck et 
al (1989) have recently described the isolation o f independent clones encoding for 
interacting components o f adhesion system, whose expression is rapidly increased by 
growth factors even in the presence o f cycloheximide. These clones are reported to be 
encoding for fibronectin, fibronectin receptor and a-actin. The messenger RNA 
corresponding to each o f these moieties showed a long half life and remained at high 
levels for at least 8 hours. This may be the reason that the effect o f these drugs 
(emetine/cycloheximide) on the adhesion strength was not as much as was expected.
It is clear that the above protein synthesis inhibition studies can not , in 
themselves, unravel the complexity o f cell adhesion strength, once the cells have 
attached and spread. Thus as revealed in the above findings once the cells acquire 
their final adhesion strength, although these drugs significantly (p=0.0001) depressed 
it was not as much as one might expect. Therefore, In the next series o f experiments 
the inhibitors were introduced before the cells had developed their adhesion 
structures.
8.2.4. EFFECT OF EMETINE OR CYCLOHEXIMIDE OR MONENSIN ON THE 
ADHESION STRENGTH OF L929 CELLS BEFORE THEY DEVELOP THEIR
ADHESION STRUCTURE 
In this experiment the effect o f protein synthesis was checked before the expected 
development o f adhesion structures. For this purpose the inoculation o f cells was 
accompanied by the addition o f drugs in the culture medium. The critical shear under 
these conditions showed interesting results. For example emetine or cycloheximide 
(1 Jig/ml) depressed the adhesion strength by 32% and 33% respectively on glass and 
33% and 31% respectively on plastic (figure 8.9).
When the L929 cells were treated with monensin (l|ig /m l) alone or together 
with emetine (l|ig /m l) at the time of inoculation, the critical shear stress was 
dramatically decreased. That is monensin alone depressed adhesion strength o f L929
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ADHESION STRENGTH OF L929 CELLS ON GLASS OR PLASTIC SUBSTRATUM IN 
RESPONSE TO EMETINE (EM) OR CYCLOHEXIMIDE (CHX) OR MONENSIN (MN) OR 
EMETINE PLUS MONENSIN (EM+MN).
L929 cells were inoculated in the culture medium (containing 10% serum) containing drugs (indicated 
on the x-axis of this figure) or without drugs. The treated (EM, CHX, MN, EM+MN) or untreated (C) 
cells were incubated for 24 hours and adhesion strength of these cells was measured in terms of the 
critical shear stress(c.s.s.) of detachment.
The error bars indicate the standard error of the mean of 10 different experiments, in each of which 20 
measurements of c.s.s. were made. The error bars represent the standard error of that mean.
A t test indicates that the difference in adhesion strength of L929 cells treated with emetine and 
cycloheximide is not significant (p=0.56), likewise the difference between adhesion strength of L929 
cells treated with monensin alone or together with emetine is not significant (p=0.06). However, 
compared to the untreated cells all drugs depressed adhesion strength highly significantly (p=0.0001).
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cells by 75% and 70% respectively on glass and plastic substrata, whereas when it 
was used with emetine it decreased adhesion strength o f these cells by 78% and 72% 
respectively on glass and plastic substrata (figure 8.9 ) It shows that the main effect 
was due to monensin. This overall and quite dramatic effect on the critical shear stress 
o f detachment was significant to p= 0.0001 (figure 8.9). These experiments were 
repeated with pre treatment o f the drug regimes (stated above) for 48 hours and no 
further decay in adhesion strength occurred compared to the 24 hours period. At each 
o f these periods the viability o f the cells was checked with trypan blue exclusion 
(materials & methods) and always showed better than 98.8% viability. These results 
indicate that L929 cells are largely dependent on endogenous fibronectin to achieve 
their final adhesion strength. This idea may be favoured by the fact that monensin is a 
specific inhibitor of fibronectin secretion and this may have caused a substantial 
reduction (70%-75% of the control value) o f the adhesion strength o f the L929 
cells.(figure 8.9)
Although the decrease in adhesion strength o f L929 cells in response to 
emetine or cycloheximide is significant (p=0.0001), these inhibitors unlike monensin, 
failed to exert a large effect on the adhesion strength o f these cells. Again the reason 
may be that a small pool o f fibronectin is retained by the cells which they secrete later 
and utilize for their adhesion (Grinnell & Feld, 1979, Curtis, 1987). Treated or 
untreated cells are shown in the pictures 8.1, 8.2 and 8.3.
As already mentioned externally introduced proteins in the cell culture system 
might send signals to the interior of cells for achieving their final adhesion strength. 
The results of these experiments showed that this signal may be stimulating protein 
synthesis and secretion. The final adhesion strength can only be achieved after the 
transmission o f signals to the interior of cells by both the exogenous and endogenous 
proteins. In fact a 70-75% reduction in adhesion strength in response to monensin is a 
strong hint for the importance o f endogenous protein(s) involvement in the adhesion 
strength of L929 cells. It may be that monensin blocked the secretion o f endogenous 
fibronectin and prevented it from becoming part o f the extracellular matrix. There are
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some published reports that at 10% serum it is vitronectin which mediates cell 
adhesion (Knox, 1984; Underwood & Bennet, 1989). Since in the present study 10% 
serum containing culture medium was used, the presented results imply that when 
vitronectin is available from the serum the adhesion strength o f L929 cells requires 
endogenous fibronectin. The secretion of the latter was inhibited by monensin which 
probably caused a severe depression of the adhesion strength (70%-75%) in this 
experiment (figure 8.9).
The results presented here indicate clearly that even in the presence o f serum, 
cells do not enter into the proposed second phase o f the adhesion strengthening when 
monensin is present. That is, no significant difference between the adhesion strength 
of cells growing in the medium containing serum (with monensin^ and o f those which 
were growing in serum free media (without monensin) was observed. One 
interpretation o f this is that externally added proteins may transmit signals to the cells 
to trigger the secretion o f fibronectin. The latter finally becomes part o f the 
extracellular matrix which in turn is responsible for the adhesion strength o f L929 
cells or in other words L929 cells depend on the endogenous fibronectin for their 
entrance into the proposed second phase of the cell adhesion.
Up to this point the adhesion proteins have all been assumed to have positive 
adhesion, that is, they increase cell-substrate binding. This may not be the case. Some 
proteins have been proposed to have anti-adhesive properties (Faissner & Kruse, 
1990). It is possible that these might show enhanced secretion in the presence of  
monensin, thus causing the low adhesion strength. Such proteins (tenascin) are very 
poorly understood and almost uncharacterized. (Faissner & Kruse, 1990). However 
the emetine plus monensin experiment probably rules this possibility out. As shown 
earlier, emetine is an extremely powerful inhibitor o f protein synthesis and so if  
monensin was enhancing the secretion o f antiadhesive proteins it could only be from a 
pool o f pre-existing molecules. Unless, again an unlikely proposition, the antiadhesive 
protein synthesis is not sensitive to emetine.
PICTURE 8.1






Emetine treated L929 cells
PICTURE 8.3
Monensin treated L929 cells
1 ? 3
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It is possible that in the presence of monensin L929 cells might have ceased 
to develop the stress fibres and adhesion plaques which were speculated to participate 
in the adhesion strengthening phenomena, (chapter 3).. Of course in these 
circumstances the cells would not be able to develop their final adhesion strength It 
remains to be determined how much fibronectin synthesis was inhibited by the 
monensin. Thus an acknowledged weakness in these proposals is whether or not the 
monensin was an effective inhibitor of fibronectin secretion. Published data confirms 
that it is effective but ideally, confirmation should have been sought that the 
inhibition was absolute. Unfortunately a fibronectin monoclonal (specific) antibody 
was not available for this study. Considering reports in the literature one can be 
reasonably certain that the bulk of the endogenous fibronectin did not participate in 
the adhesion strength of L929 cells in the presence o f monensin.
The release of endogenous fibronectin may not be obligatory for every cell 
type. For example, a murine cell strain NALIA (C4 clone) was shown to be dependent 
on a vitronectin coated substratum for its attachment. Moreover, it did not need 
endogenous protein synthesis for adhesion (Steele et al, 1991). However, this latter 
study was qualitative with respect to attachment and these researchers did not check 
whether protein synthesis is required or not for the development o f final adhesion 
strength in murine cells. However, at present it can not be generalised that fibronectin 
synthesis and secretion is necessary to achieve final adhesion strength o f each cell 
type. So far, the possible effect of monensin on the secretion o f fibronectin has been 
discussed in great detail. However it must be remembered that fibronectin as a ligand 
is only half o f the interaction. The other half is the fibronectin receptors. Many reports 
suggest that the total cell surface receptors are in large excess over the number that 
are actually used for adhesion (Brown & Juliano, 1987). Thus it seems extremely 
unlikely that the fibronectin receptors are effected by monensin.
It is revealed in the figure (8.3 & 8.4) that the response to these drugs needs 8 
hours or more for substantial protein synthesis inhibition. Moreover, these studies 
were carried out in the presence of serum in growth medium which is a source o f
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adhesion protein(s). It was thought that during these 8 hours secreted protein(s) 
together with adsorbed serum protein(s) might have established certain links with the 
cell machinery via integrin receptors, therefore, the total adhesion strength was not 
inhibited. To abolish this possibility the next series o f experiments was designed to 
rule out the role of serum. That is, until now, the discussion has been about 
experiments which were performed in the presence o f serum. From now on the 
experiments are carried out in the absence o f serum. These are discussed below.
8.2.5. ADHESION STRENGTH OF L929 CELLS IN RESPONSE TO EMETINE, 
CYCLOHEXIMIDE OR MONENSININ IN SERUM FREE MEDIA
To assess the strength of cell adhesion when solely determined by endogenous 
proteins, L929 cells were sub cultured in 1% Nutridoma (materials & methods) with 
or without drugs and incubated for 24 hours. After this time all the cells lost their 
adhesiveness and simply detached from the substratum, indicating that cell adhesion 
is an active phenomena which needs continuous on going protein synthesis in the 
absence o f serum.
As mentioned above and indicated in table 8.1, treatment o f cells with 
emetine or cycloheximide or monensin completely abolished the adhesiveness o f  
L929 cells to both glass and plastic. The cells initially attached in the presence o f  
drugs in serum free medium and retained their anchorage for 8 hours and thereon 
gradually lost their adhesiveness. The viability o f cells was checked with trypan blue 
exclusion method and it was found that they did not uptake trypan blue, therefore, 
their viability was considered intact (98%). The findings o f this experiment indicate 
that cell adhesion is not a passive process as was suggested by others (Neumeier & 
Reutter, 1985) because for continued cell adhesion, on going protein synthesis was 
required.
The question arises that if after protein synthesis inhibition, a small 
intracellular pool of adhesion proteins exist (as suggested earlier in this chapter), why 
did it not take part in the adhesion of L929 cells. The possible answer is that cells
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Drug treatment Glass Plastic
C.S.S(N/m2) C.S.S(N/m2)




Monensin + Emetine 0 0
T A B L E  8.1
L929 cells were grown in serum free medium with or without drugs (mentioned in the 
table. Results show that in drug containing cultures cells lost their adhesiveness but in 
the absence o f drugs cells showed measurable adhesion on both glass and plastic 
substratum.
1 7 8
might have secreted protein(s) which caused adhesion but in the absence o f added 
serum proteins there may be very weak or no stimulation o f secretion o f adhesion 
proteins. Since there was no serum and new protein synthesis was inhibited, the 
adhesion structures were more prone to proteolysis. For example Werb et al (1989) 
revealed that preventing the actual ligand binding with receptors could induce the 
expression o f proteolytic enzymes. Similar expression o f proteolytic enzymes may be 
involved to disrupt the adhesion structures of drug treated cells in serum free media.
Where drug treated cells in serum free media lost their adhesiveness, the 
untreated cells in serum free media showed some interaction strength to the plastic 
(9.1 ±4Nm"2) and glass (13.0 ±3.5 Nm'^ table 8.1). Again comparatively large 
standard deviation specific to serum free media indicated the heterogenity among the 
sub populations o f L929 cells. The efficiency o f the Microflow chamber that made a 
valuable distinction between such sub populations Moreover it is the Microflow 
chamber with the help o f which cell adhesion has proved to be an active process 
rather than passive one because protein synthesis is required to strengthen the cell
adhesion. Thus it will be inappropriate to equate this phenomena to the wetting o f a
surface by a fluid droplet ( Forrester & Lackie, 1984).
Finally the findings of this chapter can be summarized as follow
(a) The L929 cells growing for 24 hours are not responsive to 3 or 6 hour drug 
treatment
(b) A minor but statistically significant effect in terms o f the c.s.s. o f detachment was 
noted when L929 cells have been grown for 24 hours. Here monensin considerably 
depressed the c.s.s. o f detachment of L929 cells by 30% of the control value.
(c) A considerable reduction (40% of the control value) in adhesion strength occurred 
when emetine or cycloheximide were added at the time of inoculation o f the cells. In
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contrast to these drugs, monensin alone or together with emetine substantially 
depressed the adhesion strength o f L929 cells by 70%-78% of the control value.
(d) When the drugs were added at the time o f seeding o f cells in serum free medium, 
it was o f interest to note that cells automatically started to detach from the surface and 
after 24 hours their adhesiveness was completely abolished.
8.3 CONCLUSION
In conclusion, serum proteins cause an initial attachment and then perhaps send 
signals to the interior o f cells to enhance protein synthesis and secretion. These 
endogenous protein(s) in turn attach to the receptors and this attachment facilitates the 
orgnisation of cytoskeleton and adhesion plaque formation. This conclusion is drawn 
because when fibronectin secretion was inhibited with monensin in presence o f serum 
the adhesion strength o f L929 cells was substantially depressed(70% to 78%). In 
serum free media the inhibition of protein synthesis abolishes the adhesiveness o f  
L929 cells completely indicating that their adhesion is an active process.
Further work is needed to transform these conclusions from educated speculations to 
a solid factual basis.
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CHAPTER 9 
GENERAL D ISCUSSIO N  & CO N CLU SIO N
The research presented here had as its objectives "the development o f  a simple 
and reproducible cell adhesion measurement device and its applications to understand 
the underlying mechanism of cell adhesion and cell adhesion strengthening 
phenomena. This was necessitated due to the following reasons.
In previous experimental protocols cells are permitted to interact with the culture 
vessel and adhesion is measured by quantifying the number o f cells that bind to the 
surface in a given time period. Clearly, any attempt to maximize the use o f cell 
adhesion in various fields (from biotechnology to clinical research) demands an 
understanding o f the principles and mechanisms involved in the attachment and 
stabilization o f cell adhesion. While the previous techniques, being qualitative 
methods, can assess the former with a varying degree o f success, the latter remained 
totally unresolved. Some methodologies for qualitative assessment o f cell adhesion 
have been developed which were either unable to measure the stabilized adhesion 
(final adhesion strength) or they have run into several other obstacles (indicated in 
chapter 1 & 3). That is all these techniques suffered from the need for complex 
equipment, whereas the technique should not only be simple but also should yield 
reproducible and usable data for assessment o f quantitative cell adhesion. These 
requirements are largely met in the present study with the development o f a cell 
adhesion measuring device or "Microflow chamber".
The Microflow chamber not only measures the final strengthened adhesion but 
also is a simple and reproducible technique. At present two designs o f Microflow  
chamber exist. The first design was limited in its capacity to measure the critical shear 
stress (c.s.s.) o f detachment o f cells from glass microscope slides. The second o f my 
designs could measure the c.s.s. of detachment from glass and plastic petri dishes. 
Both designs are simple and easy to handle. One o f the main advantages o f  this 
system lies in the fact that the physical conditions o f the detachment assay are 
completely defined. Contrary to the previous techniques, the convergent channel of
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the Microflow chamber increases the velocity which gives an increasingly smooth or 
laminar flow (chapter3). Thus the formula developed to calculate the c.s.s. o f  
detachment remains valid even at a very high flow rate. In fact under precise 
hydrodynamic control a range o f well defined shear forces over the cells could be set 
up. This feature of the Microflow chamber is predominantly different from previous 
techniques.
Having developed this device, its accuracy and reproducibility was checked by 
measuring adhesion strength o f different cell lines on the same or on a series o f  
different surfaces, ranging from glass to fibronectin modified plastic. The results 
obtained were rather a mirror image o f the theoretical predictions about well defined 
forces in the convergent channel o f the Microflow chamber. This is obvious in the 
context o f the very small obtained standard deviation in each experiment carried out 
in the present study. The sophistications of this device can be seen by its sensitivity 
for recognising two systems which are only slightly different with respect o f their 
environment. Using existing techniques there may appear to be no difference between 
two systems, but the Microflow chamber can detect it by providing results with a 
statistical significance of p=0.0001 (chapter 5).
Thus the device not only can be used to compare cell adhesion to a series o f  
surfaces in a quantitative way, it is a useful tool for understanding the cell adhesion 
strengthening phenomena. For example, the adhesion strength (in term o f c.s.s.) o f  
different cell lines on different surfaces show unambiguously that cells are held to a 
surface with a certain fixed strength. Once this is exceeded by an applied force, the 
cells will be removed from the surface. This force is termed the critical shear stress o f  
detachment. The results obtained in the present study with regard to different cells 
and surfaces also indicates that a critical shear stress o f detachment is a general 
phenomena occurring with all cells and all surfaces. This generalisation gets support 
from the findings that every cell line showed its specific and constant critical shear 
value with respect to the surface on which it is growing.
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The most encouraging finding with the Microflow chamber was its high 
reproducibility as was shown by measuring the c.s.s. o f detachment o f many cell lines 
over a number o f passages. However, some cell lines showed ageing with respect o f  
c.s.s. o f detachment. Even these cells , whenever taken from liquid nitrogen always 
show a constant and specific critical shear value indicating the high reproducibility 
and sophistication o f the Microflow chamber. It is o f great interest that animal cells 
actually possess such a specific adhesion value. It also strongly implies that different 
cell lines have different adhesion mechanisms, since they show such differing 
adhesion constants. Thus the major finding in this work is that, for particular 
established cells,the adhesion strength is a constant especially if  that value is 
measured soon after establishment o f the culture from liquid nitrogen. It is to be 
hoped that primary cell lines will show a similar constant for each specific line. 
Indeed it is to be expected that the adhesion strength in such cells is to be closely 
related to the organs or the tissues from which they arose. That is, there may be a 
relationship between adhesion and differentiation.
It is not only that a device should be able to measure cell adhesion 
quantitatively but it must also be able to evaluate the physical, biological and 
environmental factors involved in cell adhesion strengthening phenomena. This 
system should be amenable to investigation o f the parameters causing the effects on 
cell adhesion. It is very pleasing that this Microflow chamber can evaluate the role o f  
different parameters contributing in a complex cell adhesion phenomenon.
The complexity o f the cell adhesion is due to numerous parameters acting 
directly or indirectly in gaining the final adhesion strength o f a cell. The factors 
examined with the help o f the Microflow chamber include the cells themselves, 
different substrates, serum, purified adhesion proteins and finally the endogenous 
adhesion proteins. Before examining these parameters there was a question in mind 
that asked "what is the mechanism involved in the specific adhesion strength of a 
particular cell line in a similar environment".
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The spreading of the cells was considered as a suspected factor for specific 
adhesion strength. That is the bigger the cell the more force may be required to detach 
it from the surface. In fact it was found that adhesion strength is not solely determined 
by the spread area of the cell. This finding was contrary to some theoretical studies 
which emphasized that adhesion strength is dependent on the surface area o f  the cell. 
Although in the present work the surface area o f cells was not measured quantitatively 
the qualitative observations under an inverted microscope suggest that big cells can 
have a lower adhesion strength than a smaller cells (chapter 4 & 5). Moreover, 
changing one parameter (e.g. serum) and keeping others constant may not have any 
impact on cell spreading but it may have a profound effect on the adhesion strength o f  
cells (chapter 5).
Indeed this finding led me to propose the two phases o f cell adhesion which 
until now has been considered to simply be a single step mechanism involving an 
attachment which leads continuously to spreading. The present study proposes that 
attachment and spreading are different aspects of. or different steps within cell 
adhesion but still this is not a complete description o f this intricate phenomena. In fact 
attachment plus or minus spreading is the first phase o f cell adhesion which activates 
the events leading to the specific, final, strengthened adhesion (second phase). The 
present work was not aimed at the elucidation o f how these events are activated, 
however, evaluation of different parameters with the help o f my Microflow chamber 
strongly pleads the case for protein-receptor bond involvement in this phenomena.
These bonds may be participating directly or they may be activating some 
unknown molecule(s) in the interior o f the cell (this is not the direct subject o f the 
present study). If these bonds are involved, whatever the mechanism, it is conceivable 
that by preventing these bonds from forming causes the adhesion strength o f cells to 
be depressed. Indeed this was proved to some extent when the synthetic peptide 
RGDS, a recognition sequence, mimicked the adhesion strength o f cells at least 
partially (chapter 6). It was again very pleasing that the Microflow chamber can 
assess and quantify the reactions which occur at the receptor level. That is, upon
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addition o f RGDS to the culture medium a measurable and significant (p=0.0001) 
depression o f  adhesion strength was observed (chapter 6). This effect was attributed 
to the protein-receptor bond involvement because it is now well known that cells 
interact with the RGDS cell attachment sites o f  the various adhesion proteins through 
cell surface receptors. Since adhesion strength was not fully depressed, this finding 
suggests a versatile mechanism which cells can use for their specific adhesion 
strength. This notion is made because the incomplete reduction o f adhesion strength 
was attributed to RGDS independent sequences within the fibronectin molecule or in 
other proteins. Nevertheless, the refinements o f the Microflow chamber were obvious, 
since it was able to recognise the dose dependent impact o f RGDS on cell adhesion 
strength.
These findings also show that RGDS is not indeed all that is required for the 
receptor binding. Further studies are needed to show the exact quantitative 
participation o f RGDS dependent and independent sequences in the cell adhesion 
strengthening phenomenon. However, determining the exact quantitative share o f  
each sequence may be interesting but is outside the scope o f this thesis, since the aim 
in this experiment was only to check whether protein-receptor bonds are involved in 
adhesion strengthening or not. Of course, the major aim was to check that the 
Microflow chamber could analyse and show a distinction between two systems i.e. 
normal culture medium and RGDS containing culture medium. The next thought was 
to see if  these bonds are involved in the adhesion strengthening phenomenon. Thus it 
was worthwhile to check the effects o f a specific protein on the adhesion 
strengthening phenomena.
Two approaches were made to examine the effect o f fibronectin, a prototype 
adhesion protein, on cell adhesion strength. That is the role o f exogenous and 
endogenous fibronectin in adhesion strengthening phenomena was evaluated.
In the first attempt surfaces were modified with fibronectin and cells were 
grown in the serum free medium. Interestingly the adhesion strength was again found 
to be substrate dependent, that is cells adhere with varying strength to different
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surfaces. For example L929 cells showed comparatively low adhesion strength on 
glass than on plastic and the highest adhesion strength on fibronectin modified 
surfaces. These findings support an earlier proposal made in this discussion that 
critical shear stress may be a general phenomenon occurring with all cells and 
surfaces.
As was mentioned earlier (chapter 7), a very exciting and another major finding in 
this work was that fibronectin coating on plastic substrates dramatically enhanced the 
adhesion strength of L929 cells. To date fibronectin has been proposed as a major 
adhesion molecule. In the previous works, the assumption has been made that it is a 
mediator between the surface o f the cell and the surface o f the substratum. Another 
way to evaluate the role o f fibronectin is that, within certain limits the more 
fibronectin there is adsorbed to the surface the stronger the adhesion strength will be. 
This is true especially, if one believes that adhesion strength is dependent on the 
number of adhesion bonds (theoretical studies cited in chapter 1).
With the successful development of the Microflow chamber this is now a 
testable hypothesis. Does cell adhesiveness follow a straightforward dose dependency 
with respect to fibronectin?. Thus it can now be checked whether or not the adhesion 
strength is directly related to the number of fibronectin molecules on the surface. As 
can seen from the chapter 7, fibronectin in small amounts has a quite unexpectedly 
dramatic effect on the adhesion strength o f L929 cells. It certainly does not appear 
that fibronectin is a passive mediator. Since only 2000 molecules per cell (pre­
adsorbed to the surface) increase adhesion strength by 9 fold. Of course the number o f  
molecules per cell is a calculated value and open to some criticism. However, as 
mentioned in the results (chapter 7) there were a maximum of 2000 molecules o f  
fibronectin/lOjim^ of substrates, causing an adhesion strength (82.5 Nm"^) 9 fold 
more than the normal value.
The strength was not increased if greater than 2000 molecules/cell were used. 
Though entirely unexpected, this finding caused the question o f how such a very 
small number of molecules could have such a profound effect on the adhesion
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strength. Although this work was not designedl to answer this question, the findings do 
open the real possibility that the fibronectin is  a signalling system or at least a part o f  
a signal. How these signals transmitted or controlled is unknown but some discussion 
o f this can be found in chapters 4 & 7.
The immediate intriguing question was what is the end product o f this 
suspected signalling mechanism. Among other suspected molecules were endogenous 
proteins. This choice was indeed fitting in the framework o f this thesis. To this end 
again with the courtesy of the Microflow chamber, the effect o f the synthesis and 
release o f the endogenous adhesion proteins on adhesion strength was examined, 
(chapter 8).
The previous studies in the literature though qualitative were focused on the 
effect o f protein synthesis on cell adhesion. To date no attempt has been made to 
check the effect o f secretion on cell adhesion. The results presented in chapter 8 
suggest that protein synthesis inhibition at the time o f the experiment may not be 
sufficient since already synthesized proteins may be secreted and utilized for cell 
adhesion. Therefore, the inhibition o f secretion was desirable. The overall inhibition 
of the secretory mechanism may not be helpful since one condition o f the adhesion 
assay is to keep cells as healthy as possible. Therefore, a specific agent which could 
block the secretion of some adhesion proteins was required. Since fibroblasts are 
reported to secrete fibronectin but not vitronectin (Preissner, 1991), it was logical to 
inhibit the secretion o f fibronectin. It followed that monensin was such a chemical 
which was reported to inhibit secretion of fibronectin.
Thus with the disruption o f fibronectin secretion, 75% of the normal adhesion 
strength of L929 cells was lost (or L929 cells showed only 25% of the normal 
adhesion strength). These results indicate that to attain the final adhesion strength 
these cells are dependent on fibronectin secretion. It also therefore, implied that 
protein-receptor bonds may still be relevant for the induction o f the adhesion because 
the recruitment o f the fibronectin receptor may be driven by the release o f fibronectin 
whose secretion was blocked by exposing cells to the monensin. Of course this
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conclusion is based on the numerous reportts published that monensin specifically 
impedes secretion o f fibronectin. What is the fate is o f the other adhesion molecules 
in monensin treated cells has yet to be determined.
These findings were also supportive for the idea o f the proposed two phases of 
cell adhesion. That is although monensin treatment does not exert any effect on 
spreading, it dramatically depressed the adhesion strength. This leads to speculations 
that cells can interact with any adhesion protein present in the serum, but this 
interaction might only establish low adhesion strength bonds (first phase) that cannot 
account for final adhesion strength. The release o f fibronectin may recruit fibronectin 
receptors which are responsible for final adhesion strength (second phase). However, 
to date, the participation o f other adhesion molecules in the complex phenomenon o f  
adhesion strength cannot be excluded.
Although the work presented here is preliminary, it suggests that if  a second 
messenger system is operative it must be linked with protein synthesis and secretion. 
Indeed these results suggest the beginning o f an enormous breakthrough in 
establishing adhesion by this adhesion protein activated second messenger system.
To elucidate this system is be the task of the future, since the Microflow chamber is 
available. The data obtained in this thesis will help to find out about and to discover 
the second messenger molecule in cell adhesion.
In conclusion, the successful development of the Microflow chamber opened a 
enormous vista o f possible work in cell adhesion which will help us to understand the 
underlying mechanism o f cell adhesion.
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